Search Within

LEUKEMIA
Results 1 - 791 of 791
New Strategies in the Chemotherapy of Leukemia: Eradicating Cancer Stem Cells in Chronic Myeloid Leukemia

Journal: Current Cancer Drug Targets
Volume: 12,Issue: 5
Page: 571-596
Authors: A. Stefanachi, F. Leonetti, O. Nicolotti, M. Catto, L. Pisani, S. Cellamare, C. Altomare and A. Carotti

In Vivo Models of Childhood Leukemia for Preclinical Drug Testing

Journal: Current Drug Targets
Volume: 8,Issue: 6
Page: 773-783
Authors: Petra S. Bachmann and Richard B. Lock

Leukemia Stem Cells and New Strategies to Overcome Resistance to Therapy

Journal: Current Stem Cell Research & Therapy
Volume: 5,Issue: 3
Page: 277-286
Authors: Xavier Thomas and Giovanna Cannas

Disseminated Intravascular Coagulation in Leukemia and Sepsis

Journal: Vascular Disease Prevention
Volume: 3,Issue: 1
Page: 1-10
Authors: Hideo Wada, Akane Sakaguchi, Yasunori Abe and Toshihiko Kobayashi

Novel Drugs for Chronic Lymphoid Leukemias: Mechanism of Action and Therapeutic Activity

Journal: Current Medicinal Chemistry
Volume: 16,Issue: 18
Page: 2212-2234
Authors: Tadeusz Robak

Adoptive Immunotherapy For Leukemia With Ex vivo Expanded T Cells

Journal: Current Drug Targets
Volume: 18,Issue: 3
Page: 271-280
Authors: Conrad R.Y. Cruz and Catherine M. Bollard

Novel and Emerging Drugs for Acute Myeloid Leukemia

Journal: Current Cancer Drug Targets
Volume: 12,Issue: 5
Page: 522-530
Authors: E. M. Stein and M. S. Tallman

New Purine Nucleoside Analogs for Acute Lymphoblastic Leukemia

Journal: Clinical Cancer Drugs
Volume: 1,Issue: 1
Page: 2-10
Authors: Tadeusz Robak

Current Status of Leukemia Cytotherapy - Exploitation with Immune Cells

Journal: Current Stem Cell Research & Therapy
Volume: 12,Issue: 3
Page: 188-196
Authors: Haiyan Bao and Depei Wu

FLT3 as a Therapeutic Target in Childhood Acute Leukemia

Journal: Current Drug Targets
Volume: 8,Issue: 6
Page: 703-714
Authors: Matthew C. Stubbs and Scott A. Armstrong

Antibody Therapy of Acute and Chronic Leukemias

Journal: Current Pharmaceutical Biotechnology
Volume: 2,Issue: 4
Page: 357-367
Authors: Spero R. Cataland, Margaret Lucas and John C. Byrd

Large Granular Lymphocyte (LGL) Leukemia: Pathobiology, Diagnosis and Treatment

Journal: Current Cancer Therapy Reviews
Volume: 3,Issue: 2
Page: 141-150
Authors: Edna Ku, Todd Alekshun, Thomas P. Loughran, Lubomir Sokol and Pearlie K. Epling-Burnette

The Use of Hematopoietic Growth Factors in the Treatment of Acute Leukemia

Journal: Current Pharmaceutical Design
Volume: 8,Issue: 5
Page: 343-355
Authors: Kenneth F. Bradstock

Invasive Pulmonary Aspergillosis in Acute Leukemia: Current Issues for Pathogenesis, Diagnosis and Treatment

Journal: Current Respiratory Medicine Reviews
Volume: 2,Issue: 1
Page: 3-13
Authors: Ridvan Ali and Tulay Ozcelik

AIDS Related Viruses, their Association with Leukemia, and Raf Signaling

Journal: Current HIV Research
Volume: 3,Issue: 4
Page: 319-327
Authors: Audy G. Whitman, Benjaman A. Bryan, Ossie F. Dyson, Dipali K. Patel, Dan Ramasamy, Senthilvelan Anantharaman, Adrian J. Reber and Shaw M. Akula

Bone Marrow Reconstitution as a Relevant Model of Genetically Programmed Leukemia

Journal: Current Medicinal Chemistry-Cardiovascular & Hematological Agents
Volume: 1,Issue: 2
Page: 83-97
Authors: A. Dolnikov, S. Shen, T. Passioura and G. Symonds

Inhibition of Raf Kinase in the Treatment of Acute Myeloid Leukemia

Journal: Current Pharmaceutical Design
Volume: 8,Issue: 25
Page: 2243-2248
Authors: Michael Crump

The Impact of Molecularly Targeted Therapies Upon the Understanding of Leukemogenesis and the Role of Hematopoietic Stem Cell Transplantation in Acute Promyelocytic Leukemia

Journal: Current Stem Cell Research & Therapy
Volume: 5,Issue: 4
Page: 372-378
Authors: Sumimasa Nagai, Tsuyoshi Takahashi and Mineo Kurokawa

Exploitation of Apoptosis Pathways for Childhood Leukemia

Journal: Current Pediatric Reviews
Volume: 7,Issue: 4
Page: 266-270
Authors: Simone Fulda

Advances in Immunotherapy of Chronic Myeloid Leukemia CML

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 7
Page: 768-774
Authors: Stefanie Andrea Erika Held, Annkristin Heine, Karin Tina Mayer, Mario Kapelle, Dominik Georg Friedrich Wolf and Peter Brossart

Advances in Nanomaterials for Diagnosis and Therapy of Leukemia

Journal: Recent Patents on Nanomedicine
Volume: 3,Issue: 2
Page: 99-104
Authors: Swati S. Vyas and Vandana B. Patravale

Immunomodulatory Drugs: Immune Checkpoint Agents in Acute Leukemia

Journal: Current Drug Targets
Volume: 18,Issue: 3
Page: 315-331
Authors: Hanna A. Knaus, Christopher G. Kanakry, Leo Luznik and Ivana Gojo

Recurrent Fusion Genes in Leukemia: An Attractive Target for Diagnosis and Treatment

Journal: Current Genomics
Volume: 18,Issue: 5
Page: 378-384
Authors: Yuhui Wang, Nan Wu, Duo Liu and Yan Jin

Targeted Elimination of Leukemia Stem Cells; a New Therapeutic Approach in Hemato-Oncology

Journal: Current Drug Targets
Volume: 11,Issue: 1
Page: 95-110
Authors: B. ten Cate, M. de Bruyn, Y. Wei, E. Bremer, W. Helfrich, Marwa El Mourabet, Sandra El-Hachem, Janet R. Harrison and David G. Binion

Antibody-directed Double Suicide Gene Therapy Targeting of MUC1- Positive Leukemia Cells In Vitro and In Vivo

Journal: Current Gene Therapy
Volume: 13,Issue: 5
Page: 346-357
Authors: Xiao-Ya Dong, Wen-Qian Wang, Yu Zhao, Xu-Dong Li, Zhi-Gang Fang, Dong-Jun Lin, Ruo-Zhi Xiao, Ren-Wei Huang, Guang-Jin Pan and Jia-Jun Liu

STIP Regulates ERK1/2 Signaling Pathway Involved in Interaction with PP1γ in Lymphoblastic Leukemia

Journal: Current Molecular Medicine
Volume: 16,Issue: 8
Page: 767-775
Authors: S. Sun, Y. Wang, H. Chen, L. Fang, Y. Cui, X. Han, D. Wu, H. Li, M. Ye, X. Zhao and J. Liu

The Cytoskeleton as a Therapeutic Target in Childhood Acute Leukemia:Obstacles and Opportunities

Journal: Current Drug Targets
Volume: 8,Issue: 6
Page: 739-749
Authors: Tracy Y. E. Liaw, Melissa H. Y. Chang and Maria Kavallaris

Novel Therapeutic Agents Against Cancer Stem Cells of Chronic Myeloid Leukemia

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10,Issue: 2
Page: 111-115
Authors: Yaoyu Chen, Cong Peng, Con Sullivan, Dongguang Li and Shaoguang Li

Hypomethylating Agents in the Treatment of Myelodysplastic Syndromes and Myeloid Leukemia

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 7
Page: 837-848
Authors: Anna Szmigielska-Kaplon and Tadeusz Robak

Imatinib Mesylate in Chronic Myeloid Leukemia

Journal: Current Stem Cell Research & Therapy
Volume: 2,Issue: 3
Page: 249-251
Authors: Angelo Michele Carella and Enrica Lerma

Targeting Transcription Factors in Acute Leukemia in Children

Journal: Current Drug Targets
Volume: 8,Issue: 6
Page: 727-737
Authors: Jason N. Berman and A. Thomas Look

MicroRNAs in Leukemias: Emerging Diagnostic Tools and Therapeutic Targets

Journal: Current Drug Targets
Volume: 11,Issue: 7
Page: 801-811
Authors: Yousaf A. Mian and Nancy J. Zeleznik-Le

Chronic Eosinophilic Leukemia, Not Otherwise Specified (CEL, NOS)

Journal: Current Cancer Therapy Reviews
Volume: 8,Issue: 1
Page: 30-34
Authors: Cherie H. Dunphy

Stem Cell Transplantation in Pediatric Leukemia and Myelodysplasia: State of the Art and Current Challenges

Journal: Current Stem Cell Research & Therapy
Volume: 2,Issue: 1
Page: 53-63
Authors: Marc Bierings, James B. Nachman, C. Michel Zwaan and James B. Nachman

Hematopoietic Stem Cell Transplantation from Alternative Donors for High-Risk Acute Leukemia: The Haploidentical Option

Journal: Current Stem Cell Research & Therapy
Volume: 2,Issue: 1
Page: 105-112
Authors: Franco Aversa, Antonio Tabilio, Andrea Velardi, Adelmo Terenzi, Franca Falzetti, Alessandra Carotti, Teresa Aloisi, Maria Liga, Mauro Di Ianni, Tiziana Zei, Antonella Santucci and Massimo F. Martelli

Targeting FLT3 Kinase in Acute Myelogenous Leukemia: Progress, Perils, and Prospects

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 4,Issue: 3
Page: 255-271
Authors: Michael C. Heinrich

Immunological Aspects of Adult T-Cell Leukemia/Lymphoma (ATLL), a Possible Neoplasm of Regulatory T-Cells

Journal: Current Immunology Reviews
Volume: 4,Issue: 4
Page: 242-250
Authors: Yasuaki Yamada and Shimeru Kamihira

Chromosomal Translocations as Biomarkers in Leukemia Diagnosis and Pharmacogenomics

Journal: Recent Patents on Biomarkers
Volume: 1,Issue: 3
Page: 241-258
Authors: Therakathinal T. Sreelekha and Vandana Viswanathan

Differences in Vanadocene Dichloride and Cisplatin Effect on MOLT-4 Leukemia and Human Peripheral Blood Mononuclear Cells

Journal: Medicinal Chemistry
Volume: 8,Issue: 4
Page: 615-621
Authors: Radim Havelek, Pavel Siman, Jana Cmielova, Alena Stoklasova, Jirina Vavrova, Jaromir Vinklarek, Jiri Knizek and Martina Rezacova

Use of Single Nucleotide Polymorphism Array Technology to Improve the Identification of Chromosomal Lesions in Leukemia

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 7
Page: 791-810
Authors: Ilaria Iacobucci, Annalisa Lonetti, Cristina Papayannidis and Giovanni Martinelli

Oncogenic MicroRNAs in the Genesis of Leukemia and Lymphoma

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 33
Page: 5260-5267
Authors: Yanyan Pan, Mei Meng, Gaochuan Zhang, Hongyan Han and Quansheng Zhou

Diterpenoids- Potential Chemopreventive and Chemotherapeutic Agents in Leukemia

Journal: Current Pharmaceutical Biotechnology
Volume: 15,Issue: 2
Page: 127-142
Authors: Swadesh Sarkar, Priya K. Gopal and Santanu Paul

Antibody Based Therapies in Acute Leukemia

Journal: Current Drug Targets
Volume: 18,Issue: 3
Page: 257-270
Authors: Nirali N. Shah

Epidemiology and Management of Infectious Complications in Contemporary Management of Chronic Leukemias

Journal: Infectious Disorders - Drug Targets
Volume: 11,Issue: 1
Page: 3-10
Authors: Jo-Anne H. Young

MicroRNAs as Main Players in the Pathogenesis of Chronic Lymphocytic Leukemia

Journal: MicroRNA
Volume: 2,Issue: 3
Page: 158-164
Authors: Arianna Bottoni and George A. Calin

Deregulation of Apoptosis - Is it Still an Important Issue in Pathogenesis of Chronic Lymphocytic Leukemia?

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 8
Page: 652-658
Authors: Monika Podhorecka, Arkadiusz Macheta, Maria Bozko, Andrzej Bozko, Nisar P. Malek and Przemyslaw Bozko


Targeting Ion Channels in Leukemias: A New Challenge for Treatment

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 5
Page: 683-696
Authors: A. Arcangeli, S. Pillozzi and A. Becchetti

Purine Nucleoside Analogs in the Treatment of Rarer Chronic Lymphoid Leukemias

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 23
Page: 3373-3388
Authors: Tadeusz Robak and Pawel Robak

Tumor-selective Cytotoxicity of a Novel Pentadiene Analogue on Human Leukemia/lymphoma Cells

Journal: Clinical Cancer Drugs
Volume: 3,Issue: 2
Page: 138-146
Authors: Yahaira Santiago-Vázquez, Umashankar Das, Armando Varela-Ramirez, Sarah T. Baca, Yoshira Ayala-Marin, Carolina Lema, Swagatika Das, Alaa Baryyan, Jonathan R. Dimmock and Renato J. Aguilera

L-Tetrahydropalmatine Induces Apoptosis in EU-4 Leukemia Cells by Down-Regulating X-Linked Inhibitor of Apoptosis Protein and Increases the Sensitivity Towards Doxorubicin

Journal: Current Molecular Medicine
Volume: 17,Issue: 3
Page: 236-245
Authors: S. Li, D. Chen, R. Pei , Y. Lu, P. Zhang, J. Ma, X. Liu, X. Du, K. Sha, L. Chen, J. Cao, X. Zhuang, J. Wu, L. Lin, Z. Fan, P. Ye, S. Tang, B. Zhang, X. Shi and K. Li

Antiproliferative and Proapoptotic Effects of Proteasome Inhibitors and their Combination with Histone Deacetylase Inhibitors on Leukemia Cells

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 9,Issue: 1
Page: 62-77
Authors: Ota Fuchs, Dana Provaznikova, Iuri Marinov, Katerina Kuzelova and Ivan Spicka

Chemopreventive and Anti-leukemic Effects of Ethanol Extracts of Moringa oleifera Leaves on Wistar Rats Bearing Benzene Induced Leukemia

Journal: Current Pharmaceutical Biotechnology
Volume: 15,Issue: 6
Page: 563-568
Authors: E.O. Akanni, A.L. Adedeji, O.T. Adedosu, O.I. Olaniran and J.K. Oloke

New Candidate Genes for Lack of Sensitivity to Therapy in Pediatric Leukemias

Journal: Current Cancer Drug Targets
Volume: 17,Issue: 4
Page: 333-343
Authors: Weronika Bereza, Joanna Szczepanek, Joanna Laskowska and Andrzej Tretyn

Microarray-Based Identification of New Targets for Specific Therapies in Pediatric Leukemia

Journal: Current Drug Targets
Volume: 8,Issue: 6
Page: 761-764
Authors: Monique L. den Boer and Rob Pieters

Potential of Plant-Derived Natural Products in the Treatment of Leukemia and Lymphoma

Journal: Current Drug Targets
Volume: 11,Issue: 7
Page: 812-822
Authors: David M. Lucas, Patrick C. Still, Lynette Bueno Perez, Michael R. Grever and A. Douglas Kinghorn

Chronic Myelogenous Leukemia

Journal: Current Cancer Therapy Reviews
Volume: 8,Issue: 1
Page: 3-13
Authors: Robert P. Hasserjian

Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 6,Issue: 3
Page: 354-366
Authors: Riccardo Masetti, Katharina Kleinschmidt, Carlotta Biagi and Andrea Pession

MicroRNAs as Regulators in Normal Hematopoietic and Leukemia Stem Cells: Current Concepts and Clinical Implications

Journal: Current Molecular Medicine
Volume: 12,Issue: 5
Page: 536-546
Authors: K. Fang, F. Qian and Y. -Q. Chen

Hypoxia Selects for a Quiescent, CML Stem/Leukemia Initiating- Like Population Dependent on CBP/Catenin Transcription

Journal: Current Molecular Pharmacology
Volume: 6,Issue: 3
Page: 204-210
Authors: Aiko Kida and Michael Kahn

Intracellular ROS Generation Mediates Maleimide-induced Cytotoxicity in Leukemia Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 9
Page: 1164-1173
Authors: Daiane Rosolen, Vania F. Noldin, Evelyn Winter, Fabiola B. Filippin-Monteiro, Fatima Campos-Buzzi, Valdir Cechinel-Filho and Tania B. Creczynski-Pasa

Advances in Stem Cell Therapy for Leukemia

Journal: Current Stem Cell Research & Therapy
Volume: 11,Issue: 2
Page: 158-165
Authors: Hong Tian, Qi Qu, Liming Liu and Depei Wu

Oncogenic Signaling in Acute Myeloid Leukemia

Journal: Current Drug Targets
Volume: 8,Issue: 2
Page: 237-246
Authors: Christian H. Brandts, Wolfgang E. Berdel and Hubert Serve

Targeting the Leukemia Microenvironment

Journal: Current Drug Targets
Volume: 8,Issue: 6
Page: 685-701
Authors: Marina Konopleva and Michael Andreeff

Notch Signaling in Leukemias and Lymphomas

Journal: Current Molecular Medicine
Volume: 8,Issue: 1
Page: 51-59
Authors: Franziska Jundt, Rolf Schwarzer and Bernd Dorken

Red Blood Cell-Encapsulated L-Asparaginase: Potential Therapy of Patients with Asparagine Synthetase Deficient Acute Myeloid Leukemia

Journal: Protein & Peptide Letters
Volume: 20,Issue: 4
Page: 392-402
Authors: Vaidehi Agrawal, Jung Hee Woo, Gautham Borthakur, Hagop Kantarjian and Arthur E. Frankel

Evaluating Treatment Response of Chronic Myeloid Leukemia: Emerging Science and Technology

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 7
Page: 779-790
Authors: Antonia Cagnetta, Anna Garuti, Carlo Marani, Michele Cea, Maurizio Miglino, Ilaria Rocco, Claudia Palermo, Giuseppina Fugazza, Gabriella Cirmena, Nicoletta Colombo, Raffaella Grasso, Alessio Nencioni, Marco Gobbi and Franco Patrone

Stem Cell Transplantation for Chronic Myeloid Leukemia (CML): Current Indications and Perspectives

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 7
Page: 775-778
Authors: Andrea Bacigalupo

Dual Induction of Mitochondrial Apoptosis and Senescence in Chronic Myelogenous Leukemia by Myrtucommulone A

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 3
Page: 363-373
Authors: Cindy Grandjenette, Michael Schnekenburger, Franck Morceau, Fabienne Mack, Katja Wiechmann, Oliver Werz, Mario Dicato and Marc Diederich

MicroRNAs in Chronic Lymphocytic Leukemia: An Old Disease with New Genetic Insights

Journal: MicroRNA
Volume: 5,Issue: 2
Page: 106-112
Authors: Maria Ciccone and George A. Calin

Monoclonal Antibodies in the Treatment of Leukemia

Journal: Current Molecular Medicine
Volume: 5,Issue: 7
Page: 663-675
Authors: Susan O'Brien, Maher Albitar and Francis J. Giles

Inhibitors of the Chemokine Receptor CXCR4: Chemotherapy of AIDS, Metastatic Cancer, Leukemia and Rheumatoid Arthritis

Journal: Letters in Drug Design & Discovery
Volume: 4,Issue: 1
Page: 20-26
Authors: Hiroshi Tsutsumi, Hirokazu Tamamura and Nobutaka Fujii

New and Old Monoclonal Antibodies for the Treatment of Chronic Lymphocytic Leukemia

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 11,Issue: 6
Page: 508-518
Authors: L. Laurenti, L. De Padua, G. D, ’, Arena, B. Vannata, I. Innocenti, M. Tarnani, S. Deaglio, S. Sica, D. G. Efremov and G. Leone

Triazene Compounds in the Treatment of Acute Myeloid Leukemia: A Short Review and a Case Report

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 19
Page: 2389-2401
Authors: L. Bonmassar, F. Marchesi, E. Pascale, O. Franzese, G.P. Margison, A. Bianchi, S. D’Atri, S. Bernardini, D. Lattuada, E. Bonmassar and A. Aquino

Effect of miR-128 in DNA Damage of HL-60 Acute Myeloid Leukemia Cells

Journal: Current Pharmaceutical Biotechnology
Volume: 15,Issue: 5
Page: 492-502
Authors: Hugo Seca, Raquel T. Lima, Gabriela M. Almeida, Manuel Sobrinho-Simoes, Rui Bergantim, Jose E. Guimaraes and M. Helena Vasconcelos

Therapeutic Value of Black Seed Oil in Methotrexate Hepatotoxicity in Egyptian Children with Acute Lymphoblastic Leukemia

Journal: Infectious Disorders - Drug Targets
Volume: 15,Issue: 1
Page: 64-71
Authors: Adel A. Hagag, Ahmed M. AbdElaal, Mohamed S. Elfaragy, Samir M. Hassan and Enas A. Elzamarany

Differential Effects of Antofine N-Oxide on Solid Tumor and Leukemia Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 10
Page: 1315-1323
Authors: Tania Bour, Xianwen Yang, Weihong Li, Francois Bernardin, Tony Kaoma, Arnaud Muller, Laurent Vallar and Andre Steinmetz

Bruton Kinase Inhibitors in Chronic Lymphocytic Leukemia

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 8
Page: 1040-1045
Authors: Alessandro Gozzetti, Veronica Candi, Corrado Zuanelli Brambilla, Giulia Papini, Alberto Fabbri and Monica Bocchia

Differential Effects of Polyphenols on Proliferation and Apoptosis in Human Myeloid and Lymphoid Leukemia Cell Lines

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 10
Page: 1601-1613
Authors: Amani A Mahbub, Christine L. Le Maitre, Sarah L. Haywood-Small, Gordon J. McDougall, Neil A. Cross and Nicola Jordan-Mahy

Diagnostics, Prognostic and Therapeutic Exploitation of Telomeres and Telomerase in Leukemias

Journal: Current Pharmaceutical Biotechnology
Volume: 7,Issue: 3
Page: 171-183
Authors: Laure Deville, Josette Hillion, Michel Lanotte, Philippe Rousselot and Evelyne Segal-Bendirdjian

Vitamin D Receptor Signaling of Monocytic Differentiation in Human Leukemia Cells: Role of MAPK Pathways in Transcription Factor Activation

Journal: Current Topics in Medicinal Chemistry
Volume: 6,Issue: 12
Page: 1267-1271
Authors: G. P. Studzinski, E. Garay, R. Patel, J. Zhang and X. Wang

Liposomal-All-trans-Retinoic Acid in the Treatment of Acute Promyelocytic Leukemia

Journal: Current Cancer Therapy Reviews
Volume: 1,Issue: 3
Page: 239-250
Authors: Bulent Ozpolat, Maribel Tirado-Gomez and Gabriel Lopez-Berestein

Targeting the Kinase Activity of the BCR-ABL Fusion Protein in Patients with Chronic Myeloid Leukemia

Journal: Current Molecular Medicine
Volume: 5,Issue: 7
Page: 615-623
Authors: Francis J. Giles, Jorge E. Cortes and Hagop M. Kantarjian

Src Family Kinases: Potential Targets for the Treatment of Human Cancer and Leukemia

Journal: Current Pharmaceutical Design
Volume: 9,Issue: 25
Page: 2043-2059
Authors: Markus Warmuth, Robert Damoiseaux, Yi Liu, Doriano Fabbro and Nathanael Gray

Immunotherapy of Acute Myeloid Leukemia

Journal: Current Pharmaceutical Biotechnology
Volume: 2,Issue: 3
Page: 209-215
Authors: Arthur E. Frankel, Maria R. Baer, Donna E. Hogge and Robert K. Stuart

The Prognosis and Treatment of Adult Acute Leukemia with 11q23/MLL According to the Fusion Partner

Journal: Current Cancer Therapy Reviews
Volume: 5,Issue: 3
Page: 227-231
Authors: Hayato Tamai, Hiroki Yamaguchi, Koiti Inokuchi and Kazuo Dan

Targeting the Acute Myeloid Leukemia Stem Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10,Issue: 2
Page: 104-110
Authors: Alexandre Krause, Luciana M. Fontanari Krause and Eduardo M. Rego

Molecular Targeting of Aberrant Transcription Factors in Leukemia: Strategies for RUNX1/ETO

Journal: Current Drug Targets
Volume: 11,Issue: 9
Page: 1181-1191
Authors: Christian Wichmann, Manuel Grez and Jorn Lausen


Beneficial and Adverse Effects of Molecularly Targeted Therapies for Acute Promyelocytic Leukemia in Central Nervous System

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 8,Issue: 5
Page: 387-392
Authors: Sumimasa Nagai, Tsuyoshi Takahashi and Mineo Kurokawa

Emerging Therapies in Chronic Myeloid Leukemia

Journal: Current Cancer Drug Targets
Volume: 12,Issue: 5
Page: 458-470
Authors: J. Gora-Tybor

Chemomodulating Effects of Flavonoids in Human Leukemia Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 9
Page: 1112-1126
Authors: Katrin Sak and Hele Everaus

A New Strategy to Target Acute Myeloid Leukemia Stem and Progenitor Cells Using Chidamide, a Histone Deacetylase Inhibitor

Journal: Current Cancer Drug Targets
Volume: 15,Issue: 6
Page: 493-503
Authors: Yin Li, Kai Chen, Yong Zhou, Yiren Xiao, Manman Deng, Zhiwu Jiang, Wei Ye, Xiangmeng Wang, Xinru Wei, Jie Li, Jiabao Liang, Zhongxin Zheng, Yao Yao, Weiguang Wang, Peng Li and Bing Xu

Acute Lymphoblastic Leukemia and Regulatory T cells: Biomarkers and Immunopathogenesis

Journal: Current Immunology Reviews
Volume: 12,Issue: 1
Page: 14-19
Authors: Carlos H. Hiroki, Rafaela P. Erthal, Ana P.L. Pereira, Letícia M. Pacholak, Thiago C. Fujita, Poliana C. Marinello, Idessânia N. Costa, Sérgio P.D. da Rocha, Maria A.E. Watanabe and Carlos E.C. de Oliveira

Epigenetics and Adult Acute Myeloid Leukemia

Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 13,Issue: 2
Page: 117-133
Authors: Maël Heiblig, Mohamed El Hamri, Gilles Salles and Xavier Thomas

Pyrimethamine as a Potent and Selective Inhibitor of Acute Myeloid Leukemia Identified by High-throughput Drug Screening

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 9
Page: 818-828
Authors: Amit Sharma, Nidhi Jyotsana, Courteney K. Lai, Anuhar Chaturvedi, Razif Gabdoulline, Kerstin Görlich, Cecilia Murphy, Jan E. Blanchard, Arnold Ganser, Eric Brown, John A. Hassell, R. Keith Humphries, Michael Morgan and Michael Heuser

Epigenetic Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemias

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 13
Page: 1274-1287
Authors: Giuseppe Leone, Francesco D'Alo, Giuseppe Zardo, Maria Teresa Voso and Clara Nervi

A Case of Ischemic Stroke in Acute Promyelocytic Leukemia at Initial Presentation: Relevance of All-Trans Retinoic Acid Treatment

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 10,Issue: 1
Page: 1-6
Authors: Angelo M. Carella, Giuseppe Antonucci, Matteo Conte, Michele Di Pumpo, Elisabetta Antonucci and Ernestina Ponziano

Sphingolipid Metabolism and Leukemia: A Potential for Novel Therapeutic Approaches

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11,Issue: 9
Page: 863-881
Authors: Tara Ann Burns and Chiara Luberto

Phenotypic Alteration of Bone Marrow HSC and Microenvironmental Association in Experimentally Induced Leukemia

Journal: Current Stem Cell Research & Therapy
Volume: 5,Issue: 4
Page: 379-386
Authors: Pratima Basak, Sumanta Chatterjee, Madhurima Das, Prosun Das, Jacintha Archana Pereira, Ranjan Kumar Dutta, Malay Chaklader, Samaresh Chaudhuri and Sujata Law

Novel and Emerging Drugs for Acute Lymphoblastic Leukemia

Journal: Current Cancer Drug Targets
Volume: 12,Issue: 5
Page: 505-521
Authors: E. Lech-Maranda and W. Mlynarski

Chronic Lymphocytic Leukemia Therapy: Beyond Chemoimmunotherapy

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 23
Page: 3356-3362
Authors: Julio Delgado, Tycho Baumann, Gabriela Ghita and Emili Montserrat

Chrysin Induces Apoptosis in Peripheral Blood Lymphocytes Isolated from Human Chronic Lymphocytic Leukemia

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 2
Page: 189-195
Authors: Milan Zaric, Marina Mitrovic, Ivana Nikolic, Dejan Baskic, Suzana Popovic, Predrag Djurdjevic, Zoran Milosavljevic and Ivanka Zelen

Unleashing the Guardian: The Targetable BCR-ABL/HAUSP/PML/PTEN Network in Chronic Myeloid Leukemia

Journal: Current Drug Targets
Volume: 18,Issue: 4
Page: 389-395
Authors: Alessandro Morotti, Davide Torti, Giovanna Carra, Cristina Panuzzo, Sabrina Crivellaro, Riccardo Taulli, Carmen Fava, Angelo Guerrasio and Giuseppe Saglio

FLT3 Inhibitors in the Management of Acute Myeloid Leukemia

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 8
Page: 1028-1032
Authors: E. Zappone, M. Defina, L. Aprile, G. Bartalucci, A. Gozzetti and M. Bocchia

Design, Synthesis and Biological Evaluation of a Phenyl Butyric Acid Derivative, N-(4-chlorophenyl)-4-phenylbutanamide: A HDAC6 Inhibitor with Anti-proliferative Activity on Cervix Cancer and Leukemia Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 10
Page: 1441-1454
Authors: Rodriguez-Fonseca Rolando Alberto, Sixto-Lopez Yudibeth, Fragoso-Vazquez M. Jonathan, Flores-Mejia Raul, Cabrera-Perez Laura Cristina, Vazquez-Moctezuma Ismael, Rosales-Hernandez Martha Cecilia, Bello Martiniano, Martinez-Archundia M, Trujillo-Ferrara Jose Guadalupe, Becerra-Martinez Elvia and Correa-Basurto Jose

New Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia

Journal: Current Pharmaceutical Biotechnology
Volume: 7,Issue: 5
Page: 371-379
Authors: Shinya Kimura, Eishi Ashihara and Taira Maekawa

Deregulation of the Mitochondrial Apoptotic Machinery and Development of Molecular Targeted Drugs in Acute Myeloid Leukemia

Journal: Current Cancer Drug Targets
Volume: 8,Issue: 3
Page: 207-222
Authors: G. Del Poeta, A. Bruno, M. I. Del Principe, A. Venditti, L. Maurillo, F. Buccisano, R. Stasi, B. Neri, F. Luciano, A. Siniscalchi, P. de Fabritiis and S. Amadori

Clinical Experience with Antiangiogenic Therapy in Leukemia

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 9
Page: 1053-1068
Authors: J. Wellbrock and W. Fiedler

Targeting BCR-ABL Oncoprotein for Leukemia Therapy: Current Biotechnology and Future Perspectives

Journal: Current Biotechnology
Volume: 1,Issue: 2
Page: 175-183
Authors: Min Shen and Q. Ping Dou

Involvement of MicroRNA181a in Differentiation and Cell Cycle Arrest Induced by a Plant-derived Antioxidant Carnosic Acid and Vitamin D Analog Doxercalciferol in Human Leukemia Cells

Journal: MicroRNA
Volume: 1,Issue: 1
Page: 26-33
Authors: Jyoti Duggal, Jonathan S. Harrison, George P Studzinski and Xuening Wang

The Venom of the Centipede Scolopendra subspinipes mutilans Inhibits the Growth of Myelogenous Leukemia Cell Lines

Journal: Letters in Drug Design & Discovery
Volume: 10,Issue: 5
Page: 390-395
Authors: Shiyan Xu, Fan Zhang, Hengyun Wang, Yu Liu, Dan Li, Zhe Wu and Zhonghua Liu

Alternative Splicing in Chronic Myeloid Leukemia (CML): A Novel Therapeutic Target?

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 7
Page: 735-748
Authors: Sophia Adamia, Patrick M. Pilarski, Michal Bar-Natan, Richard M. Stone and James D. Griffin

Recent Patents of microRNAs as Biomarkers for Breast, Leukemia, Prostate and Cervical Cancers

Journal: Recent Patents on Biomarkers
Volume: 3,Issue: 3
Page: 204-212
Authors: Mahmoud M. ElHefnawi, Sahar M. Ibrahim and Dina M. Ibrahim

De Novo Design of New Inhibitor of Mutated Tyrosine-Kinase for the Myeloid Leukemia Treatment

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 33
Page: 5057-5064
Authors: Washington Pereira and Ihosvany Camps

New Developments of Differentiation Therapy of Acute Myeloid Leukemia

Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 14,Issue: 2
Page: 86-105
Authors: Germana Castelli, Elvira Pelosi and Ugo Testa

Synthesis, Cytotoxic Activity on Leukemia Cell Lines and Quantitative Structure-Activity Relationships (QSAR) Studies of Morita-Baylis-Hillman Adducts

Journal: Medicinal Chemistry
Volume: 12,Issue: 7
Page: 602-612
Authors: Claudio G. Lima–Junior, Gláucia V. Faheina–Martins, Caio C. B. Bomfim, Bruna B. Dantas, Everton P. Silva, Demetrius A. M. de Araújo, Edilson B. A. Filho and Mário L. A. A. Vasconcellos

Transgenic Mouse Models of BCR/ABL-Positive Chronic Myelogenous Leukemia: A Review

Journal: Current Genomics
Volume: 6,Issue: 2
Page: 89-95
Authors: Koiti Inokuchi

Endogenous Inhibitors of HIV: Potent Anti-HIV Activity of Leukemia Inhibitory Factor

Journal: Current Molecular Medicine
Volume: 2,Issue: 8
Page: 713-722
Authors: B. K. Patterson, A. Tjernlund and J. Andersson

Nilotinib Therapy in Chronic Myelogenous Leukemia: The Strength of High Selectivity on BCR/ABL

Journal: Current Drug Targets
Volume: 10,Issue: 6
Page: 530-536
Authors: Massimo Breccia and Giuliana Alimena

BCR-ABL Inhibitors in Chronic Myeloid Leukemia: Process Chemistry and Biochemical Profile

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 19
Page: 2943-2959
Authors: F. Leonetti, A. Stefanachi, O. Nicolotti, M. Catto, L. Pisani, S. Cellamare and A. Carotti

Novel Approaches to Modulate Apoptosis Resistance: Basic and Clinical Implications in the Treatment of Chronic Lymphocytic Leukemia (CLL)

Journal: Current Drug Delivery
Volume: 9,Issue: 1
Page: 30-40
Authors: Aisha Masood, Mohammad A. Shahshahan and Ali R. Jazirehi

Synthesis and Biological Evaluation of a Series of 2-(3,4,5-Trimethoxybenzoyl)-Indol-3-yl Acetic Acid Derivatives as Potential Agents against Human Leukemia K562 Cells

Journal: Letters in Drug Design & Discovery
Volume: 5,Issue: 3
Page: 214-220
Authors: Romeo Romagnoli, Pier Giovanni Baraldi, Olga Cruz-Lopez, Maria Dora Carrion, Carlota Lopez Cara, Jan Balzarini, Enrica Fabbri and Robero Gambari

Synthesis, Characterization and Evaluation of Cytotoxicity of New Aminophosphonic Acid Diesters in Human Leukemia Cells

Journal: Letters in Drug Design & Discovery
Volume: 7,Issue: 4
Page: 250-259
Authors: Avula Balakrishna, Kishore K. Chiruvella, Mudumala V.N. Reddy, Rajesh Reddy, Sandip K. Nayak, Sathees C. Raghavan and Cirandur S. Reddy

Management of Early Stage Chronic Myeloid Leukemia: State-of-the-art Approach and Future Perspectives

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 7
Page: 749-754
Authors: Federica Galaverna, Chiara Ghiggi, Fabio Guolo, Germana Beltrami, Clara Dellepiane, Livia Giannoni, Andrea Carella and Angelo M. Carella

Cell Penetrating Peptides as a Therapeutic Strategy in Chronic Lymphocytic Leukemia

Journal: Protein & Peptide Letters
Volume: 22,Issue: 6
Page: 539-546
Authors: Issam Arrouss, Didier Decaudin, Sylvain Choquet, Nabih Azar, Christophe Parizot, Jean M. Zini, Fariba Nemati and Angelita Rebollo

Screening for Marine Natural Products with Potential as Chemotherapeutics for Acute Myeloid Leukemia

Journal: Current Pharmaceutical Biotechnology
Volume: 17,Issue: 1
Page: 71-77
Authors: Espen Hansen and Jeanette H. Andersen

Signal transduction in Acute Myeloid Leukemia – Implications for Novel Therapeutic Concepts.

Journal: Current Cancer Drug Targets
Volume: 15,Issue: 9
Page: 803-821
Authors: Heiko Konig and Cedric Dos Santos

Genetics, Gene Expression, and Targeted Therapies in Chronic Lymphocytic Leukemia

Journal: Current Drug Targets
Volume: 7,Issue: 10
Page: 1313-1327
Authors: Dirk Winkler, Hartmut Dohner and Stephan Stilgenbauer

Monoclonal Antibodies for the Treatment of Acute Myeloid Leukemia

Journal: Current Pharmaceutical Biotechnology
Volume: 7,Issue: 5
Page: 343-369
Authors: Syed A. Abutalib and Martin S. Tallman

Genetic Modification of Natural Killer Cells for Leukemia Therapies

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 6,Issue: 2
Page: 101-108
Authors: Chihaya Imai, Harumi Kakuda, Hiroyuki Fujisaki, Shotaro Iwamoto and Dario Campana

Membrane Tyrosine Kinase Receptors are an Important Target for the Therapy of Acute Myeloid Leukemia

Journal: Current Cancer Therapy Reviews
Volume: 4,Issue: 1
Page: 31-49
Authors: Ugo Testa

Potential New Agents for Chronic Lymphocytic Leukemia Treatment

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10,Issue: 9
Page: 666-682
Authors: Malgorzata Rogalinska and Zofia M. Kilianska

Targeting of Leukemia-Initiating Cells to Develop Curative Drug Therapies: Straightforward but Nontrivial Concept

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 1
Page: 56-71
Authors: P. Valent

Bioactive Sphingolipids in Response to Chemotherapy: A Scope on Leukemias

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11,Issue: 4
Page: 385-397
Authors: Huseyin Atakan Ekiz and Yusuf Baran


A Targeted Therapy for Protein and Lipid Kinases in Chronic Lymphocytic Leukemia

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 31
Page: 5294-5318
Authors: P. Robak and T. Robak

Targeted Anti-leukemic Therapy as Disease-stabilizing Treatment for Acute Myeloid Leukemia Relapse after Allogeneic Stem Cell Transplantation: Will it be Possible to Combine these Strategies with Retransplantation or Donor Lymphocyte Infusions?

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 1
Page: 30-47
Authors: Hakon Reikvam, Astrid Olsnes Kittang, Guro Melve, Knut Anders Mosevoll, Pal Tore Bentsen, Elisabeth Ersvaer, Bjorn Tore Gjertsen and Oystein Bruserud

The Therapeutical Potential of a Novel Pterocarpanquinone LQB-118 to Target Inhibitor of Apoptosis Proteins in Acute Myeloid Leukemia Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 2
Page: 341-351
Authors: Flaviana R. de Souza Reis, Fernanda C. Casal de Faria, Carolina P. Castro, Paloma S. de Souza, Flavia da Cunha Vasconcelos, Reinaldo D. Bello, Alcides J. da Silva, Paulo R.R. Costa and Raquel C. Maia

Nuclear Translocation of Heme Oxygenase-1 Confers Resistance to Imatinib in Chronic Myeloid Leukemia Cells

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 15
Page: 2765-2770
Authors: Daniele Tibullo, Ignazio Barbagallo, Cesarina Giallongo, Piera La Cava, Nunziatina Parrinello, Luca Vanella, Fabio Stagno, Giuseppe A. Palumbo, Giovanni Li Volti and Francesco Di Raimondo

Targeting miR-21 Induces Autophagy and Chemosensitivity of Leukemia Cells

Journal: Current Drug Targets
Volume: 14,Issue: 10
Page: 1135-1143
Authors: Hugo Seca, Raquel T. Lima, Vanessa Lopes-Rodrigues, Jose E. Guimaraes, Gabriela M. Gabriela and M. Helena Vasconcelos

Protein Phosphatase 2A as a Potential Target for Treatment of Adult T Cell Leukemia

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 8
Page: 829-842
Authors: Naoki Mori, Chie Ishikawa, Jun-Nosuke Uchihara and Takeshi Yasumoto

AKT-pathway Inhibition in Chronic Lymphocytic Leukemia Reveals Response Relationships Defined by TCL1

Journal: Current Cancer Drug Targets
Volume: 14,Issue: 8
Page: 700-712
Authors: Alexandra Schrader, Wagma Popal, Nils Lilienthal, Giuliano Crispatzu, Petra Mayer, Dan Jones, Michael Hallek and Marco Herling

Xenograft models of primary acute myeloid leukemia for the development of imaging strategies and evaluation of novel targeted therapies.

Journal: Current Pharmaceutical Biotechnology
Volume: 17,Issue: 1
Page: 42-51
Authors: Pascal Gelebart, Mihaela Popa and Emmet McCormack

Roles of Interferon Regulatory Factors in Chronic Myeloid Leukemia

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 7
Page: 594-605
Authors: Livia Manzella, Elena Tirrò, Maria Stella Pennisi, Michele Massimino, Stefania Stella, Chiara Romano, Silvia Rita Vitale and Paolo Vigneri

Survival and Immunosuppression Induced by Hepatocyte Growth Factor in Chronic Lymphocytic Leukemia

Journal: Current Molecular Medicine
Volume: 17,Issue: 1
Page: 24-33
Authors: P. Giannoni, G. Cutrona and D. de Totero

Human T-Cell Leukemia Virus Type 1: Transition from Latent Infection to Pathogenic Progression and Implications for Molecular Therapy

Journal: Current Cancer Therapy Reviews
Volume: 2,Issue: 2
Page: 101-113
Authors: Yulia Tabakin-Fix, Inbal Azran-Shaish, Yana Schavinsky-Khrapunsky, Rachel Chamias, Lilach Gohari, Mahmoud Huleihel, Min Li-Weber and Mordechai Aboud

Proteomics of p53 in Diagnostics and Therapy of Acute Myeloid Leukemia

Journal: Current Pharmaceutical Biotechnology
Volume: 7,Issue: 3
Page: 199-207
Authors: Nina Anensen, Ingvild Haaland, Clive D'Santos, Werner Van Belle and Bjorn Tore Gjertsen

Induction of Apoptosis via the Modulation of Reactive Oxygen Species (ROS) Production in the Treatment of Myeloid Leukemia

Journal: Current Pharmaceutical Biotechnology
Volume: 7,Issue: 5
Page: 323-329
Authors: Masahiro Kizaki, Mingji Xian, Morihiko Sagawa and Yasuo Ikeda

The Protease of Human T-Cell Leukemia Virus Type-1 is a Potential Therapeutic Target

Journal: Current Pharmaceutical Design
Volume: 13,Issue: 12
Page: 1285-1294
Authors: Jozsef Tozser and Irene T. Weber

Targeting RAS Signaling Pathways in Juvenile Myelomonocytic Leukemia

Journal: Current Drug Targets
Volume: 8,Issue: 6
Page: 715-725
Authors: Christian Flotho, Christian Kratz and Charlotte M. Niemeyer

FLT3 and Acute Myelogenous Leukemia: Biology, Clinical Significance and Therapeutic Applications

Journal: Current Pharmaceutical Design
Volume: 11,Issue: 26
Page: 3449-3457
Authors: A. S. Advani

Mammalian Target of Rapamycin as a Therapeutic Target in Leukemia

Journal: Current Molecular Medicine
Volume: 5,Issue: 7
Page: 653-661
Authors: Francis J. Giles and Maher Albitar

Global Gene Expression in Classification, Pathogenetic Understanding and Identification of Therapeutic Targets in Acute Myeloid Leukemia

Journal: Current Pharmaceutical Biotechnology
Volume: 8,Issue: 6
Page: 344-354
Authors: Anne Margrete Oyan, Trond Hellem Bo, Inge Jonassen, Elling Ulvestad, Bjorn Tore Gjertsen, Oystein Bruserud and Karl-Henning Kalland

Rho-Signaling Pathways in Chronic Myelogenous Leukemia

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 8,Issue: 4
Page: 261-267
Authors: Katerina Kuzelova and Zbynek Hrkal

Emerging Treatments in Acute Lymphoblastic Leukemia

Journal: Current Cancer Drug Targets
Volume: 9,Issue: 1
Page: 19-31
Authors: R. Crazzolara and L. Bendall

Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 8
Page: 853-863
Authors: Manlio Tolomeo, Francesco Dieli, Nicola Gebbia and Daniele Simoni

Bench to Bedside Targeting of FLT3 in Acute Leukemia

Journal: Current Drug Targets
Volume: 11,Issue: 7
Page: 781-789
Authors: Keith W. Pratz and Mark J. Levis

Targeting Epigenetics through Histone Deacetylase Inhibitors in Acute Lymphoblastic Leukemia

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 7
Page: 882-893
Authors: A. Mummery, A. Narendran and K.-Y. Lee

Implications of FLT3 Mutations in the Therapy of Acute Myeloid Leukemia

Journal: Reviews on Recent Clinical Trials
Volume: 2,Issue: 2
Page: 135-141
Authors: Ryan J. Mattison, Kelly R. Ostler, Frederick L. Locke and Lucy A. Godley

Discovery of 8-methoxypyrazino[1,2-a]indole as a New Potent Antiproliferative Agent Against Human Leukemia K562 Cells. A Structure-Activity Relationship Study

Journal: Letters in Drug Design & Discovery
Volume: 6,Issue: 4
Page: 298-303
Authors: Romeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, Olga Cruz-Lopez, Carlota Lopez Cara, Delia Preti, Mojgan Aghazadeh Tabrizi, Jan Balzarini, Ernest Hamel, Enrica Fabbri and Roberto Gambari

Synthesis and Evaluation of Haloacetyl, α-Bromoacryloyl and Nitrooxyacetyl Benzo[b]furan and Benzo[b]thiophene Derivatives as Potent Antiproliferative Agents Against Leukemia L1210 and K562 Cells

Journal: Letters in Drug Design & Discovery
Volume: 7,Issue: 7
Page: 476-486
Authors: Romeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, Carlota Lopez Cara, Alberto Casolari, Ernest Hamel, Enrica Fabbri and Roberto Gambari

Folate Targeted Solid Lipid Nanoparticles of Simvastatin for Enhanced Cytotoxic Effects of Doxorubicin in Chronic Myeloid Leukemia

Journal: Current Nanoscience
Volume: 8,Issue: 2
Page: 249-258
Authors: J. Varshosaz, F. Hassanzadeh, H. Sadeghi and M. Shakery

Second-Generation Tyrosine Kinase Inhibitors as First-Line Treatment Strategy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients

Journal: Current Cancer Drug Targets
Volume: 12,Issue: 4
Page: 391-401
Authors: M. Breccia and G. Alimena

Intracellular Disposition of Methotrexate in Acute Lymphoblastic Leukemia in Children

Journal: Current Drug Metabolism
Volume: 13,Issue: 6
Page: 822-834
Authors: Tiphaine Adam de Beaumais and Evelyne Jacqz-Aigrain

Microenvironmental Interactions in Chronic Lymphocytic Leukemia: Hints for Pathogenesis and Identification of Targets for Rational Therapy

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 23
Page: 3323-3334
Authors: Michele Dal Bo, Riccardo Bomben, Antonella Zucchetto, Giovanni Del Poeta, Gianluca Gaidano, Silvia Deaglio, Dimitar G. Efremov and Valter Gattei

Immune Dysfunction in Chronic Lymphocytic Leukemia: The Role for Immunotherapy

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 23
Page: 3389-3398
Authors: John C. Riches, Alan G. Ramsay and John G. Gribben

New Treatment Approaches in Acute Myeloid Leukemia: Review of Recent Clinical Studies

Journal: Reviews on Recent Clinical Trials
Volume: 7,Issue: 3
Page: 224-237
Authors: Kelly Norsworthy, Leo Luznik and Ivana Gojo

Multifaceted Mechanisms for Cell Survival and Drug Targeting in Chronic Myelogenous Leukemia

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 1
Page: 69-79
Authors: J. Kuroda, Y. Shimura, M. Yamamoto-Sugitani, N. Sasaki and M. Taniwaki

Abelson Tyrosine-Protein Kinase 1 as Principal Target for Drug Discovery Against Leukemias. Role of the Current Computer-Aided Drug Design Methodologies

Journal: Current Topics in Medicinal Chemistry
Volume: 12,Issue: 24
Page: 2745-2762
Authors: Alejandro Speck-Planche, Feng Luan and M.N.D.S. Cordeiro

BIBR 1532 Increases Arsenic Trioxide-mediated Apoptosis in Acute Promyelocytic Leukemia Cells: Therapeutic Potential for APL

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 7
Page: 1115-1125
Authors: Davood Bashash, Seyed H.Ghaffari, Farhad Zaker, Maryam Kazerani, Kebria Hezave, Saeed Hassani, Masomeh Rostami, Kamran Alimoghaddam and Ardeshir Ghavamzadeh

New Insights Into Biology of Chronic Myeloid Leukemia: Implications in Therapy

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 7
Page: 711-723
Authors: Michele Cea, Antonia Cagnetta, Alessio Nencioni, Marco Gobbi and Franco Patrone

Innovative Cell Therapy in the Treatment of Serious Adverse Events Related to Both Chemo-Radiotherapy Protocol and Acute Myeloid Leukemia Syndrome: The Infusion of Mesenchymal Stem Cells Post-Treatment Reduces Hematopoietic Toxicity and Promotes Hematopoietic Reconstitution

Journal: Current Pharmaceutical Biotechnology
Volume: 14,Issue: 9
Page: 842-848
Authors: Loic Fouillard, Sabine Francois, Sandrine Bouchet, Morad Bensidhoum, Abdelatif Elm’selmi and Alain Chapel

Ibrutinib: A New Frontier in the Treatment of Chronic Lymphocytic Leukemia by Bruton’s Tyrosine Kinase Inhibition

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 11,Issue: 4
Page: 265-271
Authors: Ajoy Lawrence Dias and Dharamvir Jain

Cytotoxicity of Novel Sulfanilamides Towards Sensitive and Multidrugresistant Leukemia Cells

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 23
Page: 2715-2725
Authors: T. AlSalim, M.E.M. Saeed, J.S. Hadi, M. Zeino, R. Gany, O. Kadioglu, S.J.J. Titinchi, H.S. Abbo and T. Efferth

5-Benzylidene-3,4-dihalo-furan-2-one derivatives inhibit human leukemia cancer cells through suppression of NF-κB and GSK-3β

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 6
Page: 744-754
Authors: Fang Wang, Jing Lin, Wen Hou, Mei-Yan Huang, Ping-Hua Sun and Wei-Min Chen

A Novel Quinoline Based Second-generation mTOR Inhibitor that Induces Apoptosis and Disrupts PI3K-Akt-mTOR Signaling in Human Leukemia HL-60 Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 10
Page: 1297-1304
Authors: Suresh Kumar, Santosh Kumar Guru, Vunnam Venkateswarlu, Fayaz Malik, Ram A. Vishwakarma, Sanghapal D. Sawant and Shashi Bhushan

Global Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia Patients

Journal: Current Pharmaceutical Biotechnology
Volume: 17,Issue: 1
Page: 52-70
Authors: Elise Aasebø, Rakel B. Forthun, Frode Berven, Frode Selheim and Maria Hernandez-Valladares

The Past, Present and Future Subclassification of Patients with Acute Myeloid Leukemia

Journal: Current Pharmaceutical Biotechnology
Volume: 17,Issue: 1
Page: 6-19
Authors: Rakel B. Forthun, Carina Hinrichs, Tara H. Dowling, Øystein Bruserud and Frode Selheim

Development of personalized molecular therapy for acute myeloid leukemia

Journal: Current Pharmaceutical Biotechnology
Volume: 17,Issue: 1
Page: 20-29
Authors: Caroline B.N. Engen, Ehsan Hajjar and Bjørn T. Gjertsen

Potential Therapeutic Approaches for the Treatment of Acute Myeloid Leukemia with AML1-ETO Translocation

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 3
Page: 215-225
Authors: Rashi Arora, Sharad Sawney and Daman Saluja

New Insights into the Molecular Resistance Mechanisms of Chronic Myeloid Leukemia

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 4
Page: 323-345
Authors: Rui Huang, Qian Kang, Huimin Liu and Yuhua Li

Targeting Signaling Pathways in Chronic Lymphocytic Leukemia

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 8
Page: 669-688
Authors: Alice F. Muggen, Simar P. Singh, Rudi W. Hendriks and Anton W. Langerak

Mechanistic and Clinical Aspects of Lenalidomide Treatment for Chronic Lymphocytic Leukemia

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 8
Page: 689-700
Authors: John C. Riches and John G. Gribben

Refractory Chronic Lymphocytic Leukemia: A Therapeutic Challenge

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 8
Page: 701-709
Authors: Lukas Smolej

Gene Selection from Microarray Data Using Binary Grey Wolf Algorithm for Classifying Acute Leukemia

Journal: Current Signal Transduction Therapy
Volume: 11,Issue: 2
Page: 76-83
Authors: S.P. Manikandan, R. Manimegalai and M. Hariharan

Novel Antigen Targets for Immunotherapy of Acute Myeloid Leukemia

Journal: Current Drug Targets
Volume: 18,Issue: 3
Page: 296-303
Authors: Meghali Goswami and Christopher S. Hourigan

Understanding Unmet Needs in the Older Acute Myeloid Leukemia (AML) Patient

Journal: Current Cancer Therapy Reviews
Volume: 12,Issue: 4
Page: 246-252
Authors: Pablo Loarte, Irina Dashkova, Leanne Tortez, Anna Dashkova, Andrzej Kozikowski, Ramy Ibrahim and Renee Pekmezaris

Novel Treatment of Acute Promyelocytic Leukemia: As2O3, Retinoic Acid and Retinoid Pharmacology

Journal: Current Pharmaceutical Biotechnology
Volume: 14,Issue: 9
Page: 849-858
Authors: George Zhu, Sarah E. Mische and Beatrice Seigneres

Membrane Tyrosine Kinase Receptors Kit and FLT3 are an Important Targets for the Therapy of Acute Myeloid Leukemia

Journal: Current Cancer Therapy Reviews
Volume: 9,Issue: 3
Page: 181-219
Authors: Ugo Testa

Proteomic Strategies for Individualizing Therapy of Acute MyeloidLeukemia (AML)

Journal: Current Pharmaceutical Biotechnology
Volume: 7,Issue: 3
Page: 159-170
Authors: Gry Sjoholt, Siv Lise Bedringaas, Anne P. Doskeland and Bjorn Tore Gjertse

Molecular Pathogenesis of Chronic Lymphocytic Leukemia

Journal: Current Molecular Medicine
Volume: 6,Issue: 6
Page: 665-675
Authors: Alexey V. Danilov, Olga V. Danilova, Andreas K. Klein and Brigitte T. Huber

Synergistic Cytotoxic Activity of Recombinant TRAIL Plus the Non-Genotoxic Activator of the p53 Pathway Nutlin-3 in Acute Myeloid Leukemia Cells

Journal: Current Drug Metabolism
Volume: 8,Issue: 4
Page: 395-403
Authors: Paola Secchiero, Carlotta Zerbinati, Maria Grazia di Iasio, Elisabetta Melloni, Mario Tiribelli, Vittorio Grill and Giorgio Zauli

Assessing Combinations of Cytotoxic Agents Using Leukemia Cell Lines

Journal: Current Drug Targets
Volume: 8,Issue: 6
Page: 765-771
Authors: C. Patrick Reynolds, Min H. Kang, Nino Keshelava and Barry J. Maurer

Targeting the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Module for Acute Myelogenous Leukemia Therapy: From Bench to Bedside

Journal: Current Medicinal Chemistry
Volume: 14,Issue: 19
Page: 2009-2023
Authors: A.M. Martelli, P.L. Tazzari, C. Evangelisti, F. Chiarini, W.L. Blalock, A.M. Billi, L. Manzoli, J.A. McCubrey and L. Cocco

Antiangiogenic Therapy in Acute Myelogenous Leukemia: Targeting of Vascular Endothelial Growth Factor and Interleukin 8 as Possible Antileukemic Strategies

Journal: Current Cancer Drug Targets
Volume: 5,Issue: 4
Page: 229-248
Authors: Kimberley J. Hatfield, Astrid M. Olsnes, Bjorn Tore Gjertsen and Oystein Bruserud

Flt3 Receptor Tyrosine Kinase as a Drug Target in Leukemia

Journal: Current Pharmaceutical Design
Volume: 10,Issue: 16
Page: 1867-1883
Authors: Dirk Schmidt-Arras, Joachim Schwable, Frank- D. Bohmer and Hubert Serve

A Conceptual View on Glucocorticoid-Induced Apoptosis, Cell Cycle Arrest and Glucocorticoid Resistance in Lymphoblastic Leukemia

Journal: Current Molecular Medicine
Volume: 3,Issue: 8
Page: 707-717
Authors: K. Renner, M. J. Ausserlechner and R. Kofler

Protein Kinase C-θ (PKCθ), a Potential Drug Target for Therapeutic Intervention with Human T Cell Leukemias

Journal: Current Cancer Drug Targets
Volume: 2,Issue: 2
Page: 125-134
Authors: Martin Villalba and Amnon Altman

Single Autosomal Trisomy in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Journal: Current Genomics
Volume: 1,Issue: 2
Page: 153-173
Authors: S. K. Ma and T. S.K. Wan

Epigenetic Targeting in Acute Myeloid Leukemia: Use of Flow Cytometry in Monitoring Therapeutic Effects

Journal: Current Pharmaceutical Biotechnology
Volume: 8,Issue: 6
Page: 401-411
Authors: Anita Ryningen and Oystein Bruserud

Human Leukemia and Lymphoma Cell Lines as Models and Resources

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 4
Page: 339-359
Authors: Roderick A.F. MacLeod, Stefan Nagel, Michaela Scherr, Bjorn Schneider, Wilhelm G. Dirks, Cord C. Uphoff, Hilmar Quentmeier and Hans G. Drexler

A Potent Anti-Carcinoma and Anti-Acute Myeloblastic Leukemia Agent, AG490

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 8,Issue: 7
Page: 717-722
Authors: Julio R. Caceres-Cortes

Targeted Drugs in Chronic Myeloid Leukemia

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 29
Page: 3036-3051
Authors: Joanna Gora-Tybor and Tadeusz Robak

Exposure of B Cell Chronic Lymphocytic Leukemia (B-CLL) Cells to Nutlin-3 Induces a Characteristic Gene Expression Profile, which Correlates with Nutlin-3-Mediated Cytotoxicity (Supplementry Table)

Journal: Current Cancer Drug Targets
Volume: 9,Issue: 4
Page: 510-518
Authors: G. Zauli, M. G. di Iasio, P. Secchiero, M. Dal Bo, D. Marconi, R. Bomben, G. Del Poeta and V. Gattei

Targeting of Hsp32 in Solid Tumors and Leukemias: A Novel Approach to Optimize Anticancer Therapy (Supplementry Material)

Journal: Current Cancer Drug Targets
Volume: 9,Issue: 5
Page: 675-689
Authors: K. V. Gleixner, M. Mayerhofer, A. Vales, A. Gruze, G. Hormann, S. Cerny-Reiterer, E. Lackner, E. Hadzijusufovic, H. Herrmann, A. K. Iyer, M.-T. Krauth, W. F. Pickl, B. Marian, R. Panzer-Grumayer, C. Sillaber, H. Maeda, C. Zielinski and P. Valent

Heat Shock Protein 90 – a Potential Target in the Treatment of Human Acute Myelogenous Leukemia

Journal: Current Cancer Drug Targets
Volume: 9,Issue: 6
Page: 761-776
Authors: H. Reikvam, E. Ersvær and O. Bruserud

Wnt/β-Catenin/LEF-1 Signaling in Chronic Lymphocytic Leukemia (CLL): A Target for Current and Potential Therapeutic Options

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 7
Page: 716-727
Authors: R. K. Gandhirajan, S. J. Poll-Wolbeck, I. Gehrke and K.-A. Kreuzer

The Crosstalk Between the Matrix Metalloprotease System and the Chemokine Network in Acute Myeloid Leukemia

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 36
Page: 4448-4461
Authors: K. J. Hatfield, H. Reikvam and O. Bruserud

Interferon alpha for Treatment of Chronic Myeloid Leukemia

Journal: Current Drug Targets
Volume: 12,Issue: 3
Page: 420-428
Authors: Bengt Simonsson, Henrik Hjorth-Hansen, Ole Weis Bjerrum and Kimmo Porkka

Novel and Emerging Drugs for Acute Myeloid Leukemia: Pharmacology and Therapeutic Activity

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 5
Page: 638-666
Authors: T. Robak, A. Szmigielska-Kaplon, A. Pluta, O. Grzybowska-Izydorczyk, A. Wolska, M. Czemerska and A Wierzbowska

Acute Myeloid Leukemia in the Elderly: Current Therapeutic Results and Perspectives for Clinical Research

Journal: Reviews on Recent Clinical Trials
Volume: 2,Issue: 1
Page: 33-41
Authors: Felicetto Ferrara and Antonio Pinto

Pharmacogenetics of Childhood Acute Lymphoblastic Leukemia

Journal: Current Pharmacogenomics
Volume: 1,Issue: 2
Page: 87-100
Authors: Maja Krajinovic, Damian Labuda and Daniel Sinnett

Leptin, Ciliary Neurotrophic Factor, Leukemia Inhibitory Factor and Interleukin- 6: Class-I Cytokines Involved in the Neuroendocrine Regulation of the Reproductive Function

Journal: Current Protein & Peptide Science
Volume: 10,Issue: 6
Page: 577-584
Authors: E. Dozio, M. Ruscica, E. Galliera, M. M. Corsi and P. Magni

Dasatinib in the Treatment of Chronic Myeloid Leukemia

Journal: Current Signal Transduction Therapy
Volume: 6,Issue: 1
Page: 99-105
Authors: Joanna Gora-Tybor and Tadeusz Robak

Novel and Emerging Drugs for Chronic Lymphocytic Leukemia

Journal: Current Cancer Drug Targets
Volume: 12,Issue: 5
Page: 471-483
Authors: S. Isfort, P. Cramer and M. Hallek

Therapy of Elderly/Comorbid Patients with Chronic Lymphocytic Leukemia

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 23
Page: 3399-3405
Authors: Lukas Smolej

Ofatumumab: A Novel Anti-CD20 Monoclonal Antibody for the Treatment of Chronic Lymphocytic Leukemia

Journal: Current Drug Therapy
Volume: 7,Issue: 4
Page: 281-289
Authors: Ravindra R. Chuda, Prakash Vishnu and David Aboulafia

Treatment of Chronic Myeloid Leukemia Elderly Patients in the Tyrosine Kinase Inhibitor Era

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 7
Page: 755-767
Authors: Domenico Russo, Michele Malagola, Cristina Skert, Carla Filì, Cesare Bergonzi, Valeria Cancelli and Federica Cattina

Multiple Metamorphoses of CD38 from Prognostic Marker to Disease Modifier to Therapeutic Target in Chronic Lymphocytic Leukemia

Journal: Current Topics in Medicinal Chemistry
Volume: 13,Issue: 23
Page: 2955-2964
Authors: Tiziana Vaisitti, Valentina Audrito, Sara Serra, Cinzia Bologna, Francesca Arruga, Davide Brusa, Roberta Buonincontri, Branimir Gizdic and Silvia Deaglio

New Therapies for Chronic Lymphocytic Leukemia

Journal: Current Cancer Therapy Reviews
Volume: 9,Issue: 4
Page: 245-257
Authors: Pawel Robak and Tadeusz Robak

Cucurbitacin B Induces DNA Damage, G2/M Phase Arrest, and Apoptosis Mediated by Reactive Oxygen Species (ROS) in Leukemia K562 Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 8
Page: 1146-1153
Authors: Jiajie Guo, Wenwen Zhao, Wenhui Hao, Guowen Ren, Jinjian Lu and Xiuping Chen

Enhancing in vivo Bioavailability in Beagle Dogs of GLM-7 as a Novel Anti-Leukemia Drug through a Self-Emulsifying Drug Delivery System for Oral Delivery

Journal: Current Drug Delivery
Volume: 13,Issue: 1
Page: 131-142
Authors: Yuli Wang, Ning Yu, Rui Guo, Meiyan Yang, Li Shan, Wei Huang, Wei Gong, Shuai Shao, Xiaoping Chen and Chunsheng Gao

Evaluating Intestinal Permeability by Measuring Plasma Endotoxin and Diamine Oxidase in Children with Acute Lymphoblastic Leukemia Treated with High-dose Methotrexate

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16,Issue: 3
Page: 387-392
Authors: Ye Meng, Ying Zhang, Mei Liu, Yong Kun Huang, Jun Zhang, Qin Yao, Ya Ling Zhao and Jing Jing Xiong

Synergism of Curcumin and Cytarabine in the Down Regulation of Multi-Drug Resistance Genes in Acute Myeloid Leukemia

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16,Issue: 1
Page: 128-135
Authors: Krupa Shah, Sheefa Mirza, Urja Desai, Nayan Jain and Rakesh Rawal

Functional and Clinical Significance of the Integrin Alpha Chain CD49d Expression in Chronic Lymphocytic Leukemia

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 8
Page: 659-668
Authors: Michele Dal Bo, Erika Tissino, Dania Benedetti, Chiara Caldana, Riccardo Bomben, Giovanni Del Poeta, Gianluca Gaidano, Francesca Maria Rossi, Pietro Bulian, Antonella Zucchetto and Valter Gattei

Therapeutic Approach to Patients with Chronic Lymphocytic Leukemia and Significant Comorbid Conditions

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 8
Page: 710-720
Authors: Lukas Smolej

Aryl Maleimides as Apoptosis Inducers on L5178-Y Murine Leukemia Cells (in silico, in vitro and ex vivo Study)

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16,Issue: 12
Page: 1615-1621
Authors: Erik Andrade-Jorge, Marycarmen Godínez-Victoria, Luvia Enid Sánchez-Torres, Luis Humberto Fabila-Castillo and José G. Trujillo-Ferrara

Para-Nonylphenol Induces Apoptosis of U937 Human Monocyte Leukemia Cells in vitro

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 16,Issue: 3
Page: 213-223
Authors: Kazuki Santa, Tomonori Ohsawa and Takehiko Sakimoto

Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives

Journal: Current Medicinal Chemistry
Volume: 24,Issue: 11
Page: 1050-1065
Authors: Raffaella Franca, Diego Favretto, Marilena Granzotto, Giuliana Decorti, Marco Rabusin and Gabriele Stocco

DTCM-Glutarimide Hinders Growth of Childhood Leukemia Cells but Fails to Improve the Efficacy of Commonly Used Chemotherapeutic Agents

Journal: Current Bioactive Compounds
Volume: 13,Issue: 1
Page: 41-46
Authors: Julia A. Pezuk, Gabriela M. Roberto, Kazuo Umezawa and Maria Sol Brassesco

Novel Monoclonal Antibodies for the Treatment of Chronic Lymphocytic Leukemia

Journal: Current Cancer Drug Targets
Volume: 8,Issue: 2
Page: 156-171
Authors: Tadeusz Robak

Tyrosine Kinase Inhibitor Resistance and Epigenetic Regulation of SHP1 Phosphatase Expression in Chronic Myeloid Leukemia

Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 12,Issue: 4
Page: 240-249
Authors: Molly Steele, Amy Liu, Kate Bernhardt, Jennifer McCall, Brett Mahon and Lela Buckingham

Hydroxy Cinnamic Acid Derivatives as Partial PPARγ Agonists: In silico Studies, Synthesis and Biological Characterization Against Chronic Myeloid Leukemia Cell Line (K562)

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 4
Page: 524-541
Authors: Hardik Joshi, Kavita Marulkar, Vikram Gota and C. S. Ramaa

Pgp and FLT3: Identification and Modulation of Two Proteins that Lead to Chemotherapy Resistance in Acute Myeloid Leukemia

Journal: Current Medicinal Chemistry
Volume: 14,Issue: 5
Page: 519-530
Authors: Janos Kappelmayer, Miklos Udvardy and Peter Antal-Szalmas

Drug Resistance in Childhood Acute Myeloid Leukemia

Journal: Current Pharmaceutical Biotechnology
Volume: 8,Issue: 2
Page: 59-75
Authors: J. Styczynski

Editorial [Hot Topic: Current Drug Targets in Childhood Acute Leukemia (Guest Editor: R.B. Lock)]

Journal: Current Drug Targets
Volume: 8,Issue: 6
Page: 683-683
Authors: R. B. Lock

Editorial [Hot Topic: Mammalian Target of Rapamycin as a Therapeutic Target in Leukemia (Executive Editors: Francis J. Giles / Maher Albitar)]

Journal: Current Molecular Medicine
Volume: 5,Issue: 7
Page: 607-607
Authors: Francis J. Giles and Maher Albitar

Tyrosine Kinases as New Molecular Targets in Treatment of Inflammatory Disorders and Leukemia

Journal: Current Pharmaceutical Design
Volume: 10,Issue: 10
Page: 1083-1091
Authors: Fatih M. Uckun and Chen Mao

New Therapies for Patients with Chronic Lymphocytic Leukemia

Journal: Current Cancer Therapy Reviews
Volume: 4,Issue: 4
Page: 235-242
Authors: Tadeusz Robak and Pawel Robak

Resistance to Imatinib in Chronic Myeloid Leukemia and Therapeutic Approaches to Circumvent the Problem

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 9,Issue: 1
Page: 21-28
Authors: Massimo Breccia and Giuliana Alimena

Molecular Pathogenesis of Philadelphia-Positive Chronic Myeloid Leukemia – is it all BCR-ABL?

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 1
Page: 3-19
Authors: H. Rumpold and G. Webersinke

A Practical Approach to Diagnosis and Treatment of Symptomatic Thromboembolic Events in Children with Acute Lymphoblastic Leukemia: Recommendations of the “Coagulation Defects” AIEOP Working Group

Journal: Recent Patents on Cardiovascular Drug Discovery (Discontinued)
Volume: 2,Issue: 1
Page: 53-62
Authors: Paola Giordano, Giovanni Carlo Del Vecchio, Paola Saracco, Marco Zecca, Angelo Claudio Molinari, Domenico De Mattia and “Cougulation Defects” AIEOP working group

The Phosphoinositide 3-Kinase (PI3K)/AKT Signaling Pathway as a Therapeutic Target for the Treatment of Human Acute Myeloid Leukemia (AML)

Journal: Current Signal Transduction Therapy
Volume: 2,Issue: 3
Page: 246-256
Authors: Alberto M. Martelli, Giovanna Tabellini, Roberta Bortul, Maria Nyakern, Pier Luigi Tazzari, Camilla Evangelisti and Lucio Cocco

Imatinib (STI571) Resistance in Chronic Myelogenous Leukemia: Molecular Basis of the Underlying Mechanisms and Potential Strategies for Treatment

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 4,Issue: 3
Page: 285-299
Authors: Sandra W. Cowan-Jacob, Valerie Guez, Gabriele Fendrich, James D. Griffin, Doriano Fabbro, Pascal Furet, Janis Liebetanz, Jurgen Mestan and Paul W. Manley

CD38 in Chronic Lymphocytic Leukemia: From Bench to Bedside?

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 11,Issue: 6
Page: 503-507
Authors: S. Deaglio, T. Vaisitti, S. Serra, V. Audrito, C. Bologna, G. D'Arena, L. Laurenti, D. Gottardi and F. Malavasi

Daunorubicin Metabolism in Leukemic Cells Isolated from Patients with Acute Myeloid Leukemia

Journal: Drug Metabolism Letters
Volume: 4,Issue: 4
Page: 228-232
Authors: Alex Bogason, Michele Masquelier, Pierre Lafolie, Cristine Skogastierna, Christer Paul, Astrid Gruber and Sigurd Vitols

Editorial [Hot Topic: Novel and Emerging Drugs for Leukemias (Guest Editor: Tadeusz Robak)]

Journal: Current Cancer Drug Targets
Volume: 12,Issue: 5
Page: 453-457
Authors: Tadeusz Robak

Editorial (Hot Topic: The Importance of Rational Chemotherapy of Chronic Lymphocytic Leukemia)

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 23
Page: 3321-3322
Authors: Monika Podhorecka and Przemyslaw Bozko

Poly (D,L-lactic-co-glycolide) Nanoparticles for the Improved Therapeutic Efficacy of All-trans-retinoic Acid: A Study of Acute Myeloid Leukemia (AML) Cell Differentiation In Vitro

Journal: Medicinal Chemistry
Volume: 8,Issue: 5
Page: 805-810
Authors: Aswathy Mary Simon, Sankar Jagadeeshan, Emimol Abraham, Ashalatha Akhilandeshwaran, Jisha J. Pillai, Nisha Asok Kumar, Asha Nair Sivakumari and Gopalakrishnapillai Sankaramangalam Vinod Kumar

Culture Supernatants from Lactobacillus plantarum Induce Necrosis on a Human Promyelocytic Leukemia Cell Line

Journal: Endocrine, Metabolic & Immune Disorders-Drug Targets
Volume: 13,Issue: 2
Page: 195-203
Authors: Elena Puertollano, Gerardo Alvarez de Cienfuegos, Alfonso Ruiz-Bravo, Manuel A. de Pablo and Maria A. Puertollano

Editorial (Thematic Issue: Chronic Myeloid Leukemia: Reaching For the Cure)

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 7
Page: 709-710
Authors: Alessio Nencioni, Michele Cea, Fabrizio Montecucco, Marco Gobbi and Franco Patrone

Glaucocalyxin A and B-induced Cell Death is Related to GSH Perturbation in Human Leukemia HL-60 Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 8
Page: 1280-1290
Authors: Wen Hua Yang, Zhen Zhang, Yang Hu Sima, Jian Zhang and Jian Wen Wang

Angiogenesis in Chronic Lymphocytic Leukemia

Journal: Current Angiogenesis (Discontinued)
Volume: 2,Issue: 2
Page: 96-103
Authors: Sotirios Sachanas, Maria K. Angelopoulou, Pinelopi Korkolopoulou, Christina Kalpadakis, Pantelis Tsirkinidis, Maria Moschogiannis, Xanthi Yiakoumis, Aglaia Dimitrakopoulou, Theodoros P. Vassilakopoulos and Gerassimos A. Pangalis

From the Table to the Bedside: Can Food-Derived Sulforaphane be used as a Novel Agent to Treat Leukemia?

Journal: Current Cancer Drug Targets
Volume: 14,Issue: 5
Page: 434-445
Authors: Koramit Suppipat and H. Daniel Lacorazza

Role of MicroRNAs in B Cell Leukemias and Lymphomas

Journal: Current Molecular Medicine
Volume: 14,Issue: 5
Page: 580-597
Authors: A. Schmidt and R. Kuppers

Editorial (Thematic Issue: Toward Personalized Treatment for Acute Myeloid Leukemia)

Journal: Current Pharmaceutical Biotechnology
Volume: 17,Issue: 1
Page: 4-5
Authors: Frode Selheim and Lars Herfindal

Editorial (Thematic Issue: Targets for Immunotherapy in Acute Leukemia)

Journal: Current Drug Targets
Volume: 18,Issue: 3
Page: 256-256
Authors: Christopher S. Hourigan

Cellular and Molecular Networks in Chronic Myeloid Leukemia: The Leukemic Stem, Progenitor and Stromal Cell Interplay

Journal: Current Drug Targets
Volume: 18,Issue: 4
Page: 377-388
Authors: Danilo Perrotti, Giovannino Silvestri, Lorenzo Stramucci, Justine Yu and Rossana Trotta

Immunomodulatory Drugs: IMiDs in Acute Myeloid Leukemia (AML)

Journal: Current Drug Targets
Volume: 18,Issue: 3
Page: 304-314
Authors: Joshua F. Zeidner and Matthew C. Foster

A Virtual Screening Approach for the Identification of High Affinity Small Molecules Targeting BCR-ABL1 Inhibitors for the Treatment of Chronic Myeloid Leukemia

Journal: Current Topics in Medicinal Chemistry
Volume: 17,Issue: 26
Page: 2989-2996
Authors: Saphy Sharda, Palash Sarmandal, Shirisha Cherukommu, Kiran Dindhoria, Manisha Yadav, Srinivas Bandaru, Anudeep Sharma, Aditi Sakhi, Tanmay Vyas, Tajamul Hussain, Anuraj Nayarisseri and Sanjeev Kumar Singh

Myelodysplastic/Myeloproliferative Neoplasms

Journal: Current Cancer Therapy Reviews
Volume: 8,Issue: 1
Page: 52-65
Authors: Cherie H. Dunphy

Life and Death of Leukemic Cells Under Bcr-Abl Signaling Control

Journal: Current Cancer Therapy Reviews
Volume: 5,Issue: 4
Page: 303-309
Authors: Junya Kuroda and Masafumi Taniwaki

Natural Compounds in Anti-Leukaemic Therapy: A Review

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 11,Issue: 6
Page: 492-502
Authors: L. De Martino, G. D'Arena, R. Filosa, A. Peduto, R. Zeppa and V. De Feo

Combination Therapy with Arsenic Trioxide for Hematological Malignancies

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10,Issue: 6
Page: 504-510
Authors: Shinichiro Takahashi

Chemical Metabolic Inhibitors for the Treatment of Blood-Borne Cancers

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 2
Page: 223-232
Authors: Martin Villalba, Nuria Lopez-Royuela, Ewelina Krzywinska, Moeez G. Rathore, Robert A. Hipskind, Houda Haouas and Nerea Allende-Vega

Casein Kinase II (CK2) as a Therapeutic Target for Hematological Malignancies

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 1
Page: 95-107
Authors: Chandrika Gowda, Mansi Sachdev, Sunil Muthusami, Malika Kapadia, Lidija Petrovic-Dovat, Melanie Hartman, Yali Ding, Chunhua Song, Jonathon L. Payne, Bi-Hua Tan and Sinisa Dovat

The JAK-STAT Pathway: A Therapeutic Target in Hematological Malignancies

Journal: Current Cancer Drug Targets
Volume: 6,Issue: 8
Page: 671-679
Authors: A. Ferrajoli, S. Faderl, F. Ravandi and Z. Estrov

LFA-1 on Leukemic Cells as a Target for Therapy or Drug Delivery

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 21
Page: 2321-2330
Authors: Rungsinee Phongpradist, Chuda Chittasupho, Siriporn Okonogi, Teruna Siahaan, Songyot Anuchapreeda, Chadarat Ampasavate and Cory Berkland

Synthesis of a Fluorescently Labeled Compound for the Detection of Arsenic-induced Apoptotic HL60 Cells

Journal: Medicinal Chemistry
Volume: 8,Issue: 2
Page: 222-229
Authors: A. Lis Femia, C. Facundo Temprana, M. Silvia Amor, Mariano Grasselli and Silvia del V. Alonso

Vascular Endothelial Growth Factor and Its Receptor as Drug Targets in Hematological Malignancies

Journal: Current Drug Targets
Volume: 8,Issue: 2
Page: 257-268
Authors: Torsten Kessler, Frauke Fehrmann, Ralf Bieker, Wolfgang E. Berdel and Rolf M. Mesters

Potential Therapeutic Applications of miRNA-Based Technology in Hematological Malignancies

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 21
Page: 2040-2050
Authors: Elisa Barbarotto and George A. Calin

Recombinant Immunotoxins for the Treatment of Chemoresistant Hematologic Malignancies

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 23
Page: 2652-2664
Authors: Robert J. Kreitman

Synthesis and In Vitro Anticancer Activity of Novel 2-((3-thioureido)carbonyl) phenyl Acetate Derivatives

Journal: Letters in Drug Design & Discovery
Volume: 11,Issue: 2
Page: 132-137
Authors: Lin Xiong, Ya-Qin Gao, Chu-E Niu, Hong-Bo Wang and Wei-Hong Li

Proteomics Approaches to Elucidate Oncogenic Tyrosine Kinase Signalingin Myeloid Malignancies

Journal: Current Pharmaceutical Biotechnology
Volume: 7,Issue: 3
Page: 185-198
Authors: Eystein Oveland, Kari E. Fladmark, Line Wergeland, Bjorn Tore Gjertsen and Randi Hovland

Sch-66336 (Sarasar®) and Other Benzocycloheptapyridyl Farnesyl Protein Transferase Inhibitors: Discovery, Biology and Clinical Observations

Journal: Current Topics in Medicinal Chemistry
Volume: 3,Issue: 10
Page: 1103-1114
Authors: Arthur G. Taveras, Paul Kirschmeier and Charles M. Baum

Design, Synthesis, and In vitro Antitumor Evaluation of Novel Phenylaminopyrimidine Derivatives

Journal: Medicinal Chemistry
Volume: 9,Issue: 3
Page: 340-350
Authors: Youguang Zheng, Ming Zheng, Yi Liu, Yunsheng Xue, Ling Zhang, Lin An, Ling Liu and Min Ji

in vitro Anti-leukaemia Activity of Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs)

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 5,Issue: 1
Page: 58-68
Authors: Gabriella Marfe and Carla Di Stefano

Recent Clinical Trials of Cladribine in Hematological Malignancies and Autoimmune Disorders

Journal: Reviews on Recent Clinical Trials
Volume: 1,Issue: 1
Page: 15-34
Authors: Tadeusz Robak, Agnieszka Wierzbowska and Ewa Robak

Developing Target Therapy Against Oncogenic Tyrosine Kinase in Myeloid Maliganacies

Journal: Current Pharmaceutical Biotechnology
Volume: 7,Issue: 5
Page: 331-337
Authors: Tomoki Naoe

Menin, Histone H3 Methyltransferases, and Regulation of Cell Proliferation: Current Knowledge and Perspective

Journal: Current Molecular Medicine
Volume: 8,Issue: 8
Page: 805-815
Authors: Xinjiang Wu and Xianxin Hua

Regulation of Death and Growth Signals at the Plasma Membrane by Sphingomyelin Synthesis: Implications for Hematological Malignancies

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 6,Issue: 3
Page: 324-333
Authors: Elodie Lafont, Kazuyuki Kitatani, Toshiro Okazaki and Bruno Segui

α-Methylene-γ-lactones as a Novel Class of Anti-leukemic Agents

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 5
Page: 688-694
Authors: Katarzyna Gach and Anna Janecka

Gallic Acid as the Main in vitro Antileukemia Compound from Kalanchoe thyrsiflora Leaf Extract

Journal: Current Traditional Medicine
Volume: 1,Issue: 3
Page: 203-216
Authors: Isabel Cristina Vieira da Silva, Livia Marques Casanova, Gleison Magalhães Freitas, Thiago Martino, Monica Farah Pereira, Fernanda Helena Pereira dos Santos, Katia Costa de Carvalho Sabino and Sônia Soares Costa

Determination of the Antiproliferative Activity of New Theobromine Derivatives and Evaluation of Their In Vitro Hepatotoxic Effects

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16,Issue: 7
Page: 925-932
Authors: Maya Georgieva, Magdalena Kondeva-Burdina, Javor Mitkov, Virginia Tzankova, Georgi Momekov and Alexander Zlatkov

Established Human Cell Lines as Models to Study Anti-leukemic Effects of Flavonoids

Journal: Current Genomics
Volume: 18,Issue: 1
Page: 3-26
Authors: Katrin Sak and Hele Everaus

Signal Transduction Therapy for Cancer - Whither Now?

Journal: Current Signal Transduction Therapy
Volume: 1,Issue: 1
Page: 1-12
Authors: Shoshana Klein and Alexander Levitzki

Current Status and Perspectives in Ceramide-Targeting Molecular Medicine

Journal: Current Pharmaceutical Design
Volume: 11,Issue: 19
Page: 2479-2487
Authors: Hirofumi Sawai, Naochika Domae and Toshiro Okazaki

Omacetaxine as an Anticancer Therapeutic: What is Old is New Again

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 1
Page: 59-64
Authors: Meir Wetzler and David Segal

Aromatic Sulfonamides Containing a Condensed Piperidine Moiety as Potential Oxidative Stress-Inducing Anticancer Agents

Journal: Medicinal Chemistry
Volume: 9,Issue: 7
Page: 911-919
Authors: Ramóna Madácsi, Iván Kanizsai, Liliána Z. Fehér, Márió Gyuris, Béla Ózsvári, András Erdélyi, János Wölfling and László G. Puskás

Histone Deacetylase Inhibitors: Potent Anti-Leukemic Agents

Journal: Current Medicinal Chemistry
Volume: 22,Issue: 17
Page: 2065-2074
Authors: Jiang Bian, Lihui Zhang, Yantao Han, Chunbo Wang and Lei Zhang

Approaches to Optimize Gene Therapy for the Treatment of Hematologic Malignancies: Overcoming the Obstacles

Journal: Current Gene Therapy
Volume: 16,Issue: 6
Page: 390-400
Authors: Yingzhe Jiang, Bing Xia, Yizhuo Zhang and Wen Xu

Cancer Stem Cells – Are Surface Markers Alone Sufficient?

Journal: Current Stem Cell Research & Therapy
Volume: 12,Issue: 1
Page: 37-44
Authors: Rohit P. Nagare, Smarakan Sneha, Syama Krishna Priya and Trivadi S. Ganesan

Nuclear Factor-κB: A Holy Grail in Cancer Prevention and Therapy

Journal: Current Signal Transduction Therapy
Volume: 1,Issue: 1
Page: 25-52
Authors: Bharat B. Aggarwal, Gautam Sethi, Asha Nair and Haruyo Ichikawa

Biological Basis of Novel Therapies for Myelodysplastic Syndrome

Journal: Current Cancer Therapy Reviews
Volume: 2,Issue: 3
Page: 199-209
Authors: Eyal C. Attar and Karen K. Ballen

Small Molecule FLT3 Tyrosine Kinase Inhibitors

Journal: Current Pharmaceutical Design
Volume: 10,Issue: 11
Page: 1183-1193
Authors: Mark Levis and Donald Small

The Use of Computational Methods in the Discovery and Design of Kinase Inhibitors

Journal: Current Pharmaceutical Design
Volume: 8,Issue: 17
Page: 1527-1545
Authors: John R. Woolfrey and G. Scott Weston

NK Cell Receptors and Their Interactions with MHC

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 28
Page: 3301-3310
Authors: Roberto Biassoni, Elisabetta Ugolotti and Andrea De Maria

Exploring Old Drugs for the Treatment of Hematological Malignancies

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 10
Page: 1509-1514
Authors: F. Gan, B. Cao, D. Wu, Z. Chen, T. Hou and X. Mao

Inhibitors of Apoptosis Proteins (IAPs) as Potential Molecular Targets for Therapy of Hematological Malignancies

Journal: Current Molecular Medicine
Volume: 11,Issue: 8
Page: 633-649
Authors: P. Smolewski and T. Robak

Leptomeningeal Metastasis: Challenges in Diagnosis and Treatment

Journal: Current Cancer Therapy Reviews
Volume: 7,Issue: 4
Page: 319-327
Authors: Ticiana Leal, Julie E. Chang, Minesh Mehta and H. Ian Robins

The Chemokine Receptor CXCR4 as a Therapeutic Target for Several Diseases

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 6,Issue: 9
Page: 989-995
Authors: Hirokazu Tamamura, Hiroshi Tsutsumi and Nobutaka Fujii

Copper Complexes of Henna-Sulforaphane Conjugates as Potent Antiproliferative Agents Against Human Myeloma KBM-5 Cells Through Blockade of Transcription Factor NF-κB

Journal: Letters in Drug Design & Discovery
Volume: 4,Issue: 4
Page: 257-262
Authors: K. Shirisha, J. Patole, S. Padhye, E. Sinn, S. Shishodia and B. B. Aggarwal

Synthesis and Anticancer Activity of Phthalimido and Naphthalimido Substituted Dihydropyrimidone Conjugates

Journal: Letters in Drug Design & Discovery
Volume: 5,Issue: 4
Page: 261-270
Authors: Ahmed Kamal, S. F. Adil, Jaki R. Tamboli, B. Siddardha and U. S.N. Murthy

Novel Purine Nucleoside Analogues for Hematological Malignancies

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 3,Issue: 2
Page: 123-136
Authors: Anna Korycka, Ewa Lech-Maranda and Tadeusz Robak

Efficient Synthesis of Aza-Phenanthroindolizidine and Aza-Phenanthroquinolizidine and Anticancer Activities

Journal: Letters in Organic Chemistry
Volume: 5,Issue: 5
Page: 383-390
Authors: Kailiang Wang, Wenlong Wang, Qingmin Wang and Runqiu Huang

Synthesis and Antitumor Activity of Novel 4-Chloro-3-Arylmaleimide Derivatives

Journal: Letters in Drug Design & Discovery
Volume: 6,Issue: 1
Page: 51-55
Authors: Guiqing Xu, Qiaojun He, Bo Yang and Yongzhou Hu

Synthesis and Antitumor Evaluation of (E)-2-Benzothiazole Hydrazones

Journal: Letters in Drug Design & Discovery
Volume: 7,Issue: 8
Page: 551-555
Authors: Antonio Francisco Nogueira, Elisa Carvalho Azevedo, Vitor Francisco Ferreira, Ana Jersia Araujo, Evelyne Alves dos Santos, Claudia Pessoa, Leticia Veras Costa-Lotufo, Raquel Carvalho Montenegro, Manoel Odorico de Moraes and Thatyana Rocha Alves Vasconcelos


Fractal Analysis of the Bone Marrow in Myelodysplastic Syndromes

Journal: Current Bioinformatics
Volume: 9,Issue: 4
Page: 408-413
Authors: Giorgio Bianciardi and Pietro Luzi

VFP: A Visual Algorithm for Predicting Gene Fusion in RNA-Seq Data

Journal: Current Bioinformatics
Volume: 11,Issue: 1
Page: 115-121
Authors: Ye Yang and Juan Liu

RBM15 Functions in Blood Diseases

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 7
Page: 579-585
Authors: Mengyu Hu, Yuxia Yang, Zhi Ji and Jianyuan Luo

An Antileukemic Glutaminase Free L-Asparaginase from Bacillus brevis

Journal: Current Biotechnology
Volume: 6,Issue: 1
Page: 58-68
Authors: Wamik Azmi, Umesh Kumar Narta, Nishant Singh, Vibhor Gupta, Shamsher Singh Kanwar and Sarita Devi

Older and New Formulations of Cladribine. Pharmacology and Clinical Efficacy in Hematological Malignancies

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 1,Issue: 1
Page: 23-38
Authors: Tadeusz Robak, Anna Korycka and Ewa Robak

Inhibition of Abl Kinases by Intramolecular and Intermolecular Interactions: A Lesson from Structure Studies and CML Therapy

Journal: Current Enzyme Inhibition
Volume: 2,Issue: 2
Page: 135-146
Authors: Baojie Li

Human Terminal Deoxynucleotidyl Transferases as Novel Targets for Anticancer Chemotherapy

Journal: Current Medicinal Chemistry
Volume: 13,Issue: 20
Page: 2353-2368
Authors: Giovanni Maga and Roberto Di Santo

Development of Low Molecular Weight CXCR4 Antagonists by Exploratory Structural Tuning of Cyclic Tetra- and Pentapeptide-Scaffolds Towards the Treatment of HIV Infection, Cancer Metastasis and Rheumatoid Arthritis

Journal: Current Medicinal Chemistry
Volume: 14,Issue: 1
Page: 93-102
Authors: Hirokazu Tamamura, Hiroshi Tsutsumi, Hiroyuki Masuno and Nobutaka Fujii

Retinoids as Differentiating Agents in Oncology: A Network of Interactions with Intracellular Pathways as the Basis for Rational Therapeutic Combinations

Journal: Current Pharmaceutical Design
Volume: 13,Issue: 13
Page: 1375-1400
Authors: Enrico Garattini, Maurizio Gianni and Mineko Terao

Kinases as Drug Discovery Targets in Hematologic Malignancies

Journal: Current Molecular Medicine
Volume: 5,Issue: 7
Page: 625-642
Authors: A. L. Hannah

Antiangiogenic Therapy in Hematologic Malignancies

Journal: Current Pharmaceutical Design
Volume: 10,Issue: 11
Page: 1221-1234
Authors: Moehler T. M., Hillengass J., Goldschmidt H. and Ho A. D.

Benzamide Riboside, a Recent Inhibitor of Inosine 5-Monophosphate Dehydrogenase Induces Transferrin Receptors in Cancer Cells

Journal: Current Medicinal Chemistry
Volume: 9,Issue: 7
Page: 759-764
Authors: Thomas Szekeres, Jan Sedlak and Ladislav Novotny

Novel Approaches to Deliver Gemcitabine to Cancers

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 11
Page: 1124-1137
Authors: L. Harivardhan Reddy and Patrick Couvreur

The Molecular Bases of the Self-Renewal and Differentiation of Leukemic Stem Cells

Journal: Current Cancer Therapy Reviews
Volume: 4,Issue: 3
Page: 178-187
Authors: Kazuhito Naka, Masako Ohmura, Takayuki Hoshii, Teruyuki Muraguchi and Atsushi Hirao

Targeting Cyclooxygenase-2 in Hematological Malignancies: Rationale and Promise

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 21
Page: 2051-2060
Authors: M. P. Bernard, S. Bancos, P. J. Sime and R. P. Phipps

Chemical and Clinical Development of Darinaparsin, a Novel Organic Arsenic Derivative

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 8,Issue: 8
Page: 904-909
Authors: Alfonso Quintas-Cardama, Srdan Verstovsek, Emil Freireich, Hagop Kantarjian, Yi Wen Chen and Ralph Zingaro

The PI3K/Akt Pathway as a Target in the Treatment of Hematologic Malignancies

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 5
Page: 550-559
Authors: Kiyotaka Kawauchi, Toshie Ogasawara, Masako Yasuyama, Kuniaki Otsuka and Osamu Yamada

The Pim Kinases: New Targets for Drug Development

Journal: Current Drug Targets
Volume: 12,Issue: 14
Page: 2059-2066
Authors: Ronan Swords, Kevin Kelly, Jennifer Carew, Stefan Nawrocki, Devalingam Mahalingam, John Sarantopoulos, David Bearss and Francis Giles

Development ofNovel Compounds to Treat Autoimmune and Inflammatory Diseases and Graft Versus Host Reactions

Journal: Endocrine, Metabolic & Immune Disorders-Drug Targets
Volume: 7,Issue: 2
Page: 93-97
Authors: S. Appel and P. Brossart

Interaction Between Arsenic Trioxide and Human Primary Cells: Emphasis on Human Cells of Myeloid Origin

Journal: Inflammation & Allergy-Drug Targets (Discontinued)
Volume: 8,Issue: 1
Page: 21-27
Authors: Francois Binet, Francis Antoine and Denis Girard

Synthesis and Biological Activity of New Class of Dioxygenated Anticancer Agents

Journal: Current Medicinal Chemistry-Anti-Cancer Agents
Volume: 5,Issue: 3
Page: 215-237
Authors: Maria Dolors Pujol, Manel Romero and Isabel Sanchez

The Use of Proteomics for Systematic Analysis of Normal and Transformed Hematopoietic Stem Cells

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 13
Page: 1730-1750
Authors: Sara Cadeco, Andrew J.K. Williamson and Anthony D. Whetton

Quantifying the Structural Requirements for Designing Newer FLT3 Inhibitors

Journal: Medicinal Chemistry
Volume: 8,Issue: 5
Page: 913-927
Authors: Rajiv Kumar Kar, Priyanka Suryadevara, Rajesh Roushan, Ganesh Chandra Sahoo, Manas Ranjan Dikhit and Pradeep Das

Synthesis and Anticancer Activity of 3a,4-dihydro-3H-indeno[1, 2-c]pyrazole-2-carboxamide Analogues

Journal: Letters in Drug Design & Discovery
Volume: 9,Issue: 9
Page: 823-827
Authors: Mohamed Jawed Ahsan

Equipping CAR-Modified T Cells with a Brake to Prevent Chronic Adverse Effects

Journal: Current Gene Therapy
Volume: 12,Issue: 6
Page: 493-495
Authors: Wei Wang and Yongsheng Wang

Targeting Bcl-2 in CLL

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 30
Page: 5109-5115
Authors: M. Rogalinska and Z.M. Kilianska

C-KIT Signaling in Cancer Treatment

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 17
Page: 2849-2880
Authors: Karmen Stankov, Stevan Popovic and Momir Mikov

Allosteric Inhibitors of Bcr-Abl: Towards Novel Myristate-Pocket Binders

Journal: Current Pharmaceutical Biotechnology
Volume: 14,Issue: 5
Page: 477-487
Authors: Marco Radi, Silvia Schenone and Maurizio Botta

Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies

Journal: Current Cancer Drug Targets
Volume: 15,Issue: 9
Page: 769-780
Authors: Lei Cao, Lei Fan, Wei Xu and Jian-Yong Li

The Evolving Landscape in the Development of Isocitrate Dehydrogenase Mutant Inhibitors

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 16,Issue: 16
Page: 1344-1358
Authors: Jiao Chen, Jie Yang and Peng Cao

Hybrid Pharmacophore Design and Synthesis of Naphthalimide– Benzimidazole Conjugates as Potential Anticancer Agents

Journal: Letters in Drug Design & Discovery
Volume: 12,Issue: 5
Page: 374-384
Authors: Ahmed Kamal, Pogula Praveen Kumar, Mohammed Naseer Ahmed Khan, Bobburi Naga Sheshadri and Naga Sheshadri

Gene Expression (Microarray) Data Analysis by Chemometric Methods

Journal: Current Analytical Chemistry
Volume: 3,Issue: 3
Page: 233-237
Authors: David X. Zhu, Richard J. Goeke, David L. Baker, James H. Hamburg, David E. Booth and Stephane E. Booth

Monoclonal Antibody-Based Therapy Strategies: Providing Options for the Cancer Patient

Journal: Current Pharmaceutical Design
Volume: 8,Issue: 19
Page: 1749-1764
Authors: Diane E. Milenic

Antitumor Activity of Benzamide Riboside In Vitro and In Vivo

Journal: Current Medicinal Chemistry
Volume: 9,Issue: 7
Page: 773-779
Authors: Ladislav Novotny, Peter Rauko, Joel A. Yalowitz and Thomas Szekeres

Interferon Therapy for Malignant Solid Tumors

Journal: Current Drug Therapy
Volume: 5,Issue: 2
Page: 132-138
Authors: Katherine E. Warren and Howard A. Young

Update on MDS Therapy: From Famine to Feast

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 8,Issue: 4
Page: 187-198
Authors: Preeti Chaudhary and Chirag Shah

Synthesis and In Vitro Biological Activity Evaluation of the Derivatives of Combretastatin A-4

Journal: Letters in Drug Design & Discovery
Volume: 3,Issue: 8
Page: 544-546
Authors: Zhaoqi Yang

Synthesis and Preliminary Antitumor Activity of Distamycin Nitrogen Mustards

Journal: Letters in Drug Design & Discovery
Volume: 4,Issue: 1
Page: 37-39
Authors: Yuqiang Wang, Zhaoqi Yang, Susan C. Wright and James W. Larrick

Cellular Pharmacology, Antineoplastic Activity and Low In Vivo Toxicity of a Carboxylato-Bridged Platinum(II) Complex bis(acetato)diammine-bis-μ-acetato diplatinum (II) Dihydrate

Journal: Medicinal Chemistry
Volume: 3,Issue: 2
Page: 157-165
Authors: Georgi Momekov, Spiro Konstantinov, Margarita Topashka-Ancheva, Adriana Bakalova, Sonja Arpadjan and Margarita Karaivanova

The Influence of Traumatic Lumbar Puncture (TLP) on Outcome of Pediatric Patients

Journal: Current Pediatric Reviews
Volume: 1,Issue: 3
Page: 249-251
Authors: Angela Rech and Algemir L. Brunetto

Antagonists Against Anti-Apoptotic Bcl-2 Family Proteins for Cancer Treatment.

Journal: Mini-Reviews in Organic Chemistry
Volume: 5,Issue: 3
Page: 171-178
Authors: Jignesh M. Doshi and Chengguo Xing

The Novel Role for Lyn in Integrin Signaling in Human Disease

Journal: Current Signal Transduction Therapy
Volume: 4,Issue: 1
Page: 59-65
Authors: Brian Tomkowicz and Andrzej Ptasznik

Clofarabine as a Novel Nucleoside Analogue Approved to Treat Patients with Haematological Malignancies: Mechanism of Action and Clinical Activity

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 9,Issue: 7
Page: 805-812
Authors: Ewa Lech-Maranda, Anna Korycka and Tadeusz Robak

Synthesis of Novel Substituted 1,3-diarylpropenone Derivatives and their In Vitro Cytotoxic Activity

Journal: Letters in Drug Design & Discovery
Volume: 6,Issue: 5
Page: 353-357
Authors: Yordanka Ivanova, Georgi Momekov and Ognyan Petrov

Inhibitors of NMT: A New Class of Chemotherapeutic Drugs

Journal: Drug Design Reviews - Online (Discontinued)
Volume: 1,Issue: 4
Page: 347-354
Authors: Gagan Bajaj, Anuraag Shrivastav, Ponniah Selvakumar, Mohammed Khysar Pasha, Yanjie Lu, Jonathan R Dimmock and Rajendra K Sharma

Genome-wide Analysis of Myelodysplastic Syndromes

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 22
Page: 3163-3169
Authors: Masashi Sanada and Seishi Ogawa

Implication of microRNAs in the Pathogenesis of MDS

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 22
Page: 3170-3179
Authors: Jing Fang, Melinda Varney and Daniel T. Starczynowski

Pharmacogenomic Approaches for Tailored Anti-Leukemic Therapy in Children

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 17
Page: 2237-2253
Authors: G. Stocco, R. Franca, F. Verzegnassi, M. Londero, M. Rabusin and G. Decorti

Anticancer Activity of Ferrocenylthiosemicarbazones

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 3
Page: 459-465
Authors: Cortez-Maya Sandra, Klimova Elena, Flores-Alamo Marcos, Martínez-Klimova Elena, Ramírez-Ramírez Arturo, Ramírez Apan Teresa and Martínez-García Marcos

New Perspective on the Dual Functions of Indirubins in Cancer Therapy and Neuroprotection

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 9
Page: 1213-1219
Authors: Ying Wang, Pui Man Hoi, Judy Yuet-Wa Chan and Simon M.-Y. Lee

Emerging Drug Target In Pancreatic Cancer: Placing Sirtuin 1 on the Canvas

Journal: Current Cancer Drug Targets
Volume: 15,Issue: 6
Page: 463-468
Authors: Marc Giry-Laterriere, Andreia V. Pinho, Nils Eling, Lorraine Chantrill and Ilse Rooman

Thymoquinone Anticancer Discovery: Possible Mechanisms

Journal: Current Drug Discovery Technologies
Volume: 12,Issue: 2
Page: 80-89
Authors: Ali H. El-Far

Design, Synthesis and Biological Evaluation of Novel Tamibarotene Derivative as Multitarget Anticancer Agent

Journal: Letters in Drug Design & Discovery
Volume: 13,Issue: 8
Page: 729-733
Authors: Yuqi Jiang, Jinning Hou, Xiaoyang Li, Wenfang Xu and Yingjie Zhang

Five Pediatric Cancers – Update on Genetic Implications

Journal: Current Pediatric Reviews
Volume: 13,Issue: 1
Page: 42-48
Authors: Stacy Cooper, Jeffrey Rubens and Joann Bodurtha

Immunotoxins in the Treatment of Hematologic Malignancies

Journal: Current Drug Targets
Volume: 7,Issue: 10
Page: 1301-1311
Authors: Robert J. Kreitman and Ira Pastan

Arsenic Trioxide in Hematological Malignancies: The New Discovery of an Ancient Drug

Journal: Current Pharmaceutical Biotechnology
Volume: 7,Issue: 6
Page: 397-405
Authors: A. Bonati, V. Rizzoli and P. Lunghi

Purine Nucleoside Analogues for the Treatment of Hematological Malignancies: Pharmacology and Clinical Applications

Journal: Current Cancer Drug Targets
Volume: 5,Issue: 6
Page: 421-444
Authors: T. Robak, A. Korycka, M. Kasznicki, A. Wrzesien-Kus and P. Smolewski

Tyrosine Kinase Blockers: New Hope for Successful Cancer Therapy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 1
Page: 66-76
Authors: Dariusz Pytel, Tomasz Sliwinski, Tomasz Poplawski, Deborah Ferriola and Ireneusz Majsterek

FK506 Binding Proteins as Targets in Anticancer Therapy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10,Issue: 9
Page: 651-656
Authors: Simona Romano, AnnaLaura Di Pace, Antonio Sorrentino, Rita Bisogni, Luigi Sivero and Maria Fiammetta Romano

Immunotherapeutic and Immunoregulatory Drugs in Haematologic Malignancies

Journal: Current Topics in Medicinal Chemistry
Volume: 6,Issue: 16
Page: 1657-1686
Authors: Gerassimos A. Pangalis, Marie-Christine Kyrtsonis, Theodoros P. Vassilakopoulos, Maria N. Dimopoulou, Marina P. Siakantaris, Christos Emmanouilides, Dimitris Doufexis, Sotirios Sahanas, Flora N. Kontopidou, Christina Kalpadakis, Maria K. Angelopoulou, Evangelia M. Dimitriadou, Styliani I. Kokoris and Panayiotis Panayiotidis

Promising Activity of Mammalian Target of Rapamycin Inhibitors in Hematologic Malignancies Therapy

Journal: Current Signal Transduction Therapy
Volume: 6,Issue: 1
Page: 44-54
Authors: Ota Fuchs

The Role of B Cell Receptor Stimulation in CLL Pathogenesis

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 23
Page: 3335-3355
Authors: Laurens P. Kil, Saravanan Yuvaraj, Anton W. Langerak and Rudi W. Hendriks

Mechanistic Insights into the Antileukemic Activity of Hyperforin

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 1
Page: 1-10
Authors: C. Billard, F. Merhi and B. Bauvois

Inhibition of PCAF by Anacardic Acid Derivative Leads to Apoptosis and Breaks Resistance to DNA Damage in BCR-ABL-expressing Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 5
Page: 762-767
Authors: Monika Kusio- Kobialka, Wioleta Dudka- Ruszkowska, Massimo Ghizzoni, Frank J. Dekker and Katarzyna Piwocka

Origins and Consequences of AID Expression in Lymphoid Neoplasms

Journal: Current Immunology Reviews
Volume: 9,Issue: 2
Page: 72-85
Authors: Damien Montamat-Sicotte, Florencia Palacios, Javier M. Di Noia and Pablo Oppezzo

Differential Network Analysis in Human Cancer Research

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 1
Page: 4-10
Authors: Ryan Gill, Somnath Datta and Susmita Datta

Expression and Function of the Transient Receptor Potential Ion Channel Family in the Hematologic Malignancies

Journal: Current Molecular Pharmacology
Volume: 6,Issue: 3
Page: 137-148
Authors: Maria B. Morelli, Sonia Liberati, Consuelo Amantini, Massimo Nabiss, Matteo Santoni, Valerio Farfariello and Giorgio Santoni

Transforming Mutations of Jak3 (A573V and M511I) Show Differential Sensitivity to Selective Jak3 Inhibitors

Journal: Clinical Cancer Drugs
Volume: 3,Issue: 2
Page: 131-137
Authors: G. Steven Martinez, Jeremy A. Ross and Robert A. Kirken

Antihyperlipidemic, Antioxidant and Cytotoxic Activities of Methanolic and Aqueous Extracts of Different Parts of Star Fruit

Journal: Current Pharmaceutical Biotechnology
Volume: 17,Issue: 10
Page: 915-925
Authors: Sultan A.M. Saghir, Amirin Sadikun, Fouad S.R. Al-Suede, Amin M.S.A. Majid and Vikneswaran Murugaiyah

In Vitro Anticancer Effects of Two New Potent Hydrazide Compounds on Leukemic Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16,Issue: 12
Page: 1646-1651
Authors: Shahrzad Tavakolfar, Elham Mousavi, Ali Almasirad, Amir Amanzadeh, Seyyed Mohamamd Atyabi, Parichehr Yaghamii, Somayeh Samiee-Sadr and Mona Salimi

Is Going for Cure in CML Targeting Aberrant Glycogen Synthase Kinase 3β?

Journal: Current Drug Targets
Volume: 18,Issue: 4
Page: 396-404
Authors: Concetta Saponaro, Michele Maffia, Nicola Di Renzo and Addolorata Maria Luce Coluccia

Hepoxilin Analogs, Potential New Therapeutics in Disease

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 8
Page: 963-969
Authors: C. R. Pace-Asciak, X. Li, N. Qiao, D. Reynaud, P. Demin and M. Abdelhaleem

Potential Use of Pharmacological Cyclin-Dependent Kinase Inhibitors as Anti-HIV Therapeutics

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 16
Page: 1949-1961
Authors: Anne Pumfery, Cynthia d. l. Fuente, Reem Berro, Sergei Nekhai, Fatah Kashanchi and Sheng-Hao Chao

Cytotoxic Molecules from Natural Sources: Tapping the Brazilian Biodiversity

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 6,Issue: 4
Page: 367-375
Authors: Ivana Barbosa Suffredini, Antonio Drauzio Varella and Riad Naim Younes

Intracellular Restriction Factors In Mammalian Cells - An Ancient Defense System Finds A Modern Foe

Journal: Current HIV Research
Volume: 4,Issue: 2
Page: 141-168
Authors: Jorg G. Baumann

The Bcl10 / Malt1 Signaling Pathway as a Drug Target in Lymphoma

Journal: Current Drug Targets
Volume: 7,Issue: 10
Page: 1335-1340
Authors: P. Jost, C. Peschel and J. Ruland

NF-κB Signaling and Carcinogenesis

Journal: Current Pharmaceutical Design
Volume: 13,Issue: 5
Page: 447-462
Authors: Takashi Okamoto, Takaomi Sanda and Kaori Asamitsu

Myelodysplastic Syndromes: Review of Pathophysiology and Current Novel Treatment Approaches

Journal: Current Cancer Drug Targets
Volume: 7,Issue: 6
Page: 541-558
Authors: E. D. Warlick and B. D. Smith

Stromal Derived Growth Factor-1alpha as a Beacon for Stem Cell Homing in Development and Injury

Journal: Current Neurovascular Research
Volume: 2,Issue: 4
Page: 319-329
Authors: C. M. Claps, K. E. Corcoran, K. J. Cho and P. Rameshwar

Development of Molecular Targeted Anticancer Agents: Successes, Failures and Future Directions

Journal: Current Pharmaceutical Design
Volume: 11,Issue: 2
Page: 265-272
Authors: Eric X. Chen and Lillian L. Siu

The Epigenomic Viewpoint on Cellular Differentiation of Myeloid Progenitor Cells as it Pertains to Leukemogenesis

Journal: Current Genomics
Volume: 6,Issue: 3
Page: 137-143
Authors: Vincent E. Sollars

Therapeutic Potential of Janus Kinase 3 (JAK3) Inhibitors

Journal: Current Pharmaceutical Design
Volume: 10,Issue: 15
Page: 1767-1784
Authors: M. Cetkovic-Cvrlje and H. E. Tibbles

Cytokine Transport Across the Injured Blood-Spinal Cord Barrier

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 16
Page: 1620-1624
Authors: Weihong Pan and Abba J. Kastin

Metabolism and the Paradoxical Effects of Arsenic: Carcinogenesis and Anticancer

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 22
Page: 2293-2304
Authors: Xing Cui, Yayoi Kobayashi, Makoto Akashi and Ryuichi Okayasu

Transcriptome and Proteome Analyses of Drug Interactions with Natural Products

Journal: Current Drug Metabolism
Volume: 9,Issue: 10
Page: 1038-1048
Authors: Hai Fang, Kankan Wang and Ji Zhang

Imatinib and Its Successors – How Modern Chemistry has Changed Drug Development

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 2
Page: 120-133
Authors: Bernhard A. Muller

Tyrosine Kinase Inhibitors

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 5
Page: 462-483
Authors: C. Natoli, B. Perrucci, F. Perrotti, L. Falchi and S. Iacobelli

Personalized Medicine in Oncology: A Personal View with Myths and Facts

Journal: Current Clinical Pharmacology
Volume: 5,Issue: 3
Page: 141-147
Authors: Jos H. Beijnen and Jan H.M. Schellens

Exploratory Study on the Effects of Biodegradable Nanoparticles with Drugs on Malignant B Cells and on a Human/Mouse Model of Burkitt Lymphoma

Journal: Current Clinical Pharmacology
Volume: 5,Issue: 4
Page: 246-250
Authors: Gustavo H. Marin, Eduardo Mansilla, Nelly Mezzaroba, Sonia Zorzet, Luis Nunez, Gustavo Larsen, Jose M. Tau, Alberto Maceira, Ruben Spretz, Carol Mertz, Sabrina Ingrao, Claudio Tripodo, Francesco Tedesco and Paolo Macor

Current Treatment Concepts of CML

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 1
Page: 31-43
Authors: A. A. Leitner, A. Hochhaus and M. C. Muller

Recent Developments in the Third Generation Inhibitors of Bcr-Abl for Overriding T315I Mutation

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 14
Page: 2146-2157
Authors: X. Y. Lu, Q. Cai and K. Ding

Deciphering the Role of Forkhead Transcription Factors in Cancer Therapy

Journal: Current Drug Targets
Volume: 12,Issue: 9
Page: 1284-1290
Authors: Jer-Yen Yang and Mien-Chie Hung

Epidemiology and Prevention of Bacterial Infections in Patients with Hematologic Malignancies

Journal: Infectious Disorders - Drug Targets
Volume: 11,Issue: 1
Page: 11-17
Authors: Jeffrey Tessier and Costi D. Sifri

Novel (S)-(-)- and R-(+)-seco-iso-cyclopropylfurano[e]indoline-5,6,7- trimethoxyindole-2-carboxamide (iso-CFI) Analogs of Duocarmycin C2: Synthesis and Biological Evaluation

Journal: Medicinal Chemistry
Volume: 2,Issue: 2
Page: 139-146
Authors: John A. Hartley, Moses Lee, Konstantinos Kiakos, Stephen Hudson, Heather Townes, Kaitlin Summerville, Adrienne Scott, Brian Lingerfelt and Bethany Purnell

Design, Synthesis and Biological Testing of Cyclohexenone Derivatives of Combretastatin-A4

Journal: Letters in Drug Design & Discovery
Volume: 4,Issue: 2
Page: 144-148
Authors: Jennifer Ruprich, Andrew Prout, John Dickson, Brent Younglove, Lawrence Nolan, Khyati Baxi, Regan LeBlanc, Lori Forrest, Patrice Hills, Herman Holt Jr, Hilary Mackay, Toni Brown, Susan L. Mooberry and Moses Lee

Implication of Possible Therapies Targeted for the Tachykinergic System with the Biology of Neurokinin Receptors and Emerging Related Proteins

Journal: Recent Patents on CNS Drug Discovery
Volume: 2,Issue: 1
Page: 79-84
Authors: Pranela Rameshwar

Last Findings on Dual Inhibitors of Abl and Src Tyrosine-Kinases

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7,Issue: 2
Page: 191-201
Authors: S. Schenone, F. Manetti and M. Botta

Stereochemistry as a Determinant of the Anti-Leukemic Potency of Halopyridyl and Thiazolyl Thiourea Compounds

Journal: Letters in Drug Design & Discovery
Volume: 4,Issue: 5
Page: 318-326
Authors: Taracad K. Venkatachalam, Alexi O. Vassilev, Alexi Benyunov, Olga O. Grigoriants, Heather E. Tibbles and Fatih M. Uckun

Cell Cycle Regulatory Kinase Modulators: Interim Progress and Issues

Journal: Current Topics in Medicinal Chemistry
Volume: 5,Issue: 12
Page: 1109-1117
Authors: Edward A. Sausville

Selenium Compounds and Apoptotic Modulation: A New Perspective in Cancer Therapy

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 8,Issue: 10
Page: 1020-1031
Authors: Carmen Sanmartin, Daniel Plano and Juan Antonio Palop

Natural Products and their Analogues as Efficient Anticancer Drugs

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 9,Issue: 5
Page: 560-571
Authors: Sergiu Coseri

Effects of Salinomycin on Cancer Stem Cell in Human Lung Adenocarcinoma A549 Cells

Journal: Medicinal Chemistry
Volume: 7,Issue: 2
Page: 106-111
Authors: Yi Wang

Inhibition of Apoptosis in Pediatric Cancer by Survivin

Journal: Current Pediatric Reviews
Volume: 7,Issue: 4
Page: 277-284
Authors: Ayman Samkari and Rachel A. Altura

Synthesis and Antitumoral Evaluation of Benzyl (1S)-2-[2-(monosubstituted-benzylidene)hydrazino]-1-(hydroxymethyl)-2-oxoethylcarbamate

Journal: Letters in Drug Design & Discovery
Volume: 9,Issue: 3
Page: 257-262
Authors: Raquel Carvalho Montenegro, Leticia Veras Costa Lotufo, Manoel Odorico de Moraes, Claudia do O Pessoa, Felipe Augusto Rocha Rodrigues, Alessandra Campbell Pinheiro, Thais Cristina Mendonça Nogueira and Marcus Vinicius Nora de Souza

Fucose Specific Lectins in Cancer Research and Diagnosis

Journal: Drug Design Reviews - Online (Discontinued)
Volume: 2,Issue: 5
Page: 349-359
Authors: Oksana Y. Praizel, Rima P. Evstigneeva, Igor A. Yamskov and Alexander A. Shtil

Progress in the Development of Aminopeptidase N (APN/CD13) Inhibitors

Journal: Current Medicinal Chemistry-Anti-Cancer Agents
Volume: 5,Issue: 3
Page: 281-301
Authors: Wenfang Xu and Qianbin Li

Synthetic Retinoids and Their Nuclear Receptors

Journal: Current Medicinal Chemistry-Anti-Cancer Agents
Volume: 4,Issue: 3
Page: 199-230
Authors: M. I. Dawson

Actinium-225 in Targeted Alpha-Particle Therapeutic Applications

Journal: Current Radiopharmaceuticals
Volume: 4,Issue: 4
Page: 306-320
Authors: David A. Scheinberg and Michael R. McDevitt

A Triphenyltin(IV) Nicotinate Derivative – Synthesis and Toxicity Towards Different Tumour and Normal Cell Lines

Journal: Letters in Drug Design & Discovery
Volume: 9,Issue: 8
Page: 737-741
Authors: Santiago Gomez-Ruiz, Zeljko Zizak and Goran N. Kaluderovic

Targeting Heme for the Identification of Cytotoxic Agents

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 3
Page: 515-522
Authors: Shiming Zhang, Hui Chen, Jessica Webster and Glenn S. Gerhard

Advances in the Management of Malignant Hemopathies: The Role of Statins

Journal: Recent Patents on DNA & Gene Sequences (DIscontinued)
Volume: 7,Issue: 1
Page: 57-61
Authors: Romeo-Gabriel Mihaila

NFκB Pathway and microRNA-9 and -21 are Involved in Sensitivity to the Pterocarpanquinone LQB-118 in Different CML Cell Lines

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 3
Page: 345-352
Authors: Fernanda Costas C. de Faria, Maria Eduarda Bento Leal, Paula Sabbo Bernardo, Paulo R.R. Costa and Raquel C. Maia

In Vitro Antitumoral Activity of Palladium(II) and Platinum(II) Complexes with O,O'-Dialkyl Esters of Ethylene-bis(S)-Leucine

Journal: Letters in Drug Design & Discovery
Volume: 11,Issue: 4
Page: 387-394
Authors: Jelena M. Vujic, Goran N. Kaluderovic, Tatjana P. Stanojkovic, Jadranka A. Antic and Srecko R. Trifunovic

Could Resveratrol be a Useful Drug for the Treatment of Malignant Hemopathies?

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 9,Issue: 3
Page: 340-353
Authors: Romeo G. Mihaila

The Emerging Role of Bcr-Abl-Induced Cystoskeletal Remodeling in Systemic Persistence of Leukemic Stem Cells

Journal: Current Drug Delivery
Volume: 11,Issue: 5
Page: 582-591
Authors: Adrian Bartos and Patrycja M. Dubielecka

New Technologies: Non-Hormonal Female Contraception

Journal: Current Women`s Health Reviews
Volume: 10,Issue: 2
Page: 72-81
Authors: M. Blake Evans and Chon-Hwa Tsai-Morris

The Role of Intestinal Microbiota in Graft versus Host Disease

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 16,Issue: 3
Page: 193-199
Authors: Muna Qayed and John T. Horan

Practical Considerations for Omics Experiments in Biomedical Sciences

Journal: Current Pharmaceutical Biotechnology
Volume: 17,Issue: 1
Page: 105-114
Authors: Marc Vaudel, Harald Barsnes, Rolf Bjerkvig, Andreas Bikfalvi, Frode Selheim, Frode S Berven and Thomas Daubon

Novel dibenzo[b,d]furan–1H-1,2,4-triazole derivatives: Synthesis and antitumor activity

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16,Issue: 3
Page: 377-386
Authors: Xing Chen, Yi-Min Shi, Chao Huang, Sha Xia, Li-Juan Yang and Xiao-Dong Yang

The Immucillins: Design, Synthesis and Application of Transition- State Analogues

Journal: Current Medicinal Chemistry
Volume: 22,Issue: 34
Page: 3897-3909
Authors: Gary B. Evans, Vern L. Schramm and Peter C. Tyler

Transient Abnormal Myelopoiesis in Down’s Syndrome - A Diagnostic Dilemma

Journal: Applied Clinical Research, Clinical Trials and Regulatory Affairs
Volume: 2,Issue: 1
Page: 46-48
Authors: Mahmoud A. Kiblawi, Alina Naeem, Subhranshu S. Kar and Mohamed S. Mosaad

Synthesis of 4-piperidone Based Curcuminoids with Anti-inflammatory and Anti-Proliferation Potential in Human Cancer Cell Lines

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16,Issue: 7
Page: 841-851
Authors: Amit Anthwal, Kundan Singh, M. S.M. Rawat, Amit K. Tyagi, Ashanul Haque, Imran Ali and Diwan S. Rawat

Preferentially Expressed Antigen in Melanoma (PRAME) and the PRAME Family of Leucine-Rich Repeat Proteins

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 5
Page: 400-414
Authors: Nora Hermes, Stefanie Kewitz and Martin S. Staege

Anti-Cancer Potential of a Novel SERM Ormeloxifene

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 33
Page: 4177-4184
Authors: Rishi Kumar Gara, Vasudha Sundram, Subhash C. Chauhan and Meena Jaggi

The Polyhedric Abl Kinases and their Pharmacologic Inhibitors

Journal: Current Enzyme Inhibition
Volume: 13,Issue: 2
Page: 129-138
Authors: Elisa Lupino and Marco Piccinini

Novel Artemisinin-Derived Dimers: Synthesis and Evaluation of Anti-cancer Activities

Journal: Letters in Drug Design & Discovery
Volume: 14,Issue: 1
Page: 102-111
Authors: Vu Tuan Kien, Le Huy Binh, Phan Hai Phong, Doan Thi Hien, Nguyen Thi Thuy My, Nguyen Hai Nam, Do Thi Thao, Michael Baltas and Tran Khac Vua

Nuclear Proteins: Promising Targets for Cancer Drugs

Journal: Current Cancer Drug Targets
Volume: 5,Issue: 8
Page: 595-610
Authors: Y.- L. Yao and W.- M. Yang

Strategies for Biology- and Molecular-Based Treatment of Myelodysplastic Syndromes

Journal: Current Drug Targets
Volume: 6,Issue: 6
Page: 713-725
Authors: E. H. Lindberg

The Impact of Thrombopoietin on Clinical Practice

Journal: Current Pharmaceutical Design
Volume: 8,Issue: 5
Page: 369-377
Authors: Russell Basser

Structure-Based Design of Novel Anticancer Agents

Journal: Current Cancer Drug Targets
Volume: 1,Issue: 1
Page: 59-71
Authors: F. M. Uckun, E. A. Sudbeck, C. Mao, S. Ghosh, X.-P. Liu, A. O. Vassilev, C. S. Navara and R. K. Narla

The Usefulness of Phalangeal Quantitative Ultrasound in the Assessment of Skeletal Status in Children and Adolescents

Journal: Current Medical Imaging Reviews
Volume: 4,Issue: 3
Page: 194-201
Authors: Zenon P. Halaba

Small Molecules ATP-Competitive Inhibitors of FLT3: A Chemical Overview

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 29
Page: 3113-3132
Authors: S. Schenone, C. Brullo and M. Botta

Antitumor Properties and Modulation of Antioxidant Enzymes Activity by Aloe vera Leaf Active Principles Isolated via Supercritical Carbon Dioxide Extraction

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 2
Page: 129-138
Authors: H. A. El-Shemy, M. A.M. Aboul-Soud, A. A. Nassr-Allah, K. M. Aboul-Enein, A. Kabash and A. Yagi

Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 3
Page: 254-284
Authors: B. C. Potts, M. X. Albitar, K. C. Anderson, S. Baritaki, C. Berkers, B. Bonavida, J. Chandra, D. Chauhan, J. C. Cusack, W. Fenical, I. M. Ghobrial, M. Groll, P. R. Jensen, K. S. Lam, G. K. Lloyd, W. McBride, D. J. McConkey, C. P. Miller, S. T.C. Neuteboom, Y. Oki, H. Ovaa, F. Pajonk, P. G. Richardson, A. M. Roccaro, C. M. Sloss, M. A. Spear, E. Valashi, A. Younes and M. A. Palladino

Bortezomib Targets the Caspase-Like Proteasome Activity in Cervical Cancer Cells, Triggering Apoptosis That Can be Enhanced by Nelfinavir

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 7
Page: 799-809
Authors: A. Bruning, M. Vogel, I. Mylonas, K. Friese and A. Burges

A Structure-Function Perspective of Jak2 Mutations and Implications for Alternate Drug Design Strategies: The Road not Taken

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 30
Page: 4659-4673
Authors: K. Gnanasambandan and P.P. Sayeski

Cancer Pharmacogenomics: Germline DNA, Tumor DNA, or Both?

Journal: Current Pharmacogenomics
Volume: 5,Issue: 2
Page: 87-101
Authors: E. Cerri, A. Falcone and F. Innocenti

Cytidine Deaminases as a Weapon Against Retroviruses and a New Target for Antiviral Therapy

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 8,Issue: 3
Page: 231-238
Authors: Akifumi Takaori-Kondo, Taisuke Izumi and Kotaro Shirakawa

The Role of FLT3 Kinase as an AML Therapy Target

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 19
Page: 2758-2765
Authors: Michal Beffinger and Anna Skwarska

Novel Insights in Molecular Mechanisms of CLL

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 23
Page: 3363-3372
Authors: Nicola Zanesi, Veronica Balatti, Arianna Bottoni, Carlo M. Croce and Yuri Pekarsky

Novel Approaches in the Synthesis of Batracylin and Its Analogs: Rebirth of an Old Player?

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 26
Page: 4475-4487
Authors: K. Dzierzbicka, W. Januchta and A. Skladanowski

State of the Art of the Therapeutic Perspective of Sorafenib Against Hematological Malignancies

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 28
Page: 4875-4884
Authors: G. Zauli, R. Voltan, V. Tisato and P. Secchiero

The Role of microRNAs in the Pathogenesis and Treatment of Hematopoietic Malignancies

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 7
Page: 1201-1210
Authors: Corina A. Schmid, Vanessa J. Craig, Anne Muller and Michael Flori

Optimizing Outcomes Following Allogeneic Hematopoietic Progenitor Cell Transplantation in AML: The Role of Hypomethylating Agents

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 6
Page: 661-669
Authors: Massimo Martino, Roberta Fedele, Tiziana Moscato and Francesca Ronco

Synthesis of 1-aroyl-3,5-dimethyl-1H-pyrazoles as Anti-HCV and Anticancer Agents

Journal: Letters in Drug Design & Discovery
Volume: 11,Issue: 2
Page: 121-131
Authors: Sevil Aydın, Neerja Kaushik-Basu, Suna Özbaş-Turan, Jülide Akbuğa, Pınar Mega Tiber, Oya Orun, K. R. Gurukumar, Amartya Basu and Ş. Güniz Küçükgüzel

Synthesis of Novel 2,3,4-trisubstituted-oxazolidine Derivatives and In Vitro Cytotoxic Evaluation

Journal: Medicinal Chemistry
Volume: 10,Issue: 6
Page: 609-618
Authors: Saulo F. Andrad, Edmar F.S. Campos, Claudia S. Teixeira, Cristiano C. Bandeira, Stefania N. Lavorato, Nelilma C. Romeiro, Caryne M. Bertollo, Monica C. Oliveira, Elaine M. Souza-Fagundes and Ricardo J. Alves

Posterior Reversible Encephalopathy Syndrome in Leukemic Children: A Sensitive Issue

Journal: Current Drug Safety
Volume: 10,Issue: 2
Page: 180-183
Authors: Wala Ben Kridis, Moez Mdhaffer, Yosr Hentati, Fatma Kammoun, Abir Milad, Sondes Haddar, Khaireddine Ben Mahfoudh, Chahinez Triki and Moez Elloumi

New Benzimidazole-Derived Isothioureas as Potential Antileukemic Agents - Studies In Vitro

Journal: Medicinal Chemistry
Volume: 11,Issue: 4
Page: 364-372
Authors: Miroslawa Koronkiewicz, Anna Romiszewska, Zdzislaw Chilmonczyk and Zygmunt Kazimierczuk

Thiopurine Biotransformation and Pharmacological Effects: Contribution of Oxidative Stress

Journal: Current Drug Metabolism
Volume: 17,Issue: 6
Page: 542-549
Authors: Marco Pelin, Sara De Iudicibus, Margherita Londero, Riccardo Spizzo, Sveva Dei Rossi, Stefano Martelossi, Alessandro Ventura, Giuliana Decorti and Gabriele Stocco

New, Substituted Derivatives of Dicarboximides and their Cytotoxic Properties

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16,Issue: 7
Page: 852-864
Authors: Bożena Kuran, Mariola Napiórkowska, Jerzy Kossakowski, Marcin Cieślak, Julia Kaźmierczak-Barańska, Karolina Królewska and Barbara Nawrot

β-lactam Structured, 4-(4-(Methylsulfonyl)phenyl)-1-pentyl-3-phenoxyazetidin-2-one: Selectively Targets Cancerous B Lymphocyte Mitochondria

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 9
Page: 1292-1301
Authors: Nahal Pirahmadi, Afshin Zarghi, Ahmad Salimi, Hadi Arefi and Jalal Pourahmad

Synthesis, in vitro Antiproliferative and Antiinflammatory Activities, and Kinase Inhibitory effects of New 1,3,4-triarylpyrazole Derivatives

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 1
Page: 75-84
Authors: Mohammed I. El-Gamal, Mohammed S. Abdel-Maksoud, Mahmoud M. Gamal El-Din, Ji-Sun Shin, Kyung-Tae Lee, Kyung Ho Yoo and Chang-Hyun Oh

Targeted Therapies in Gynecologic Cancers

Journal: Current Cancer Drug Targets
Volume: 6,Issue: 4
Page: 333-363
Authors: Hye S. Chon, Wei Hu and John J. Kavanagh

Mitochondria-Regulated Death Pathway Mediates (DIPP-L-Leu)2-LLysOCH3- Induced K562 Cells Apoptosis.

Journal: Protein & Peptide Letters
Volume: 13,Issue: 2
Page: 129-134
Authors: Jie Yang, Yuyang Jiang, Feng Liu and Yufen Zhao

Molecular Advances Toward the Understanding of the Patho-Biology of Idiopathic Myelofibrosis

Journal: Current Immunology Reviews
Volume: 2,Issue: 2
Page: 169-186
Authors: Anna R. Migliaccio, Alessandro M. Vannucchi, Giovanni Migliaccio and Ronald Hoffman

Radioimmunotherapy of Non-Hodgkins Lymphomas

Journal: Current Drug Targets
Volume: 7,Issue: 10
Page: 1293-1300
Authors: Bruce D. Cheson

Clinical Pharmacogenomics of Thiopurine S-methyltransferase

Journal: Current Clinical Pharmacology
Volume: 1,Issue: 1
Page: 119-128
Authors: Shufeng Zhou

Purine Nucleoside Phosphorylase: A Potential Target for the Development of Drugs to Treat T-Cell- and Apicomplexan Parasite-Mediated Diseases

Journal: Current Drug Targets
Volume: 8,Issue: 3
Page: 413-422
Authors: R. G. Silva, J. E. S. Nunes, F. Canduri, J. C. Borges, L. M. Gava, F. B. Moreno, L. A. Basso and D. S. Santos

Signaling Through RAS-RAF-MEK-ERK: from Basics to Bedside

Journal: Current Medicinal Chemistry
Volume: 14,Issue: 5
Page: 601-623
Authors: Armin Zebisch, Armin P. Czernilofsky, Gyorgy Keri, Julja Smigelskaite, Heinz Sill and Jakob Troppmair

JAK2 as a Molecular Marker in Myeloproliferative Diseases

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 5,Issue: 3
Page: 198-203
Authors: R. Mata, D. Subira, A. Garcia-Raso and P. Llamas

Kit: Molecule of Interest for the Diagnosis and Treatment of Mastocytosis and other Neoplastic Disorders

Journal: Current Cancer Drug Targets
Volume: 7,Issue: 5
Page: 492-503
Authors: Mrinal M. Patnaik, Ayalew Tefferi and Animesh Pardanani

Stem Cells, Cancer, Liver, and Liver Cancer Stem Cells: Finding a Way Out of the Labyrinth...

Journal: Current Cancer Drug Targets
Volume: 7,Issue: 6
Page: 582-590
Authors: A. C. Piscaglia, T. D. Shupe, B. E. Petersen and A. Gasbarrini

MDM2 and Human Malignancies: Expression, Clinical Pathology, Prognostic Markers, and Implications for Chemotherapy

Journal: Current Cancer Drug Targets
Volume: 5,Issue: 1
Page: 27-41
Authors: Elizabeth Rayburn, Ruiwen Zhang, Jie He and Hui Wang

High Throughput Screening for Protein Kinase Inhibitors

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 8,Issue: 2
Page: 181-195
Authors: Holger Wesche, Shou-Hua Xiao and Steve W. Young

OPLS-DA as a Suitable Method for Selecting a Set of Gene Transcripts Discriminating RAS- and PTPN11-Mutated Cells in Acute Lymphoblastic Leukaemia

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 14,Issue: 1
Page: 36-46
Authors: Giuseppe Musumarra, Daniele F. Condorelli and Cosimo G. Fortuna

The Multiple Facets of Hematopoietic Stem Cells

Journal: Current Neurovascular Research
Volume: 1,Issue: 3
Page: 197-206
Authors: Rebecca J. Chan and Mervin C. Yoder

Deaza Analogs of Folic Acid as Antitumor Agents

Journal: Current Pharmaceutical Design
Volume: 9,Issue: 31
Page: 2615-2625
Authors: R. L. Kisliuk

Thioguanine, Mercaptopurine: Their Analogs and Nucleosides as Antimetabolites

Journal: Current Pharmaceutical Design
Volume: 9,Issue: 31
Page: 2627-2642
Authors: Galal H. Elgemeie

Iron Chelators as Anti-Neoplastic Agents: Current Developments and Promise of the PIH Class of Chelators

Journal: Current Medicinal Chemistry
Volume: 10,Issue: 12
Page: 1035-1049
Authors: D. B. Lovejoy and D. R. Richardson

Natural Product Origins of Hsp90 Inhibitors

Journal: Current Cancer Drug Targets
Volume: 3,Issue: 5
Page: 325-330
Authors: Yoshimasa Uehara

Rituxan® Immunotherapy and Zevalin® Radioimmunotherapy in the Treatment of Non-Hodgkins Lymphoma

Journal: Current Pharmaceutical Biotechnology
Volume: 4,Issue: 4
Page: 221-238
Authors: Christine A. White

Receptor Selective Synthetic Retinoids as Potential Cancer Chemotherapy Agents

Journal: Current Cancer Drug Targets
Volume: 2,Issue: 1
Page: 77-86
Authors: D. L. Crowe

Toxicity and Efficacy of Benzamide Riboside in Cancer Chemotherapy Models

Journal: Current Medicinal Chemistry
Volume: 9,Issue: 7
Page: 787-792
Authors: Hiremagalur N. Jayaram, Joel A. Yalowitz, Francisco Arguello, John F. Greene and Jr

Chemistry and Biochemistry of 2, 5-Oligoadenylate-Based Antisense Strategy

Journal: Current Medicinal Chemistry
Volume: 8,Issue: 10
Page: 1189-1212
Authors: Steven A. Adah, Suzanne F. Bayly, Hagen Cramer, Robert H. Silverman and Paul F. Torrence

Reversal of Multidrug Resistance by the P-Glycoprotein Modulator, LY335979, from the Bench to the Clinic

Journal: Current Medicinal Chemistry
Volume: 8,Issue: 1
Page: 39-50
Authors: A. H. Dantzig, K. L. Law, J. Cao and J. J. Starling

Intercalators as Anticancer Drugs

Journal: Current Pharmaceutical Design
Volume: 7,Issue: 17
Page: 1745-1780
Authors: M. F. Brana, M. Cacho, A. Gradillas, B. de Pascual-Teresa and A. Ramos

Contribution of Specific Transport Systems to Anthracycline Transport in Tumor and Normal Cells

Journal: Current Drug Metabolism
Volume: 2,Issue: 4
Page: 355-366
Authors: Kazuki Nagasawa, Katsuhito Nagai, Noriaki Ohnishi, Teruyoshi Yokoyama and Sadaki Fujimoto

Recombinant Technology in Transfusion Medicine

Journal: Current Pharmaceutical Biotechnology
Volume: 1,Issue: 2
Page: 117-135
Authors: Neil D. Avent

The Role of Nucleoside Transport in the Antineoplastic Activity of Purine Nucleoside Chemotherapeutic Agents

Journal: Current Cancer Therapy Reviews
Volume: 4,Issue: 1
Page: 21-30
Authors: Carol E. Cass and Karen M. King

Structure-Based Rationale for Interleukin 5 Receptor Antagonism

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 12
Page: 1231-1239
Authors: Tetsuya Ishino, Adrian E. Harrington, Hosahudya Gopi and Irwin Chaiken

Runx1/AML1 is a Guardian of Hematopoietic Stem Cells

Journal: Current Cancer Therapy Reviews
Volume: 4,Issue: 3
Page: 188-195
Authors: Lena Motoda, Motomi Osato and Yoshiaki Ito

Developmental Immunotoxicity (DIT) in Drug Safety Testing: Matching DIT Testing to Adverse Outcomes and Childhood Disease Risk

Journal: Current Drug Safety
Volume: 3,Issue: 3
Page: 216-226
Authors: Rodney R. Dietert

Recent Approaches to Improve the Antitumor Efficacy of Temozolomide

Journal: Current Medicinal Chemistry
Volume: 16,Issue: 2
Page: 245-257
Authors: Lucio Tentori and Grazia Graziani

Urea Derivatives as Anticancer Agents

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 4
Page: 471-480
Authors: Huan-Qiu Li, Peng-Cheng Lv, Tao Yan and Hai-Liang Zhu

HER2 Targeted Therapies for Cancer and the Gastrointestinal Tract

Journal: Current Drug Targets
Volume: 10,Issue: 6
Page: 537-542
Authors: Noor Al-Dasooqi, Rachel Gibson, Joanne Bowen and Dorothy Keefe

Organic Synthesis and Antisense Effects of Oligonucleotide-Peptide Conjugates

Journal: Current Organic Chemistry
Volume: 13,Issue: 14
Page: 1366-1377
Authors: Satoshi Murao and Masayuki Fujii

Coupling the Inhibition of Viral Transduction with a Positive Fluorescence Signal

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 13,Issue: 4
Page: 352-357
Authors: Jenifer Clausell-Tormos, Andrew D. Griffiths and Christoph A. Merten

Cancer Vaccines: Emphasis on Pediatric Cancers

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 3
Page: 292-299
Authors: Terri Guinipero and Olivera J. Finn

Targeting CREB for Cancer Therapy: Friend or Foe

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 4
Page: 384-391
Authors: X. Xiao, B.X. Li, B. Mitton, A. Ikeda and K.M. Sakamoto

The Anticancer Face of Interferon Alpha (IFN-Alpha): From Biology to Clinical Results, with a Focus on Melanoma

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 29
Page: 3327-3336
Authors: S. Pasquali and S. Mocellin

Fighting Tumor Cell Survival: Advances in the Design and Evaluation of Pim Inhibitors

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 34
Page: 4114-4133
Authors: F. Anizon, A. A. Shtil, V. N. Danilenko and P. Moreau

The Use of Structural Biology in Janus Kinase Targeted Drug Discovery

Journal: Current Drug Targets
Volume: 12,Issue: 4
Page: 546-555
Authors: Nilda L. Alicea-Velazquez and Titus J. Boggon

Non-Genotoxic p53-Activators and their Significance as Antitumor Therapy of Future

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 7
Page: 1038-1049
Authors: S. K. Nayak, P. S. Panesar and H. Kumar

Targeted Therapies and other Agents as First-Line Maintenance and Beyond: Particular Benefit in Pulmonary Adenocarcinoma Patients

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 11
Page: 1640-1650
Authors: F. Petrelli, K. Borgonovo, M. Cabiddu, M. Ghilardi and S. Barni

Current Advances in Retroviral Gene Therapy

Journal: Current Gene Therapy
Volume: 11,Issue: 3
Page: 218-228
Authors: Youngsuk Yi, Moon Jong Noh and Kwan Hee Lee

Development of a Plate-Based Assay for High-Content Analysis of Individual Untethered Non-Adherent Cells

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 14,Issue: 7
Page: 583-589
Authors: Chen Wang, Lili Wang and Changqi Zhao

Mechanisms of Action of Imidazoacridinone and Triazoloacridinone Derivatives in View of their Biological Activity

Journal: Current Pharmaceutical Analysis
Volume: 7,Issue: 4
Page: 286-295
Authors: Marcin Koba and Tomasz Baczek

Sphingolipid Signaling and Hematopoietic Malignancies: To the Rheostat and Beyond

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11,Issue: 9
Page: 782-793
Authors: Kenneth C. Loh, Dianna Baldwin and Julie D. Saba

Sphingolipid Metabolism and Drug Resistance in Hematological Malignancies

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11,Issue: 9
Page: 891-903
Authors: Valerie Gouaze-Andersson and Myles C. Cabot

Review: Recent Clinical Trials in Epigenetic Therapy

Journal: Reviews on Recent Clinical Trials
Volume: 1,Issue: 2
Page: 169-182
Authors: Yasuhiro Oki and Jean-Pierre J. Issa

Nelarabine- A New Purine Analog in the Treatment of Hematologic Malignancies

Journal: Reviews on Recent Clinical Trials
Volume: 1,Issue: 3
Page: 185-192
Authors: Sophie Curbo and Anna Karlsson

Second Generation Abl Kinase Inhibitors and Novel Compounds to Eliminate the Bcr-Abl/T315I Clone

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 1,Issue: 3
Page: 347-355
Authors: Shinya Kimura

Bortezomib in the Treatment of Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 1,Issue: 3
Page: 397-403
Authors: Aldo M. Roccaro, Angelo Vacca and Domenico Ribatti

NF-κ B and Rheumatic Diseases

Journal: Endocrine, Metabolic & Immune Disorders-Drug Targets
Volume: 6,Issue: 4
Page: 359-372
Authors: Takashi Okamoto

Inhibitory Effect of Acetogenins on Mammalian DNA Polymerase and Human Cancer Cell Growth

Journal: Letters in Drug Design & Discovery
Volume: 4,Issue: 4
Page: 239-245
Authors: Chisato Ishimaru, Toshifumi Takeuchi, Yuko Yonezawa, Isoko Kuriyama, Msasaharu Takemura, Ikuo Kato, Fumio Sugawara, Hiromi Yoshida and Yoshiyuki Mizushina

Synthesis and Antitumor Properties of N1-(Hydroxymethyl Phenylmethyl) Pyrimidine Derivatives and their Intermediates

Journal: Letters in Drug Design & Discovery
Volume: 4,Issue: 4
Page: 249-256
Authors: Liying Chen, Nageswara Kode, Devangachinta Murthy and Shashikant Phadtare

Pleiotrophin as a Possible New Target for Angiogenesis-Related Diseases and Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 2,Issue: 2
Page: 175-186
Authors: Constantinos Mikelis, Marina Koutsioumpa and Evangelia Papadimitriou

T Cell Polarization and the Formation of Immunological Synapses: From Antigen Recognition to Virus Spread

Journal: Current Immunology Reviews
Volume: 3,Issue: 3
Page: 170-188
Authors: Ana Monica Pais-Correia, Maria Isabel Thoulouze and Andres Alcover

A Novel Achiral seco-Amino-Cyclopropylindoline (CI) Analog of CC-1065 and the Duocarmycins: Design, Synthesis and Biological Studies

Journal: Medicinal Chemistry
Volume: 1,Issue: 1
Page: 13-19
Authors: James L. Toth, John D. Trzupek, Lloyd V. Flores, Konstantinos Kiakos, John A. Hartley, William T. Pennington and Moses Lee

Cytochrome P450 Retinoic Acid 4-Hydroxylase Inhibitors: Potential Agents for Cancer Therapy

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 2,Issue: 3
Page: 261-269
Authors: V. C.O. Njar

Multidrug Resistance and Cancer: The Role of the Human ABC Transporter ABCG2

Journal: Current Protein & Peptide Science
Volume: 3,Issue: 5
Page: 503-511
Authors: Karin F. K. Ejendal and Christine A. Hrycyna

A Literature Review of the Recent Radiotherapy Clinical Trials in Pediatric Brain Tumors

Journal: Reviews on Recent Clinical Trials
Volume: 4,Issue: 1
Page: 42-55
Authors: Anna Skowronska-Gardas

Pediatric Immune Dysfunction and Health Risks Following Early-Life Immune Insult

Journal: Current Pediatric Reviews
Volume: 5,Issue: 1
Page: 36-51
Authors: Rodney R. Dietert and Judith T. Zelikoff

Drug Targets in Human T-Lymphotropic Virus Type 1 (HTLV-1) Infection

Journal: Infectious Disorders - Drug Targets
Volume: 9,Issue: 2
Page: 159-171
Authors: Peter Boross, Peter Bagossi, Irene T. Weber and Jozsef Tozser

Targeting Stem Cells-Clinical Implications for Cancer Therapy

Journal: Current Stem Cell Research & Therapy
Volume: 4,Issue: 2
Page: 147-153
Authors: Lan Chun Tu, Greg Foltz, Edward Lin, Leroy Hood and Qiang Tian

Retinoids as Critical Modulators of Immune Functions: New Therapeutic Perspectives for Old Compounds

Journal: Endocrine, Metabolic & Immune Disorders-Drug Targets
Volume: 9,Issue: 2
Page: 113-131
Authors: Michele Montrone, Debora Martorelli, Antonio Rosato and Riccardo Dolcetti

Pediatric Health Effects of Chronic Exposure to Extremely Low Frequency Electromagnetic Fields

Journal: Current Pediatric Reviews
Volume: 5,Issue: 4
Page: 234-240
Authors: Juan Antonio Ortega-Garcia, Marlene Martin, Enrique Navarro-Camba, Julia Garcia-Castell, Offie P. Soldin and Josep Ferris-Tortajada

Purification and Characterization of a Laccase with Inhibitory Activity Toward HIV-1 Reverse Transcriptase and Tumor Cells from an Edible Mushroom (Pleurotus cornucopiae)

Journal: Protein & Peptide Letters
Volume: 17,Issue: 8
Page: 1040-1047
Authors: Jack Ho Wong, Tzi Bun Ng, Yun Jiang, Fang Liu, Stephen Cho Wing Sze and Kalin Yanbo Zhang

Immune System Modulates the Function of Adult Neural Stem Cells

Journal: Current Immunology Reviews
Volume: 6,Issue: 3
Page: 167-173
Authors: Oscar Gonzalez-Perez, Fernando Jauregui-Huerta and Alma Yadira Galvez-Contreras

An Antifungal Peptide with Antiproliferative Activity Toward Tumor Cells from Red Kidney Beans

Journal: Protein & Peptide Letters
Volume: 18,Issue: 6
Page: 594-600
Authors: Miao Li, Hexiang Wang and Tzi Bun Ng

Biologic Characteristics of Bone Marrow Mesenchymal Stem Cells in Myelodysplastic Syndromes

Journal: Current Stem Cell Research & Therapy
Volume: 6,Issue: 2
Page: 122-130
Authors: Maria-Christina Kastrinaki, Charalampos Pontikoglou, Mirjam Klaus, Emily Stavroulaki, Konstantia Pavlaki and Helen A. Papadaki

The Epidemiology and Health Effects of Tobacco Smoke Exposure

Journal: Current Pediatric Reviews
Volume: 7,Issue: 2
Page: 76-80
Authors: Karen M. Wilson and Emily Weis

HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP): Still an Obscure Disease

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 11,Issue: 4
Page: 239-245
Authors: Micheli Mainardi Pillat, Moises Evandro Bauer, Augusto Cesar Penalva de Oliveira, Henning Ulrich and Jorge Casseb

Daptomycin: A Review of Properties, Clinical Use, Drug Delivery and Resistance

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 12,Issue: 3
Page: 202-209
Authors: C. Vilhena and A. Bettencourt

Folate Receptor Targeted Liposomes

Journal: Drug Design Reviews - Online (Discontinued)
Volume: 2,Issue: 7
Page: 547-552
Authors: Angelo P. Amico, Ilaria Covelli and Pietro Fiore

An Update on the Other Telomerase Inhibitors: Non-G-Quadruplex Interactive Agent, Non-Antisense, Non-Reverse Transcriptase Telomerase Inhibitors

Journal: Medicinal Chemistry Reviews - Online (Discontinued)
Volume: 2,Issue: 4
Page: 325-343
Authors: L. A. Beltz and K. P. Manfredi

Signal Transducer and Activator of Transcription 5 (STAT5), a Crucial Regulator of Immune and Cancer Cells

Journal: Current Drug Target - Immune, Endocrine & Metabolic Disorders
Volume: 5,Issue: 4
Page: 449-463
Authors: Ilka Wittig and Bernd Groner

Remodeling Chromatin and Stress Resistance in the Central Nervous System: Histone Deacetylase Inhibitors as Novel and Broadly Effective Neuroprotective Agents

Journal: Current Drug Target -CNS & Neurological Disorders
Volume: 4,Issue: 1
Page: 41-50
Authors: Brett Langley, JoAnn M. Gensert, M. Flint Beal and Rajiv R. Ratan

New Approaches to Mechanism Analysis for Drug Discovery Using DNA Microarray Data Combined with KeyMolnet

Journal: Current Drug Discovery Technologies
Volume: 2,Issue: 2
Page: 89-98
Authors: Hiromi Sato, Seiichi Ishida, Kyoko Toda, Rieko Matsuda, Yuzuru Hayashi, Makoto Shigetaka, Miki Fukuda, Yohko Wakamatsu and Akiko Itai

Dual Inhibitors of Src and Abl Tyrosine Kinases

Journal: Drug Design Reviews - Online (Discontinued)
Volume: 1,Issue: 3
Page: 203-214
Authors: Diane H. Boschelli

Keeping Obesity and Metabolic Syndrome at Bay with Central Leptin and Cytokine Gene Therapy

Journal: Current Medicinal Chemistry-Central Nervous System Agents
Volume: 3,Issue: 3
Page: 189-199
Authors: S. P. Kalra and P. S. Kalra

Implication of Raft Microdomains in Drug Induced Apoptosis

Journal: Current Medicinal Chemistry-Anti-Cancer Agents
Volume: 3,Issue: 4
Page: 263-270
Authors: Christine Bezombes, Guy Laurent and Jean-Pierre Jaffrezou

The ‘Other’ Telomerase Inhibitors: Non-G-Quadruplex Interactive Agent, Non-Antisense, Non-Reverse Transcriptase Telomerase Inhibitors

Journal: Current Medicinal Chemistry-Anti-Cancer Agents
Volume: 2,Issue: 5
Page: 589-603
Authors: L. A. Beltz

Novel Targets for Apoptosis Modulation: BAG3 Protein and Other Co- Chaperones

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 3,Issue: 2
Page: 80-86
Authors: Anna Basile, Morena d'Avenia, Alessandra Rosati, Michelina Festa, Antonia Falco, Maria C. Turco and Maria Pascale

A Novel Technology for Hematopoietic Stem Cell Expansion Using Combination of Nanofiber and Growth Factors

Journal: Recent Patents on Nanotechnology
Volume: 4,Issue: 2
Page: 125-134
Authors: Jingwei Lu, Reeva Aggarwal, Vincent J. Pompili and Hiranmoy Das

Tyrosine Kinase Inhibitors, Pancreatic Hyperenzymemia and Acute Pancreatitis: A Review

Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 5,Issue: 2
Page: 165-168
Authors: Raffaele Pezzilli, Dario Fabbri, Andrea Imbrogno and Roberto Corinaldesi

The Synthesis and Evaluation of Novel Lactate Dehydrogenase Nanobioconjugates

Journal: Current Nanoscience
Volume: 8,Issue: 2
Page: 299-304
Authors: Samina Nazir, Tajammul Hussain, Salman Akbar Malik and Ayesha Younus

World Health Organization Classification of Myelodysplastic Syndromes

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 22
Page: 3149-3162
Authors: Magdalena Czader and Attilio Orazi

Current and Emerging Therapies in Primary Myelofibrosis

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 12,Issue: 1
Page: 6-20
Authors: Sabarish Ayyappan, Murali Janakiram and Radha Raghupathy

Pharmacokinetic and Pharmacogenetic Analysis of Oral Busulfan in Stem Cell Transplantation: Prediction of Poor Drug Metabolism to Prevent Drug Toxicity

Journal: Current Drug Safety
Volume: 7,Issue: 3
Page: 211-217
Authors: Norberto Krivoy, Tsila Zuckerman, Hela Elkin, Lia Froymovich, Jacob M. Rowe and Edna Efrati

Is the Autophagy Induced by Thiopurines Beneficial or Deleterious?

Journal: Current Drug Metabolism
Volume: 13,Issue: 9
Page: 1267-1276
Authors: Luis G. Guijarro, Irene D. Roman, Mª Dolores Fernandez-Moreno, Javier P. Gisbert and Borja Hernandez- Breijo

Can Breast Cancer Stem Cells Evade the Immune System?

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 35
Page: 6036-6049
Authors: George R. Nahas, Shyam A. Patel, Sarah A. Bliss and Pranela Rameshwar

The Tribbles-1 Protein in Humans: Roles and Functions in Health and Disease

Journal: Current Molecular Medicine
Volume: 13,Issue: 1
Page: 80-85
Authors: E. Dugast, E. Kiss-Toth, J.-P. Soulillou, S. Brouard and J. Ashton-Chess

Recurrent Rearrangements in Prostate Cancer: Causes and Therapeutic Potential

Journal: Current Drug Targets
Volume: 14,Issue: 4
Page: 450-459
Authors: Nicole M. White, Felix Y. Feng and Christopher A. Maher

Glycosaminoglycan Sulodexide Inhibition of MMP-9 Gelatinase Secretion and Activity: Possible Pharmacological Role Against Collagen Degradation in Vascular Chronic Diseases

Journal: Current Vascular Pharmacology
Volume: 11,Issue: 3
Page: 354-365
Authors: Ferdinando Mannello, Virginia Medda, Daniela Ligi and Joseph D. Raffetto

Inhibition of Hedgehog/Gli Signaling by Botanicals: A Review of Compounds with Potential Hedgehog Pathway Inhibitory Activities

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 5
Page: 580-595
Authors: Sara K. Drenkhahn, Glenn A. Jackson, Anna Slusarz, Nicholas J.E. Starkey and Dennis B. Lubahn

Cinnamic Acid Derivatives Induce Cell Cycle Arrest in Carcinoma Cell Lines

Journal: Medicinal Chemistry
Volume: 9,Issue: 5
Page: 633-641
Authors: Matej Sova, Zeljko Zizak, Jelena A. Antic Stankovic, Matevz Prijatelj, Samo Turk, Zorica D. Juranic, Irena Mlinaric-Rascan and Stanislav Gobec

Synthesis of resveratrol acrylamides derivatives and biological evaluation of their anti-proliferative effect on cancer cell lines

Journal: Letters in Drug Design & Discovery
Volume: 11,Issue: 1
Page: 2-9
Authors: Ban-Feng Ruan, Si-Qi Wang, Xiao-Lin Ge and Ri-Sheng Yao

The Anti-Oxidant Properties of Isothiocyanates: A Review

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 7,Issue: 3
Page: 213-225
Authors: Sônia M. de Figueiredo, Sidney A.V. Filho, José A. Nogueira-Machado and Rachel B. Caligiorne

In Vitro, In Vivo and In Silico Analysis of the Anticancer and Estrogen-like Activity of Guava Leaf Extracts

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 20
Page: 2322-2330
Authors: L.Y. Rizzo, G.B. Longato, A.LT.G. Ruiz, S.V. Tinti, A. Possenti, D.B. Vendramini-Costa, A. Sartoratto, G.M. Figueira, F.L.N. Silva, M.N. Eberlin, T.A.C.B. Souza, M.T. Murakami, E. Rizzo, M.A. Foglio, F. Kiessling, T. Lammers and J.E. Carvalho

Immunomodulating and Anti-Allergic Effects of Negroamaro and Koshu Vitis vinifera Fermented Grape Marc (FGM)

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 6
Page: 864-868
Authors: Giuseppe Marzulli, Thea Magrone, Luisa Vonghia, Masahiro Kaneko, Hiroaki Takimoto, Yoshio Kumazawa and Emilio Jirillo


Antagonists of IAP Proteins: Novel Anti-Tumor Agents

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 34
Page: 3877-3892
Authors: Yichao Wan, Tingting Liu, Xuben Hou, Yanyan Dun, Peng Guan and Hao Fang

Bortezomib and Arsenious Acid Synergistically Inhibit HL-60 Cells Viability in vitro and in vivo

Journal: Current Signal Transduction Therapy
Volume: 9,Issue: 1
Page: 1-8
Authors: Yunbi Fu, Li li, Qixin Sun and Fanyi Meng

A Comprehensive Review on Perfusion Method Development for Bone Marrow Collection and Stem Cell Transplantation

Journal: Current Stem Cell Research & Therapy
Volume: 9,Issue: 6
Page: 522-525
Authors: Narasimhulu Korrapati and Harikrishna Y. Nanganuru

Emergence of Azole Therapy for Cancer Associated Fungal Infections and Their Potential Human Toxicity

Journal: The Natural Products Journal
Volume: 4,Issue: 2
Page: 153-158
Authors: Lesley R. Varughese, Sneha Choubey, Mukesh Yadav and Vikas Beniwal

Clinical Pharmacology of EGFR/Met Inhibitors in Non-Small Cell Lung Cancer

Journal: Current Drug Targets
Volume: 15,Issue: 14
Page: 1263-1272
Authors: Shigehiro Yagishita and Akinobu Hamada

Novel Histone Deacetylase Inhibitors for the Treatment of Pediatric Brain Tumors

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 14,Issue: 2
Page: 90-95
Authors: Pamela V. de Andrade, Augusto F. Andrade, Rosane G. de Paula Queiroz, Felipe A. Trevisan, Luiz G. Tone and Elvis T. Valera

Synthesis and Cytotoxic Properties of Halogen and Aryl-/Heteroarylpiperazinyl Derivatives of Benzofurans

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 1
Page: 115-121
Authors: Mariola Krawiecka, Bozena Kuran, Jerzy Kossakowski, Marcin Cieslak, Julia Kazmierczak- Baranska, Karolina Krolewska and Barbara Nawrot

A Review on the Synthesis and Anti-cancer Activity of 2-substituted Quinolines

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 5
Page: 631-646
Authors: Kaalin Gopaul, Suhas A. Shintre and Neil A. Koorbanally

Novel Self-Inactivating Vectors for Reconstitution of Wiskott-Aldrich Syndrome

Journal: Current Gene Therapy
Volume: 15,Issue: 3
Page: 245-254
Authors: Emanuele G. Coci, Tobias Maetzig, Daniela Zychlinski, Michael Rothe, Julia D. Suerth, Christoph Klein and Axel Schambach

Differential Interactions of Cytochrome P450 3A5 and 3A4 with Chemotherapeutic Agent-Vincristine: A Comparative Molecular Dynamics Study

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 4
Page: 475-483
Authors: Nikhat Saba, Rajabrata Bhuyan, Suman Kumar Nandy and Alpana Seal

Hck Inhibitors as Potential Therapeutic Agents in Cancer and HIV Infection

Journal: Current Medicinal Chemistry
Volume: 22,Issue: 13
Page: 1540-1564
Authors: F. Musumeci, S. Schenone, C. Brullo, A. Desogus, L. Botta and C. Tintori

Synthesis and Cytotoxic Activities of a Curcumin Analogue and Its bis- Mannich Derivatives

Journal: Letters in Drug Design & Discovery
Volume: 12,Issue: 8
Page: 643-649
Authors: Kadir Ozden Yerdelen, Halise Inci Gul, Hiroshi Sakagami, Naoki Umemura and Murat Sukuroglu

Development of Hedgehog Pathway Inhibitors (HPI) in Treatment of Cancer

Journal: Current Chemical Biology
Volume: 8,Issue: 3
Page: 132-148
Authors: Dipankar Pramanik

Targeted Cancer Therapy: The Next Generation of Cancer Treatment

Journal: Current Drug Discovery Technologies
Volume: 12,Issue: 1
Page: 3-20
Authors: Troy A. Baudino

Purine Analogues as Kinase Inhibitors: A Review

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 10,Issue: 3
Page: 308-341
Authors: Sahil Sharma, Samir Mehndiratta, Sunil Kumar, Jagjeet Singh, Preet M.S. Bedi and Kunal Nepali

MicroRNAs in Myeloid Hematological Malignancies

Journal: Current Genomics
Volume: 16,Issue: 5
Page: 336-348
Authors: Maria Ciccone and George Adrian Calin

1,3,4-oxadiazole-2-thione Derivatives; Novel Approach for Anticancer and Tubulin Polymerization Inhibitory Activities

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16,Issue: 2
Page: 269-277
Authors: Mohamed Abdel-Aziz, Kamel A. Metwally, Amira M. Gamal-Eldeen and Omar M. Aly

Drug Design Targeting the CXCR4/CXCR7/CXCL12 Pathway

Journal: Current Topics in Medicinal Chemistry
Volume: 16,Issue: 13
Page: 1441-1451
Authors: Dongsheng Xu, Rongshi Li, Jianguo Wu, Li Jiang and Haizhen A. Zhong

Pharmacophore-Based 3D-QSAR Modeling, Virtual Screening and Molecular Docking Analysis for the Detection of MERTK Inhibitors with Novel Scaffold

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 19,Issue: 1
Page: 73-96
Authors: Suwen Zhou, Lu Zhou, Ruguo Cui, Yahui Tian, Xiaoli Li, Rong You and Liangliang Zhong

Synthesis and Biological Activity of 3-(substitutedphenyl)- 6-(4-methoxyphenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine

Journal: Immunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 16,Issue: 1
Page: 70-80
Authors: Niranjan Kaushik, Nitin Kumar and Anoop Kumar

Clinical Impact of Hypomethylating Agents in the Treatment of Myelodysplastic Syndromes

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 16
Page: 2349-2357
Authors: Carlo Finelli, Matilde Y. Follo, Marta Stanzani, Sarah Parisi, Cristina Clissa, Sara Mongiorgi, Marilena Barraco and Lucio Cocco

Cyclic Peptide Containing Hydrophobic and Positively Charged Residues as a Drug Delivery System for Curcumin

Journal: Current Drug Delivery
Volume: 13,Issue: 3
Page: 409-417
Authors: Amir Nasrolahi Shirazi, Naglaa Salem El-Sayed, Rakesh Kumar Tiwari, Kathy Tavakoli and Keykavous Parang

Induced pluripotent stem cell-derived mesenchymal stem cells: A leap toward personalized therapies.

Journal: Current Stem Cell Research & Therapy
Volume: 11,Issue: 2
Page: 141-148
Authors: Jason Whitt, Krishna C. Vallabhaneni, Patrice Penfornis and Radhika Pochampally

The Interactions Between Diabetes Mellitus and Myelodysplastic Syndromes: Current State of Evidence and Future Directions

Journal: Current Diabetes Reviews
Volume: 12,Issue: 3
Page: 231-239
Authors: Eyad Hamoudeh, Amer M. Zeidan, Lisa Barbarotta and Nina Rosano

Synthesis and Evaluation of Compounds Containing 4-arylpiperazinyl Moieties Linked to a 2-(pyridin-3-yl)-1H-benzimidazole as p38 MAP Kinase Inhibitors

Journal: Letters in Drug Design & Discovery
Volume: 13,Issue: 7
Page: 691-696
Authors: Mohamed Ashraf Ali, Hasnah Osman, Raju Suresh Kumar, Abdulrahman I. Almansour, Natarajan Arumugam, Vijay H. Masand and Theivendren Panneerselvam

Synthesis of Diflunisal Thiazolidinones as Anticancer Agents

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16,Issue: 10
Page: 1266-1274
Authors: Sevil Şenkardeş, Özlem B. Özakpınar, Derya Özsavcı, Azize Şener, Özge Çevik and Ş. Güniz Küçükgüzel

Novel Immunotherapies for Hematological Malignancies

Journal: Current Molecular Pharmacology
Volume: 9,Issue: 3
Page: 264-271
Authors: Monali Vasekar, Syed Rizvi, Xin Liu, Kent E. Vrana and Hong Zheng

Mevalonate Pathway and Human Cancers

Journal: Current Molecular Pharmacology
Volume: 10,Issue: 2
Page: 77-85
Authors: Seyedeh Zahra Bathaie, Mahboobeh Ashrafi, Mahshid Azizian and Fuyuhiko Tamanoi

Anticancer Evaluation of 3,4,5,4'-trans-tetramethoxystilbene (DMU-212) and Its Analogs Against an Extensive Panel of Human Tumor Cell Lines

Journal: Letters in Drug Design & Discovery
Volume: 12,Issue: 7
Page: 521-528
Authors: Nikhil Reddy Madadi and Peter Anthony Crooks

Synthesis and Evaluation of Anticancer Activity of 5-Ylidene-4- Aminothiazol-2(5H)-one Derivatives

Journal: Medicinal Chemistry
Volume: 11,Issue: 6
Page: 517-530
Authors: Danylo Kaminskyy, Ivanna Subtel’na, Borys Zimenkovsky, Olexandr Karpenko, Andrzej Gzella and Roman Lesyk

Genetic and Epigenetic Drug Targets in Myelodysplastic Syndromes

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 1
Page: 135-169
Authors: Karmen Stankov, Suncica Stankov and Jasmina Katanic

Ester of Quinoxaline-7-carboxylate 1,4-di-N-oxide as Apoptosis Inductors in K-562 Cell Line: An in vitro, QSAR and DFT Study

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 5
Page: 682-691
Authors: Gildardo Rivera, Sergio Andrade-Ochoa, Manolo S. Ortega Romero, Isidro Palos, Antonio Monge and Luvia Enid Sanchez-Torres

Hematopoietic Stem Cells Therapies

Journal: Current Stem Cell Research & Therapy
Volume: 12,Issue: 2
Page: 124-133
Authors: Mihaela Chivu-Economescu and Martin Rubach

Purine Nucleoside Analogs as Immunosuppressive and Antineoplastic Agents: Mechanism of Action and Clinical Activity

Journal: Current Medicinal Chemistry
Volume: 13,Issue: 26
Page: 3165-3189
Authors: Tadeusz Robak, Ewa Lech-Maranda, Anna Korycka and Ewa Robak

Retinoids in Cancer Chemoprevention

Journal: Current Cancer Drug Targets
Volume: 4,Issue: 3
Page: 285-298
Authors: Masataka Okuno, Soichi Kojima, Rie Matsushima-Nishiwaki, Hisashi Tsurumi, Yasutoshi Muto, Scott L. Friedman and Hisataka Moriwaki

WT1 as a Novel Target Antigen for Cancer Immunotherapy

Journal: Current Cancer Drug Targets
Volume: 2,Issue: 1
Page: 45-54
Authors: Y. Oka, A. Tsuboi, O. A. Elisseeva, K. Udaka and H. Sugiyama

Rationally Designed Anti-mitotic Agents with Pro-Apoptotic Activity

Journal: Current Pharmaceutical Design
Volume: 7,Issue: 16
Page: 1627-1639
Authors: Fatih M. Uckun

Down-Regulation of Notch1 Expression is Involved in HL-60 Cell Growth Inhibition Induced by 4-Hydroxynonenal, a Product of Lipid Peroxidation

Journal: Medicinal Chemistry
Volume: 4,Issue: 6
Page: 551-557
Authors: Stefania Pizzimenti, Giuseppina Barrera, Elisabetta Calzavara, Leonardo Mirandola, Cristina Toaldo, Mario Umberto Dianzani, Paola Comi and Raffaella Chiaramonte

Editorial (Thematic Issue: “miRNA and Cancer; Computational and Experimental Approaches”)

Journal: Current Pharmaceutical Biotechnology
Volume: 15,Issue: 5
Page: 429-429
Authors: Yusuf Tutar

Establishing Genomic/Transcriptomic Links Between Alzheimer’s Disease and Type 2 Diabetes Mellitus by Meta-Analysis Approach

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 3
Page: 501-516
Authors: Zeenat Mirza, Mohammad A. Kamal, Adel M. buzenadah, Mohammed H. Al-Qahtani and Sajjad Karim

Editorial (Thematic Issue: Advances with microRNAs in Tumorigenesis and Cancer Therapy)

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 33
Page: 5245-5245
Authors: Zhiwei Wang

Design of Peptide-Based Vaccines for Cancer

Journal: Current Medicinal Chemistry
Volume: 13,Issue: 14
Page: 1591-1607
Authors: G. A. Pietersz, D. S. Pouniotis and V. Apostolopoulos

Amplicons as Vaccine Vectors

Journal: Current Gene Therapy
Volume: 6,Issue: 3
Page: 383-392
Authors: Kathlyn Santos, Cindy M.P. Duke and Stephen Dewhurst

EGF-R Small Inhibitors and Anti-EGF-R Antibodies: Advantages and Limits of a New Avenue in Anticancer Therapy

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 1,Issue: 2
Page: 209-222
Authors: Michele Caraglia, Monica Marra, Giusy Meo, Raffaele Addeo, Pierosandro Tagliaferri and Alfredo Budillon

Development of WT1 Peptide Cancer Vaccine Against Hematopoietic Malignancies and Solid Cancers

Journal: Current Medicinal Chemistry
Volume: 13,Issue: 20
Page: 2345-2352
Authors: Y. Oji, H. Sugiyama, I. Kawase, O. A. Elisseeva, H. Nakajima, K. Udaka, M. Kawakami, A. Tsuboi and Y. Oka

Implications of Somatic Mutations in the AML1/RUNX1 Gene in Myelodysplastic Syndrome (MDS): Future Molecular Therapeutic Directions for MDS

Journal: Current Cancer Drug Targets
Volume: 6,Issue: 6
Page: 553-563
Authors: Hironori Harada, Yuka Harada and Akiro Kimura

Current status of Immunotherapy in B Cell Malignancies

Journal: Current Drug Targets
Volume: 7,Issue: 10
Page: 1371-1374
Authors: D. M. Kofler, C. Mayr and C.-M. Wendtner

Interferons: Mechanisms, Biological Activities and Survey of their Use in Human Diseases

Journal: Current Bioactive Compounds
Volume: 2,Issue: 4
Page: 431-444
Authors: Dalia Obeid and Brigitte Bauvois

Mechanisms of Resistance to Imatinib in CML Patients: A Paradigm for the Advantages and Pitfalls of Molecularly Targeted Therapy

Journal: Current Cancer Drug Targets
Volume: 6,Issue: 8
Page: 645-657
Authors: E. Ritchie and G. Nichols

Modulation of the Cell Cycle and Induction of Apoptosis in Human Cancer Cells by Synthetic Bile Acids

Journal: Current Cancer Drug Targets
Volume: 6,Issue: 8
Page: 681-689
Authors: Nam Deuk Kim, Eunok Im, Young Hyun Yoo and Yung Hyun Choi

Characterization of an Etoposide-Glutathione Conjugate Derived from Metabolic Activation by Human Cytochrome P450

Journal: Current Drug Metabolism
Volume: 7,Issue: 8
Page: 897-911
Authors: Naiyu Zheng, Shaokun Pang, Tomoyuki Oe, Carolyn A. Felix, Suzanne Wehrli and Ian A. Blair

Targeting the EGFR Pathway for Cancer Therapy

Journal: Current Medicinal Chemistry
Volume: 13,Issue: 29
Page: 3483-3492
Authors: James B. Johnston, Sri Navaratnam, Marshall W. Pitz, Jerry M. Maniate, Emilia Wiechec, Heinrich Baust, Joel Gingerich, Georgios P. Skliris, Leigh C. Murphy and Marek Los

Gain-of-Function Mutations of Receptor Tyrosine Kinases in Gastrointestinal Stromal Tumors

Journal: Current Genomics
Volume: 7,Issue: 8
Page: 469-475
Authors: K. Isozaki and S. Hirota

Possible Effects of Early Treatments of Hsp90 Inhibitors on Preventing the Evolution of Drug Resistance to Other Anti-Cancer Drugs

Journal: Current Medicinal Chemistry
Volume: 14,Issue: 2
Page: 223-232
Authors: Li Xiao, Parsa Rasouli and Douglas M. Ruden

Haploidentical Stem Cell Transplantation in Childhood

Journal: Current Cancer Therapy Reviews
Volume: 3,Issue: 1
Page: 37-44
Authors: Peter Bader, Andre Willasch, Dietrich Niethammer and Thomas Klingebiel

Design of New Oxazaphosphorine Anticancer Drugs

Journal: Current Pharmaceutical Design
Volume: 13,Issue: 9
Page: 963-978
Authors: Jun Liang, Min Huang, Wei Duan, Xue-Qing Yu and Shufeng Zhou

Interferon: Cellular Executioner or White Knight?

Journal: Current Medicinal Chemistry
Volume: 14,Issue: 12
Page: 1279-1289
Authors: S. G. Maher, A. L. Romero-Weaver, A. J. Scarzello and A. M. Gamero

The Kinase Inhibitor Imatinib - An Immunosuppressive Drug?

Journal: Current Cancer Drug Targets
Volume: 7,Issue: 3
Page: 251-258
Authors: D. Wolf, H. Tilg, H. Rumpold, G. Gastl and A. M. Wolf

Notch Signaling in Normal and Disease States: Possible Therapies Related to Glycosylation

Journal: Current Molecular Medicine
Volume: 7,Issue: 4
Page: 427-445
Authors: Raajit Rampal, Kelvin B. Luther and Robert S. Haltiwanger

Cyclopentenyl Cytosine (CPEC): An Overview of its in vitro and in vivo Activity

Journal: Current Cancer Drug Targets
Volume: 7,Issue: 5
Page: 504-509
Authors: K.J.M. Schimmel, H. Gelderblom and H.J. Guchelaar

Prospects of Embryonic Stem Cells in Treatment of Hematopoietic Disorders

Journal: Current Pharmaceutical Biotechnology
Volume: 8,Issue: 5
Page: 305-317
Authors: Anand S. Srivastava, Rakesh Malhotra, Babak Esmaeli-Azad, Tom Lane and Ewa Carrier

Retroviral Gene Therapy: Safety Issues and Possible Solutions

Journal: Current Gene Therapy
Volume: 5,Issue: 1
Page: 25-35
Authors: Youngsuk Yi, Sung Ho Hahm and Kwan Hee Lee

Antitumor Therapeutic Strategies Based on the Targeting of Epidermal Growth Factor-Induced Survival Pathways

Journal: Current Drug Targets
Volume: 6,Issue: 3
Page: 289-300
Authors: P. Tagliaferri, P. Tassone, S. Blotta, C. Viscomi, F. Grillone, A. Budillon, M. Caraglia and S. Venuta

Chelating Agents Used for Plutonium and Uranium Removal in Radiation Emergency Medicine

Journal: Current Medicinal Chemistry
Volume: 12,Issue: 23
Page: 2765-2770
Authors: Satoshi Fukuda

Beyond Oncolytic Virotherapy: Replication-Competent Retrovirus Vectors for Selective and Stable Transduction of Tumors

Journal: Current Gene Therapy
Volume: 5,Issue: 6
Page: 655-667
Authors: Charlotte Dalba, David Klatzmann, Christopher R. Logg and Noriyuki Kasahara

Src Family Kinases as Regulators of Angiogenesis: Therapeutic Implications

Journal: Current Cancer Therapy Reviews
Volume: 1,Issue: 1
Page: 45-50
Authors: Donald P. Lesslie III and Gary E. Gallick

Changes in the Apoptotic and Survival Signaling in Cancer Cells and Their Potential Therapeutic Implications

Journal: Current Cancer Drug Targets
Volume: 4,Issue: 2
Page: 147-163
Authors: Albert F. Kabore, James B. Johnston and Spencer B. Gibson

Safety Concerns Related to Hematopoietic Stem Cell Gene Transfer Using Retroviral Vectors

Journal: Current Gene Therapy
Volume: 4,Issue: 3
Page: 263-276
Authors: Peter Haviernik and Kevin D. Bunting

Retinoic Acid Metabolism and Mechanism of Action: A Review

Journal: Current Drug Metabolism
Volume: 4,Issue: 1
Page: 1-10
Authors: Julie Marill, Nadia Idres, Claude C. Capron, Eric Nguyen and Guy G. Chabot

Pharmacological Strategies to Increase the Antitumor Activity of Methylating Agents

Journal: Current Medicinal Chemistry
Volume: 9,Issue: 13
Page: 1285-1301
Authors: Lucio Tentori and Grazia Graziani

Monoclonal Antibodies: A New Era in the Treatment of Non-Hodgkins Lymphoma

Journal: Current Pharmaceutical Biotechnology
Volume: 2,Issue: 4
Page: 301-311
Authors: A. J. Grillo-Lopez, B.K. Dallaire, A. McClure, R. Weaver, C. Varns, A. Wei, R. Allen, D. Lee, D. Shen, J. Leonard, P.Multani and C.A.White

Vitamin D Analogs: Mechanism of Action and Therapeutic Applications

Journal: Current Medicinal Chemistry
Volume: 8,Issue: 13
Page: 1661-1679
Authors: Sunil Nagpal, Jianfen Lu and Marcus F. Boehm

Selective Destruction of Tumor Cells through Specific Inhibition of Products Resulting from Chromosomal Translocations

Journal: Current Cancer Drug Targets
Volume: 1,Issue: 2
Page: 109-119
Authors: A. Rodriguez-Garcia, M. Sanchez-Martin, J. Perez-Losada, P. A. Perez-Mancera, A. Sagrera-Aparisi, N. Gutierrez-Cianca, C. Cobaleda and I. Sanchez-Garcia

Inhibitors of Tyrosine Kinases in the Treatment of Psoriasis

Journal: Current Pharmaceutical Design
Volume: 6,Issue: 9
Page: 933-942
Authors: H. Ben-Bassat and B. Y. Klein

Membrane Transporters and Antifungal Drug Resistance

Journal: Current Drug Targets
Volume: 1,Issue: 3
Page: 261-284
Authors: Vassil St. Georgiev

The Multiple Roles of The Transcription Factors MAZ and Pur-1, Two Proteins encoded by Housekeeping Genes

Journal: Current Genomics
Volume: 1,Issue: 2
Page: 175-187
Authors: J. Song, H. Tsutsui, C. Jin, H. Ugai and K. K. Yokoyama

Biological Activities of 19-Nor-1alpha,25-Dihydroxyvitamin D3 Analogs Singly Dehydroxylated at the C-1 or C-3 Position of the A-Ring

Journal: Current Pharmaceutical Design
Volume: 6,Issue: 7
Page: 791-801
Authors: Noboru Kubodera, Toshio Okano, Kimie Nakagawa, Keiichi Ozono and Koichi Mikami

Antitumour Metallocenes: Structure-Activity Studies and Interactions with Biomolecules.

Journal: Current Medicinal Chemistry
Volume: 7,Issue: 12
Page: 1289-1303
Authors: Margaret M. Harding and George Mokdsi

The Ubiquitin-Proteasome System and Proteasome Inhibitors in Central Nervous System Diseases

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 7,Issue: 4
Page: 250-273
Authors: Imtiaz M. Shah and Mario Di Napoli

From Single- to Multi-Target Drugs in Cancer Therapy: When Aspecificity Becomes an Advantage

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 5
Page: 422-432
Authors: S. Giordano and A. Petrelli

Inhibitors of Vascular Endothelial Growth Factor in Cancer

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 6,Issue: 4
Page: 343-347
Authors: Mohammad H. Pourgholami and David L. Morris

2-Chloroadenosine and Human Prostate Cancer Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 8,Issue: 7
Page: 783-789
Authors: I. Bellezza, A. Tucci and A. Minelli

The Gamma Catenin/CBP Complex Maintains Survivin Transcription in β-catenin Deficient/Depleted Cancer Cells

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 2
Page: 213-225
Authors: Y.-M. Kim, H. Ma, V. G. Oehler, E. J. Gang, C. Nguyen, D. Masiello, H. Liu, Y. Zhao, J. Radich and M. Kahn

Cancer Stem Cells in Hematological Disorders: Current and Possible New Therapeutic Approaches

Journal: Current Pharmaceutical Biotechnology
Volume: 12,Issue: 2
Page: 217-225
Authors: C. Annaloro, F. Onida, G. Saporiti and G. Lambertenghi Deliliers

Using Insights into Pim1 Structure to Design New Anticancer Drugs

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 35
Page: 3964-3978
Authors: Silvia Schenone, Cristina Tintori and Maurizio Botta

Naphthalimides and Azonafides as Promising Anti-Cancer Agents

Journal: Current Medicinal Chemistry
Volume: 16,Issue: 10
Page: 1192-1213
Authors: Laurent Ingrassia, Florence Lefranc, Robert Kiss and Tatjana Mijatovic

The Immunomodulatory Role of Angiocidin, a Novel Angiogenesis Inhibitor

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 17
Page: 1937-1948
Authors: A. Gaurnier-Hausser and G. P. Tuszynski

WT1 Peptide Vaccine as a Paradigm for “Cancer Antigen-Derived Peptide”-Based Immunotherapy for Malignancies: Successful Induction of Anti-Cancer Effect by Vaccination with a Single Kind of WT1 Peptide

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 7
Page: 787-797
Authors: Yoshihiro Oka, Akihiro Tsuboi, Fumihiro Fujiki, Zheyu Li, Hiroko Nakajima, Naoki Hosen, Toshiaki Shirakata, Sumiyuki Nishida, Yusuke Oji, Ichiro Kawase and Haruo Sugiyama

The Combination of Conventional Chemotherapy with New Targeted Therapy in Hematologic Malignancies: The Safety and Efficiency of Low- Dose Cytarabine Supports its Combination with New Therapeutic Agents in Early Clinical Trials

Journal: Current Cancer Therapy Reviews
Volume: 5,Issue: 4
Page: 243-255
Authors: Hanne Fredly, Elisabeth Ersvaer, Camilla Stapnes, Bjorn Tore Gjertsen and Oystein Bruserud

Myeloid Malignancies and the Marrow Microenvironment: Some Recent Studies in Patients with MDS

Journal: Current Cancer Therapy Reviews
Volume: 5,Issue: 4
Page: 310-314
Authors: A. Mario Marcondes, Aravind Ramakrishnan and H. Joachim Deeg

Ganoderma lucidum: A Potent Pharmacological Macrofungus

Journal: Current Pharmaceutical Biotechnology
Volume: 10,Issue: 8
Page: 717-742
Authors: Bhagwan S. Sanodiya, Gulab S. Thakur, Rakesh K. Baghel, G. B.K.S. Prasad and P. S. Bisen

Valproic Acid in the Complex Therapy of Malignant Tumors

Journal: Current Drug Targets
Volume: 11,Issue: 3
Page: 361-379
Authors: J. Hrebackova, J. Hrabeta and T. Eckschlager

Cardiotoxicity of Tyrosine-Kinase-Targeting Drugs

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 8,Issue: 1
Page: 11-21
Authors: A. Garcia-Alvarez, X. Garcia-Albeniz, J. Esteve, M. Rovira and X. Bosch

Dexamethasone Synergizes with Lenalidomide to Inhibit Multiple Myeloma Tumor Growth, But Reduces Lenalidomide-Induced Immunomodulation of T and NK Cell Function

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 2
Page: 155-167
Authors: A. K. Gandhi, J. Kang, L. Capone, A. Parton, L. Wu, L. H. Zhang, D. Mendy, A. Lopez-Girona, T. Tran, L. Sapinoso, W. Fang, S. Xu, G. Hampton, J. B. Bartlett and P. Schafer

Germinal and Somatic Trisomy 21 Mosaicism: How Common is it, What are the Implications for Individual Carriers and How Does it Come About?

Journal: Current Genomics
Volume: 11,Issue: 6
Page: 409-419
Authors: Maj A. Hulten, Jon Jonasson, Ann Nordgren and Erik Iwarsson

Current Treatment Concepts of Philadelphia-Negative MPN

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 1
Page: 44-55
Authors: D. Wolf, J. Rudzki and G. Gastl

Dasatinib: An Anti-Tumour Agent via Src Inhibition

Journal: Current Drug Targets
Volume: 12,Issue: 4
Page: 563-578
Authors: Antonio Gnoni, Ilaria Marech, Nicola Silvestris, Angelo Vacca and Vito Lorusso

Chemopreventive Properties and Molecular Mechanisms of the Bioactive Compounds in Hibiscus Sabdariffa Linne

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 8
Page: 1245-1254
Authors: Hui-Hsuan Lin, Jing-Hsien Chen and Chau-Jong Wang

Promotion of Apoptosis in Cancer Cells by Selective Purine-Derived Pharmacological CDK Inhibitors: One Outcome, Many Mechanisms

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 3
Page: 256-271
Authors: Jozefa Wasierska-Gadek and Margarita Maurer

The Ubiquitin+Proteasome Protein Degradation Pathway as a Therapeutic Strategy in the Treatment of Solid Tumor Malignancies

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11,Issue: 2
Page: 242-246
Authors: James J. Driscoll, Alex Minter, Daniel A. Driscoll and Jason K. Burris

Kinase Regulation by Sulfur and Selenium Containing Compounds

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 4
Page: 496-523
Authors: C. Sanmartin, D. Plano, M. Font and J. A. Palop

Role of the Hypoxic Microenvironment in the Antitumor Activity of Tyrosine Kinase Inhibitors

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 19
Page: 2885-2892
Authors: I. Filippi, A. Naldini and F. Carraro

Development of Novel Therapeutics Targeting the Urokinase Plasminogen Activator Receptor (uPAR) and Their Translation Toward the Clinic

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 19
Page: 1970-1978
Authors: Andrew P. Mazar, Richard W. Ahn and Thomas V. O'Halloran

Cytogenetic and Molecular Abnormalities in Myelodysplastic Syndrome

Journal: Current Molecular Medicine
Volume: 11,Issue: 8
Page: 678-685
Authors: H. Nagoshi, S. Horiike, J. Kuroda and M. Taniwaki

The Impact of Folate Status on the Efficacy of Colorectal Cancer Treatment

Journal: Current Drug Metabolism
Volume: 12,Issue: 10
Page: 975-984
Authors: Letizia Porcelli, Yehuda G. Assaraf, Amalia Azzariti, Angelo Paradiso, Gerrit Jansen and Godefridus J. Peters

Effects of BCR-ABL Inhibitors on Anti-Tumor Immunity

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 34
Page: 5174-5184
Authors: M. Krusch and H. R. Salih

Modulating Mesenchymal Stromal Cell Function with Cholesterol Synthesis Inhibitors

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 34
Page: 5196-5205
Authors: A. Poggi and M. R. Zocchi

The Hsp32 Inhibitors SMA-ZnPP and PEG-ZnPP Exert Major Growth-Inhibitory Effects on CD34+/CD38+ and CD34+/CD38- AML Progenitor Cells

Journal: Current Cancer Drug Targets
Volume: 12,Issue: 1
Page: 51-63
Authors: H. Herrmann, M. Kneidinger, S. Cerny-Reiterer, T. Rulicke, M. Willmann, K. V. Gleixner, K. Blatt, G. Hormann, B. Peter, P. Samorapoompichit, W. Pickl, G. Y. Bharate, M. Mayerhofer, W. R. Sperr, H. Maeda and P. Valent

Evaluation of the Cytotoxic and Pro-Apoptotic Activities of Eu(III) Complexes with Appended DNA Intercalators in a Panel of Human Malignant Cell Lines

Journal: Medicinal Chemistry
Volume: 2,Issue: 5
Page: 439-445
Authors: Georgi Momekov, Todor Deligeorgiev, Aleksey Vasilev, Kalina Peneva, Spiro Konstantinov and Margarita Karaivanova

Clinical Significance of Thiopurine S-Methyltransferase Gene Polymorphisms

Journal: Current Pharmacogenomics
Volume: 5,Issue: 2
Page: 103-115
Authors: Shu-Feng Zhou and Balram Chowbay

A Cationic Liposomal Vincristine Formulation with Improved Vincristine Retention, Extended Circulation Lifetime and Increased Anti-Tumor Activity

Journal: Letters in Drug Design & Discovery
Volume: 4,Issue: 6
Page: 426-433
Authors: Murray S. Webb, Nancy L. Boman, Dana Masin, Donald Yapp, Euan Ramsay, Gigi N.C. Chiu, Pieter R. Cullis and Marcel B. Bally

Forodesine (BCX-1777, Immucillin H) - A New Purine Nucleoside Analogue: Mechanism of Action and Potential Clinical Application

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7,Issue: 9
Page: 976-983
Authors: Anna Korycka, Jerzy Z. Blonski and Tadeusz Robak

Farnesyltransferase Inhibitors: Overview of their Action and Role in Solid Malignancy Therapy

Journal: Letters in Drug Design & Discovery
Volume: 2,Issue: 1
Page: 26-35
Authors: Stefano Margaritora, Alfredo Cesario, Venanzio Porziella, Pierluigi Granone, Alessia Catassi and Patrizia Russo

Ring-Expanded (“Fat”) Nucleosides as Broad-Spectrum Anticancer and Antiviral Agents

Journal: Current Topics in Medicinal Chemistry
Volume: 2,Issue: 10
Page: 1093-1109
Authors: Ramachandra S. Hosmane

Structural Development of Biological Response Modifiers Based on Retinoids and Thalidomide

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 2,Issue: 6
Page: 543-551
Authors: Yuichi Hashimoto


Self-Renewal Versus Differentiation in Hematopoietic Stem and Progenitor Cells: A Focus on Asymmetric Cell Divisions

Journal: Current Stem Cell Research & Therapy
Volume: 3,Issue: 1
Page: 9-16
Authors: Bernd Giebel and Ingmar Bruns

Inhibitors of ABL and the ABL-T315I Mutation

Journal: Current Topics in Medicinal Chemistry
Volume: 8,Issue: 10
Page: 905-921
Authors: Glenn Noronha, Jianguo Cao, Chun P. Chow, Elena Dneprovskaia, Richard M. Fine, John Hood, Xinshan Kang, Boris Klebansky, Dan Lohse, Chi Ching Mak, Andrew McPherson, Moorthy S.S. Palanki, Ved P. Pathak, Joel Renick, Richard Soll and Binqi Zeng

Use of the Non-Toxic Cryoprotectant Trehalose Enhances Recovery and Function of Fish Embryonic Stem Cells Following Cryogenic Storage

Journal: Current Stem Cell Research & Therapy
Volume: 3,Issue: 4
Page: 277-287
Authors: Surjya N. Dash, Padmanav Routray, Chidananda Dash, Bhikari C. Guru, Priyabrat Swain and Niranjan Sarangi

Hemopoiesis in Ph-Negative Chronic Myeloproliferative Disorders

Journal: Current Stem Cell Research & Therapy
Volume: 4,Issue: 2
Page: 154-160
Authors: Emmanouil Spanoudakis and Costas Tsatalas

On the Synthesis and Anticancer Testing of α,β-Unsaturated Ketones as Analogs of Combretastatin-A4

Journal: Letters in Drug Design & Discovery
Volume: 6,Issue: 7
Page: 531-537
Authors: Sameer Chavda, Ryan Davis, Amanda Ferguson, Camille Riddering, Kristin Dittenhafer, Hilary Mackay, Balaji Babu, Moses Lee, Adam Siegfried, William Pennington, Miriam Shadfan, Susan L. Mooberry, Bijay K. Mishra and Hari N. Pati

Oxidative Stress-Induced Caspases are Regulated in Human Myeloid HL-60 Cells by Calcium Signal

Journal: Current Signal Transduction Therapy
Volume: 5,Issue: 2
Page: 181-186
Authors: D. Gonzalez, I. Bejarano, C. Barriga, A.B. Rodriguez and J.A. Pariente

Posaconazole: A New Antifungal Weapon

Journal: Reviews on Recent Clinical Trials
Volume: 6,Issue: 3
Page: 204-219
Authors: Georgios Aperis and Polichronis Alivanis

4-Aryl-4H-Chromene-3-Carbonitrile Derivatives: Evaluation of Src Kinase Inhibitory and Anticancer Activities

Journal: Medicinal Chemistry
Volume: 7,Issue: 5
Page: 466-472
Authors: Asal Fallah-Tafti, Rakesh Tiwari, Amir Nasrolahi Shirazi, Tahmineh Akbarzadeh, Deendayal Mandal, Abbas Shafiee, Keykavous Parang and Alireza Foroumadi

In Silico Identification and Analysis of Drug Resistant Mutants of ABL Tyrosine Kinase Based on Detrimental Missense Mutations

Journal: Current Signal Transduction Therapy
Volume: 6,Issue: 3
Page: 396-404
Authors: R. Rajasekaran, C. George Priya Doss, G. Arun Prasad and Rao Sethumadhavan

Structure, Substrate Complexation and Reaction Mechanism of Bacterial Asparaginases

Journal: Current Chemical Biology
Volume: 1,Issue: 1
Page: 75-86
Authors: Mario Sanches, Sandra Krauchenco and Igor Polikarpov

Development of Cancer Vaccine Targeting WT1 Product which is Expressed in Various Kinds of Malignant Neoplasms

Journal: Medicinal Chemistry Reviews - Online (Discontinued)
Volume: 2,Issue: 6
Page: 447-454
Authors: Y. Oka, A. Tsuboi, O. A. Elisseeva, H. Nakajima, Y. Oji and H. Sugiyama

Etoposide, Topoisomerase II and Cancer

Journal: Current Medicinal Chemistry-Anti-Cancer Agents
Volume: 5,Issue: 4
Page: 363-372
Authors: E. L. Baldwin and N. Osheroff

In Vitro and In Vivo Sirolimus for Modulation of Allogeneic Hematopoietic Stem Cell Transplantation

Journal: Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents
Volume: 5,Issue: 6
Page: 555-564
Authors: Daniel H. Fowler and Ronald E. Gress

Farnesylated Proteins as Anticancer Drug Targets: From Laboratory to the Clinic

Journal: Current Medicinal Chemistry-Anti-Cancer Agents
Volume: 4,Issue: 2
Page: 123-138
Authors: Patrizia Russo, Maura Loprevite, Alfredo Cesario and Andrea Ardizzoni

Interleukin-2 Immunotherapy and AIDS-Related Cytomegalovirus Retinitis

Journal: Current HIV Research
Volume: 2,Issue: 4
Page: 333-342
Authors: Richard D. Dix and Scott W. Cousins

Multidrug Resistance in Cancer Chemotherapy and Xenobiotic Protection Mediated by the Half ATP-Binding Cassette Transporter ABCG2

Journal: Current Medicinal Chemistry-Anti-Cancer Agents
Volume: 4,Issue: 1
Page: 31-42
Authors: B. Han and J.- T. Zhang

The Interaction of Histone Deacetylase Inhibitors and DNA Methyltransferase Inhibitors in the Treatment of Human Cancer Cells

Journal: Current Medicinal Chemistry-Anti-Cancer Agents
Volume: 3,Issue: 3
Page: 187-199
Authors: Wei-Guo Zhu and Gregory A. Otterson

Apoptosis Induced by Topoisomerase Inhibitors

Journal: Current Medicinal Chemistry-Anti-Cancer Agents
Volume: 3,Issue: 4
Page: 271-290
Authors: Olivier Sordet, Qasim A. Khan, Kurt W. Kohn and Yves Pommier

IL-6 and Crohns Disease

Journal: Current Drug Target -Inflammation & Allergy
Volume: 2,Issue: 2
Page: 125-130
Authors: Hiroaki Ito

Recombinant Adenovirus-mediated Cytotoxic Gene Therapy and Lymphoproliferative Disorders: Analysis Based on Pharmacodynamics

Journal: Current Drug Target - Immune, Endocrine & Metabolic Disorders
Volume: 2,Issue: 2
Page: 109-118
Authors: Francesco Turturro

Targeted α-Particle Therapy: A Clinical Overview

Journal: Current Radiopharmaceuticals
Volume: 1,Issue: 3
Page: 251-253
Authors: Massimo Salvatori, Luca Indovina and Luigi Mansi

Detecting Growing Mammary Tumors with Monoclonal Antibodies Against Vascular Endothelial Growth Factor Receptor – 3

Journal: Current Radiopharmaceuticals
Volume: 3,Issue: 1
Page: 60-65
Authors: Paivi Karnani, Kalevi Kairemo and Ilari Paakkari

Interrelationships Between HIV/AIDS and Risk Behavior Prejudice Among Medical Students in Southern China

Journal: Current HIV Research
Volume: 7,Issue: 6
Page: 606-611
Authors: Kit Yee Chan, Yi Yang, Ze-rong Li, Mark A. Stoove and Daniel D. Reidpath

Differential Phosphoproteome Analysis of K562 Cells Exposed to 3-Azido- 3-Deoxythymidine (AZT)

Journal: Current Proteomics
Volume: 9,Issue: 1
Page: 40-54
Authors: Gabriele D'Andrea, Sara Venditti, Laura Di Francesco, Valerio Bernabei, M. Eugenia Schinina and Argante Bozzi

Genomics and Cancer Drug Resistance

Journal: Current Pharmaceutical Biotechnology
Volume: 13,Issue: 5
Page: 651-673
Authors: Antonio S. Rodrigues, Joana Dinis, Marta Gromicho, Celia Martins, Antonio Laires and Jose Rueff

Targeting the Cancer Initiating Cell: The Ultimate Target for Cancer Therapy

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 13
Page: 1784-1795
Authors: James A. McCubrey, Linda S. Steelman, Stephen L. Abrams, Negin Misaghian, William H. Chappell, Jorg Basecke, Ferdinando Nicoletti, Massimo Libra, Giovanni Ligresti, Francac Stivala, Danijela Maksimovic-Ivanic, Sanja Mijatovic, Giuseppeo Montalto, Melchiorre Cervello, Piotr Laidler, Antonio Bonati, Camilla Evangelisti, Lucio Cocco and Alberto M. Martelli

Cancer Stem Cells and Novel Targets for Antitumor Strategies

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 19
Page: 2838-2849
Authors: Gerald J. Prud’homme

Spinophilin: A New Tumor Suppressor at 17q21

Journal: Current Molecular Medicine
Volume: 12,Issue: 5
Page: 528-535
Authors: A. Carnero

Anticancer Effects of the Organosilicon Multidrug Resistance Modulator SILA 421

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12,Issue: 6
Page: 663-671
Authors: Ulrike Olszewski, Robert Zeillinger, Meltem Demirel Kars, Attila Zalatnai, Jozsef Molnar and Gerhard Hamilton

Cyclin-Dependent Kinase Inhibition by Flavoalkaloids

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 12,Issue: 7
Page: 632-649
Authors: S. K. Jain, S. B. Bharate and R. A. Vishwakarma

Conformationally Constrained Peptides as Protein Tyrosine Kinase Inhibitors

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 20
Page: 2852-2866
Authors: Rakesh K. Tiwari and Keykavous Parang

Immunosuppressive Therapy for Myelodysplastic Syndromes

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 22
Page: 3184-3189
Authors: Christiane Dobbelstein and Arnold Ganser

Approach to New Therapeutics: Investigation by the Use of MDS-derived Cell Lines

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 22
Page: 3204-3214
Authors: Takayuki Tsujioka, Akihito Matsuoka, Yumi Tohyama and Kaoru Tohyama

Novel Therapeutic Approaches to Regulate Human Dihydrofolate Reductase Activity and Expression

Journal: Current Enzyme Inhibition
Volume: 8,Issue: 2
Page: 107-117
Authors: Emine Ercikan Abali, Hilal Celikkaya, Yi-Ching Hsieh, Debabrata Banerjee and Joseph R. Bertino

Significance of Genome-Wide Analysis of Copy Number Alterations and UPD in Myelodysplastic Syndromes using Combined CGH – SNP Arrays

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 22
Page: 3739-3747
Authors: Ausaf Ahmad and M. Anwar Iqbal

Removal of the Tag from His-tagged ILYd4, a Human CD59 Inhibitor, Significantly Improves its Physical Properties and its Activity

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 27
Page: 4187-4196
Authors: Lin Wu, Sanbao Su, Fengming Liu, Tao Xu, Xiaoxiao Wang, Yan Huang, Xinlu Sun, Xiaowen Ge, Ting Chen, Huixia Liu, Chun Wang, Michael Chorev, Ting Xu and Xuebin Qin

On the Power of Additional and Complex Chromosomal Aberrations in CML

Journal: Current Genomics
Volume: 13,Issue: 6
Page: 471-476
Authors: Karin M. Greulich-Bode and Barbara Heinze

Immune Therapy of Multiple Sclerosis - Future Strategies

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 29
Page: 4489-4497
Authors: Sven G. Meuth, Kerstin Gobel and Heinz Wiendl

The Nuclear Orphan Receptors NR4A as Therapeutic Target in Cancer Therapy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12,Issue: 9
Page: 1001-1014
Authors: Alexander J. A. Deutsch, Hannes Angerer, Tamara E. Fuchs and Peter Neumeister

Microwave Assisted Synthesis, Characterization of Some New Isatin and Thiophene Derivatives as Cytotoxic and Chemopreventive Agents

Journal: Letters in Drug Design & Discovery
Volume: 9,Issue: 10
Page: 934-941
Authors: Kiran Gangarapu, Sarangapani Manda, Sreekanth Thota, Rajeshwar Yerra, Subhas S. Karki, Jan Balzarini, Erik De Clercq and Harukuni Tokuda

Anti-cancer and Other Bioactivities of Korean Angelica gigas Nakai (AGN) and Its Major Pyranocoumarin Compounds

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12,Issue: 10
Page: 1239-1254
Authors: Jinhui Zhang, Li Li, Cheng Jiang, Chengguo Xing, Sung-Hoon Kim and Junxuan Lu

Differential Involvement of Myosin II and VI in the Spontaneous and SDF- 1-induced Migration of Adult CD133+ Hematopoietic Stem/Progenitor Cells and Leukemic Cells

Journal: Current Cancer Therapy Reviews
Volume: 8,Issue: 4
Page: 283-292
Authors: Jbireal M. Ali Jbireal, Thomas Dittmar, Bernd Niggemann, Johannes Fischer and Frank Entschladen

Epigenetic Mismatches with Mutated Transcribing Genes at Leukemogenic S-Phase Binding/Start Sites – Potential Targets for Therapy with Enzyme Inhibitors

Journal: Current Stem Cell Research & Therapy
Volume: 7,Issue: 6
Page: 420-429
Authors: Gregor Prindull

Human Skin-Derived Fibroblasts Acquire In Vitro Anti-Tumor Potential after Priming with Paclitaxel

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 3
Page: 523-530
Authors: Augusto Pessina, Valentina Cocce, Arianna Bonomi, Loredana Cavicchini, Francesca Sisto, Maura Ferrari, Emilio Ciusani, Stefania Navone, Giovanni Marfia, Eugenio Parati and Giulio Alessandri

Molecular Mechanism of Anti-tumor Effect by Triptolide in Hematological Malignancies

Journal: Current Signal Transduction Therapy
Volume: 8,Issue: 1
Page: 84-90
Authors: Youping Wang and Yan Chen

Exposure and Genotoxicity Assessment Methodologies - The Case of Formaldehyde Occupational Exposure

Journal: Current Analytical Chemistry
Volume: 9,Issue: 3
Page: 476-484
Authors: Susana Viegas, Carina Ladeira, Mario Gomes, Carla Nunes, Miguel Brito and Joao Prista

TRAIL-Based Therapeutic Approaches for the Treatment of Pediatric Malignancies

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 17
Page: 2254-2271
Authors: C. Gasparini, L. Vecchi Brumatti, L. Monasta and G. Zauli

A Novel High Throughput 1536-Well Notch1 γ -Secretase AlphaLISA Assay

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 16,Issue: 6
Page: 415-424
Authors: De-Ming Chau, David Shum, Constantin Radu, Bhavneet Bhinder, David Gin, M. Lane Gilchrist, Hakim Djaballah and Yue-Ming Li

How Recent Advances in High-risk Myelodysplastic Syndrome Physiopathology May Impact Future Treatments

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 30
Page: 5362-5373
Authors: Thomas Cluzeau, Guillaume Robert, Arnaud Jacquel and Patrick Auberger

Significance of Prion and Prion-Like Proteins in Cancer Development, Progression and Multi-Drug Resistance

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 8
Page: 895-904
Authors: Caroline Hinton, Helma Antony, Saeed M. Hashimi, Alan Munn and Ming Q. Wei

Synthesis, Characterization, Antimycobacterial and Anticancer Evaluation of New 1,2,4-Triazole Derivatives

Journal: Letters in Drug Design & Discovery
Volume: 11,Issue: 3
Page: 290-296
Authors: G. Cihan-Ustundag, B. Simsek, E. Ilhan and G. Capan

Double-Edged Effects of Arsenic Compounds: Anticancer and Carcinogenic Effects

Journal: Current Drug Metabolism
Volume: 14,Issue: 10
Page: 1029-1041
Authors: Kanwal Rehman and Hua Naranmandura

Synthesis of 2,5-Disubstituted-1,3,4-oxadiazole Analogs as Novel Anticancer and Antimicrobial Agents

Journal: Letters in Drug Design & Discovery
Volume: 11,Issue: 4
Page: 413-419
Authors: Mohamed Jawed Ahsan, Jyotika Sharma, Sandeep Bhatia, Pramod Kumar Goyal, Kailash Shankhala and Mukand Didel

Apoptosis Induction by Erucylphosphohomocholine via the 18 kDa Mitochondrial Translocator Protein: Implications for Cancer Treatment

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 4
Page: 559-577
Authors: Leo Veenman, Moshe Gavish and Wilfried Kugler

Synthesis and In Vitro Antiproliferative Activity of Thiazole-Based Nitrogen Mustards: The Hydrogen Bonding Interaction between Model Systems and Nucleobases

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 9
Page: 1271-1281
Authors: Krzysztof Z. Laczkowski, Konrad Misiura, Marta Switalska, Joanna Wietrzyk, Angelika Baranowska Laczkowska, Berta Fernandez, Agata Paneth and Tomasz Plech

New Potent and Selective Inhibitor of Pim-1/3 Protein Kinases Sensitizes Human Colon Carcinoma Cells to Doxorubicin

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 9
Page: 1228-1236
Authors: Pascale Moreau, Lyubov G. Dezhenkova, Fabrice Anizon, Lionel Nauton, Vincent Thery, Shuguang Liang, Dmitry N. Kaluzhny and Alexander A. Shtil

Mechanism-based Combinations with Pim Kinase Inhibitors in Cancer Treatments

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 42
Page: 6670-6681
Authors: Qingshan Yang, Lisa S. Chen and Varsha Gandhi

Strategic Role of Nuclear Inositide Signalling in Myelodysplastic Syndromes Therapy

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 14,Issue: 11
Page: 873-883
Authors: Lucia Manzoli, Sara Mongiorgi, Cristina Clissa, Carlo Finelli, Anna Maria Billi, Alessandro Poli, Marilisa Quaranta, Lucio Cocco and Matilde Y. Follo

Gene Expression Analysis Approach to Establish Possible Links Between Parkinson's Disease, Cancer and Cardiovascular Diseases

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 8
Page: 1334-1345
Authors: Sajjad Karim, Zeenat Mirza, Mohammad A. Kamal, Adel M. Abuzenadah and Mohammed H. Al-Qahtani


The Nuclear Orphan Receptor NR4A1 and NR4A3 as Tumor Suppressors in Hematologic Neoplasms

Journal: Current Drug Targets
Volume: 16,Issue: 1
Page: 38-46
Authors: Kerstin Wenzl, Katharina Troppan, Peter Neumeister and Alexander J.A. Deutsch

Cancer Stem Cells: The ‘Achilles Heel’ of Chemo-Resistant Tumors

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 10,Issue: 1
Page: 2-22
Authors: In-Sun Hong, Hwa-Yong Lee and Jeong-Seok Nam

5-Lipoxygenase and Cyclooxygenase Inhibitory Dammarane Triterpenoid 1 from Borassus flabellifer Seed Coat Inhibits Tumor Necrosis Factor-α Secretion in LPSInduced THP-1 Human Monocytes and Induces Apoptosis in MIA PaCa-2 Pancreatic Cancer Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 8
Page: 1066-1077
Authors: Nagendra Sastry Yarla, Rajaram Azad, Mahaboob Basha, Abdul Rajack, D. S. V. G. K. Kaladhar, Bharat Kumar Allam, Rajeswara Rao. Pragada, Krishna Nand Singh, Sunanda Kumari K, Reddanna Pallu, Umadevi Parimi, Anupam Bishayee and Govinda Rao. Duddukuri

Dual Inhibition of Cdc7 and Cdk9 by PHA-767491 Suppresses Hepatocarcinoma Synergistically with 5-Fluorouracil

Journal: Current Cancer Drug Targets
Volume: 15,Issue: 3
Page: 196-204
Authors: Wei Li, Xiao-Le Zhao, Shi-Qiang Shang, Hong-Qiang Shen and Xi Chen

Prognostic Value and Clinicopathological Differences of Bmi1 in Gastric Cancer: A Meta-analysis

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16,Issue: 4
Page: 407-413
Authors: Bin Yuan, Hong Zhao, Xiaofeng Xue, Jin Zhou, Xu Wang, Ye Han, Lifeng Zhang, Xiaobo Guo and Qiaoming Zhi

Emerging Role and Targeting of Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 (CEACAM6) in Human Malignancies

Journal: Clinical Cancer Drugs
Volume: 2,Issue: 2
Page: 100-111
Authors: Benny Johnson and Daruka Mahadevan

The Function and Regulation of BMP6 in Various Kinds of Stem Cells

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 25
Page: 3634-3643
Authors: Ruinan Shen, Ruobing Jia, Wenjie Liu, Qisheng Lin, Yanan Hai and Zuping He

Cyanobacteria as a Source for Novel Anti-Leukemic Compounds

Journal: Current Pharmaceutical Biotechnology
Volume: 17,Issue: 1
Page: 78-91
Authors: Anu Humisto, Lars Herfindal, Jouni Jokela, Antti Karkman, Ronja Bjørnstad, Romi R. Choudhury and Kaarina Sivonen

Pyrazolopyrimidine Derivatives as Antineoplastic Agents: with a Special Focus on Thyroid Cancer

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 16,Issue: 2
Page: 86-93
Authors: Silvia Martina Ferrari, Concettina La Motta, Stefania Sartini, Enke Baldini, Gabriele Materazzi, Ugo Politti, Ilaria Ruffilli, Salvatore Ulisse, Paolo Miccoli, Alessandro Antonelli and Poupak Fallahi

Organ Preference of Cancer Metastasis and Metastasis-Related Cell Adhesion Molecules Including Carbohydrates

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 15,Issue: 3
Page: 164-186
Authors: Takanori Kawaguchi

Thiarabine, 1-(4-Thio-β-D-arabinofuranosyl)cytosine. A Deoxycytidine Analog With Excellent Anticancer Activity

Journal: Current Medicinal Chemistry
Volume: 22,Issue: 34
Page: 3881-3896
Authors: W.B. Parker, W.R. Waud and J.A. Secrist III

Gene Microarray Analyses of Daboia russelli russelli Daboiatoxin Treatment of THP-1 Human Macrophages Infected with Burkholderia pseudomallei.

Journal: Current Molecular Medicine
Volume: 15,Issue: 10
Page: 961-974
Authors: R. Perumal Samy, J. Manikandan, A. Pachiappan, E.E. Ooi, L.T. Aw, B.G. Stiles, O.L. Franco, M. Kandasamy, K.M. Mathi, G. Rane, K.S. Siveen, C. Arunachalam, M.E. Zayed, S.A. Alharbi, A.P. Kumar, G. Sethi, L.H.K. Lim and V.T. Chow

A “Double-Edged” Scaffold: Antitumor Power within the Antibacterial Quinolone

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 6
Page: 520-577
Authors: Gregory S. Bisacchi and Michael R. Hale

Current Understanding of HSP90 as a Novel Therapeutic Target: An Emerging Approach for the Treatment of Cancer

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 20
Page: 2947-2959
Authors: Absarul Haque, Qamre Alam, Mohammad Zubair Alam, Esam I. Azhar, Khalid Hussain Wali Sait, Nisrin Anfinan, Gohar Mushtaq, Mohammad Amjad Kamal and Mahmood Rasool

Design Strategies, Structures and Molecular Interactions of Small Molecule Src Inhibitors

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16,Issue: 8
Page: 992-1002
Authors: Sureyya Olgen

Phytochemicals as Adjunctive with Conventional Anticancer Therapies

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 27
Page: 4201-4218
Authors: Mohammad Hosein Farzaei, Roodabeh Bahramsoltani and Roja Rahimi

Interferon-Related Depression: A Primer on Mechanisms, Treatment, and Prevention of a Common Clinical Problem

Journal: Current Neuropharmacology
Volume: 14,Issue: 7
Page: 743-748
Authors: Ekta Franscina Pinto and Chittaranjan Andrade

Assessment of Adverse Drug Reaction Due to Cancer Chemotherapy in a Teaching Oncology Hospital in Isfahan, Central of Iran

Journal: Reviews on Recent Clinical Trials
Volume: 11,Issue: 3
Page: 266-272
Authors: Golnaz Vaseghi, Alireza Abed, Elham Jafari, Neda Eslami and Azadeh Eshraghi

A Novel Monocyte-based Pyrogen Test Based on the Mechanism of Human Fever Reaction

Journal: Current Pharmaceutical Analysis
Volume: 12,Issue: 3
Page: 227-233
Authors: Can Wang, Shanshan Dong, Hongbo Zhao, Ziqiang Wang, Qin Zhou, Lihong Wu, Hong Shao and Gang Chen

IT-143, A Polymer Micelle Nanoparticle, Widens Therapeutic Window of Daunorubicin

Journal: Pharmaceutical Nanotechnology
Volume: 4,Issue: 1
Page: 3-15
Authors: Tara Lee Costich, Adam Carie, J. Edward Semple, Brad Sullivan, Tomas Vojkovsky, Tyler Ellis, Taylor Buley, Suzanne Bakewell and Kevin Sill

Gene Therapy in Fanconi Anemia: A Matter of Time, Safety and Gene Transfer Tool Efficiency

Journal: Current Gene Therapy
Volume: 16,Issue: 5
Page: 297-308
Authors: Els Verhoeyen, Francisco Jose Roman-Rodriguez, Francois-Loic Cosset, Camille Levy and Paula Rio

Role of Inflammation-Associated Microenvironment in Tumorigenesis and Metastasis

Journal: Current Cancer Drug Targets
Volume: 14,Issue: 1
Page: 30-45
Authors: Feng Gao, Bin Liang, Srinivasa T. Reddy, Robin Farias-Eisner and Xiulan Su

Benzodiazepine Scaffold as Drug-like Molecular Simplification of FR235222: A Chemical Tool for Exploring HDAC Inhibition

Journal: Current Topics in Medicinal Chemistry
Volume: 17,Issue: 4
Page: 441-459
Authors: Rosario Randino, Ilaria Moronese, Elena Cini, Valentina Bizzarro, Marco Persico, Manuela Grimaldi, Mario Scrima, Anna Maria D`Ursi, Ettore Novellino, Eduardo Sobarzo-Sánchez, Luca Rastrelli, Caterina Fattorusso, Antonello Petrella, Manuela Rodriquez and Maurizio Taddei

HTLV-1 Associated Neurological Disorders

Journal: Current Topics in Medicinal Chemistry
Volume: 17,Issue: 12
Page: 1320-1330
Authors: Muhammad Yasir Khan, Ishaq Nasib Khan, Muhammad Farman, Saleh Al Karim, Ishtiaq Qadri, Muhammad Amjad Kamal, Khalid Al Ghamdi and Steve Harakeh

Discovery of Potent Bruton’s Tyrosine Kinase Inhibitors Using Ligand Based Modeling

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 2
Page: 265-275
Authors: Wafa A. Mera, Malek Alzihlif, Mutasem O. Taha and Mohammad A. Khanfar

Non Coding RNAs: A New Avenue for the Self-Tailoring of Blood Cancer Treatment

Journal: Current Drug Targets
Volume: 18,Issue: 1
Page: 35-55
Authors: Gabriella Misso, Mayra Rachele Zarone, Anna Grimaldi, Maria Teresa Di Martino, Angela Lombardi, Hiromichi Kawasaki, Paola Stiuso, Pierfrancesco Tassone, Pierosandro Tagliaferri and Michele Caraglia

Development of a Predictive Pharmacophore Model and a 3D-QSAR Study for an in silico Screening of New Potent Bcr-Abl Kinase Inhibitors

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 17,Issue: 3
Page: 188-204
Authors: Eleni Vrontaki, Georgia Melagraki, Stella Voskou, Marios S. Phylactides, Thomas Mavromoustakos, Marina Kleanthous and Antreas Afantitis

Nano Conjugated PLGA-Chlorambucil: Synthesis In Vitro Anti Non- Hodgkin's Lymphoma Cellular Assay

Journal: Letters in Drug Design & Discovery
Volume: 14,Issue: 7
Page: 827-836
Authors: Saeed Akbarian, Jafar Sojoodi, Fatemeh Monnavari, Hossein Heidari, Pegah Khosravian, Hamid A. Javar, Artin Assadi, Rahimeh Rasouli, Mostafa Saffari, Seyed A.S. Shandiz, Hadi Hejazinia, Farnoor D. Omoomi, Mohammad Saffari and Mehdi S. Ardestani

CD20-based Immunotherapy of B-cell Derived Hematologic Malignancies

Journal: Current Cancer Drug Targets
Volume: 17,Issue: 5
Page: 423-444
Authors: Dariush Shanehbandi, Jafar Majidi, Tohid Kazemi, Behzad Baradaran and Leili Aghebati-Maleki

Reactive Oxygen and Nitrogen Species in Carcinogenesis: Implications of Oxidative Stress on the Progression and Development of Several Cancer Types

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 17,Issue: 11
Page: 904-919
Authors: Joanna Kruk and Hassan Y. Aboul-Enein

ATRA Entrapped in DSPC Liposome Enhances Anti-metastasis Effect on Lung and Liver During B16F10 Cell Line Metastasis in C57BL6 Mice

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 6
Page: 875-884
Authors: Reshma Mahima Reji, Siddikuzzaman and Berlin Grace V.M

Insight to Pharmacokinetics of TKIs: Optimizing Practical Guidelines for Individualized Therapy

Journal: Current Drug Metabolism
Volume: 18,Issue: 3
Page: 199-206
Authors: Ruiqing Wang, Chaoqin Zhong, Chen Zhang, Mingqiang Hua and Daoxin Ma

Biosynthesis and Biological Activities of In Vitro Derived Solasodine Glycoalkaloids from Solanum laciniatum

Journal: The Natural Products Journal
Volume: 7,Issue: 3
Page: 199-207
Authors: Hanan Abd Al-Hay Al-Ashaal

In Vitro Sensitivity Profiling of Neuroblastoma Cells Against A Comprehensive Small Molecule Kinase Inhibitor Library to Identify Agents for Future Therapeutic Studies

Journal: Current Cancer Drug Targets
Volume: 17,Issue: 6
Page: 569-584
Authors: Anjali Singh, Vanessa Meier-Stephenson, Aarthi Jayanthan and Aru Narendran

In Vitro Anticancer Evaluation of Platinum(II/IV) Complexes with Diisoamyl Ester of (S,S)-ethylenediamine-N,N’-di-2-propanoic Acid

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 8
Page: 1136-1143
Authors: Bojana B. Zmejkovski, Nebojša Pantelić, Lana Filipović, Sandra Aranđelović, Siniša Radulović, Tibor J. Sabo and Goran N. Kaluđerović

Demonstration of Biological and Immunological Equivalence of a Generic Glatiramer Acetate

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16,Issue: 6
Page: 714-723
Authors: Josephine D`Alessandro, Kevin Garofalo, Ganlin Zhao, Christopher Honan, Jay Duffner, Ishan Capila, Ian Fier, Ganesh Kaundinya, Daniel Kantor and Tanmoy Ganguly

Enhanced Risk for Specific Somatic Myeloproliferative Neoplastic Mutations in Patients with Stroke

Journal: Current Neurovascular Research
Volume: 14,Issue: 3
Page: 222-231
Authors: Chih-Cheng Chen, Chia-Chen Hsu, Cih-En Huang, Yi-Yang Chen, Jrhau Lung, Hsing-Ying Ho, Chian-Pei Li and Jiann-Der Lee

Protodioscin, Isolated from the Rhizome of Dioscorea tokoro Collected in Northern Japan is the Major Antiproliferative Compound to HL-60 Leukemic Cells

Journal: Current Bioactive Compounds
Volume: 13,Issue: 2
Page: 170-174
Authors: Manami Oyama, Tetsuo Tokiwano, Satoru Kawaii, Yasunori Yoshida, Kouichi Mizuno, Keimei Oh and Yuko Yoshizawa

Molecularly Targeted Therapy for Gastrointestinal Cancer

Journal: Current Cancer Drug Targets
Volume: 5,Issue: 3
Page: 171-193
Authors: Marcus W. Wiedmann and Karel Caca

Antitumor Properties of Podophyllotoxin and Related Compounds

Journal: Current Pharmaceutical Design
Volume: 6,Issue: 18
Page: 1811-1839
Authors: M. Gordaliza, M. A. Castro, J. M. Miguel del Corral and A. San Feliciano

Influence of Enzyme-Inducing Antiepileptic Drugs on Trough Level of Imatinib in Glioblastoma Patients

Journal: Current Clinical Pharmacology
Volume: 3,Issue: 3
Page: 198-203
Authors: Stefan Pursche, Eberhard Schleyer, Malte von Bonin, Gerhard Ehninger, Samir Mustafa Said, Roland Prondzinsky, Thomas Illmer, Yanfeng Wang, Christian Hosius, Zariana Nikolova, Martin Bornhauser and Gregor Dresemann

Formulation Optimization of Etoposide Loaded PLGA Nanoparticles by Double Factorial Design and their Evaluation

Journal: Current Drug Delivery
Volume: 7,Issue: 1
Page: 51-64
Authors: Khushwant S. Yadav and Krutika K. Sawant

Function and Malfunction of Hematopoietic Stem Cells in Primary Bone Marrow Failure Syndromes

Journal: Current Stem Cell Research & Therapy
Volume: 2,Issue: 1
Page: 39-52
Authors: Antonio M. Risitano, Jaroslaw P. Maciejewski, Carmine Selleri, Bruno Rotoli, Antonio M. Risitano and Jaroslaw P. Maciejewski

Should the Status of the Pathway Mediated by BRCA1 and BRCA2 be Evaluated Before Selecting Cancer Chemotherapy Drugs?

Journal: Current Pharmacogenomics
Volume: 5,Issue: 4
Page: 280-291
Authors: Bernard Friedenson

Histamine as a Potential Adjuvant to Immuno and Radiotherapy for Cancer Treatment: Discovering New Functions for the Oldest Biogenic Amine

Journal: Current Immunology Reviews
Volume: 6,Issue: 4
Page: 357-370
Authors: Vanina A. Medina and Elena S. Rivera

Antineoplastic Activities, Apoptotic Mechanism of Action and Structural Properties of a Novel Silver(I) Chelate

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 18
Page: 2363-2373
Authors: Kareem I. Batarseh

Farnesyltransferase Inhibitors: A Comprehensive Review Based on Quantitative Structural Analysis

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 38
Page: 4888-4923
Authors: N. S.H.N. Moorthy, S. F. Sousa, M. J. Ramos and P. A. Fernandes

Synthesis, Antioxidant, Anticancer and Antiviral Activities of Novel Quinoxaline Hydrazone Derivatives and their Acyclic C-Nucleosides

Journal: Medicinal Chemistry
Volume: 10,Issue: 5
Page: 521-532
Authors: Alaa A. El-Tombary and Soad A.M. El-Hawash

Cellomics as Integrative Omics for Cancer

Journal: Current Proteomics
Volume: 10,Issue: 3
Page: 237-245
Authors: Daniel Boda

Statins and Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 5
Page: 706-712
Authors: Natalia G. Vallianou, Alexandra Kostantinou, Marios Kougias and Christos Kazazis

Na+/K+ ATPase Inhibitors in Cancer

Journal: Current Drug Targets
Volume: 15,Issue: 10
Page: 988-1000
Authors: Konstantinos Alevizopoulos, Theodora Calogeropoulou, Florian Lang and Christos Stournaras

Anticancer Antifolates: Current Status and Future Directions

Journal: Current Pharmaceutical Design
Volume: 9,Issue: 31
Page: 2593-2613
Authors: John J. McGuire

Molecule of the Month

Journal: Current Topics in Medicinal Chemistry
Volume: 7,Issue: 17
Page: 1753-1753
Authors: Kirk L. Stevens

MEET THE GUEST EDITOR [Hot Topic: Modern Omics-Based Platform for High Throughput Screening for Novel Drug Targets (Part 2) (Guest Editor: Canhua Huang)]

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 15,Issue: 4
Page: 338-338
Authors: Canhua Huang

Results 1 - 791 of 791